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Abstract  
There is substantial evidence from cellular, animal and epidemiological studies in 
support of a role for calcium, and in particular, dairy foods in the regulation of 
weight (McCarron, 1983; Davies et al.  2000; Heaney, 2003a; Jacqmain et al.  2003; 
Parikh & Yanovski, 2003; Soares et al.  2004a; Azadbakht et al.  2005). These 
studies suggest, but do not provide, a causal link between increased calcium intake 
and reduced adiposity. In contrast, randomised controlled trails (RCT) are limited 
and their outcomes, to date, are conflicting in their findings (Zemel et al.  2004b; 
Harvey-Berino et al.  2005; Thompson et al.  2005; Zemel et al.  2005a; 2005b).  The 
primary mechanism involves the control of intracellular calcium by calcitrophic 
hormones, vitamin D3 and PTH. It is proposed that a higher calcium intake lowers 
the calcitrophic hormones, thus reducing intracellular calcium and attenuating lipid 
storage (Zemel et al.  2000). Other flow through effects may include the greater 
utilisation of fat as a fuel source, increased thermogenesis, increased fat excretion, 
improved satiety and reduced food intake.  (Melanson et al.  2003; Sun & Zemel, 
2004; Boon et al.  2005a; Gunther et al.  2005b; Jacobsen et al.  2005b; Melanson et 
al.  2006).  
 
In this thesis we demonstrate that the acute ingestion of calcium, increased 
postprandial fat oxidation in overweight and obese humans. The results were 
consistent between the two sources of calcium tested (dairy and calcium citrate). 
Circulating levels of non-esterified fatty acids (NEFA) were less suppressed, while 
glycerol tended to be higher following both high calcium meals (Cummings et al.  
2006).  There was no evidence of a modulation of subjective feelings of hunger, or 
satiety, nor immediate food intake (buffet) or 24 hour food intake. A prolongation of 
the inter-meal interval was however observed in subjects consuming the high 
calcium meals.   
 
A single-blind 12 week RCT, with a 12 week wash out period, compared two energy 
restricted (ER) diets either high (HC 1200 mg/d) or low in calcium (LD 600 mg/d). 
Forty overweight/obese male and female subjects were recruited for the study with 
29 subjects completing both arms of the study. Anthropometric data and body 
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composition from DEXA were measured before, during and following each diet.  
There was no difference between the diets in the loss of body weight, total fat mass 
or trunk fat mass. A greater reduction in waist circumference of 1.23 cm was 
observed when subjects had consumed the HC diet; this however was just short of 
significance (P=0.052). There was a smaller reduction of resting energy expenditure 
on the hypocaloric HC diet with a trend for a greater fat oxidation at week 10 of 
intervention. No differences were observed between the treatment groups for fasting 
levels of glucose, insulin, Hba1c, LDL-C, HDL-C or TC. We also found an inverse 
relationship between resting metabolic rate at the start of ER and body fat lost when 
subjects consumed the LC diet, but not the HC diet.  This is a novel finding in that it 
would be expected to see an inverse relationship between initial RMR and the 
amount of fat lost; however, the HC diet seems to achieve the same fat loss as the LC 
diet by taking away the effect of initial body size/composition.    
 
Overall, the ingestion of a single meal containing 500 mg of dietary and elemental 
calcium has some benefits for the obese individual. Six hours post-prandially fat 
oxidation is stimulated following the consumption of the dietary and elemental 
calcium breakfast meals. During a 12-week weight loss period, a higher calcium 
intake did not result in a greater weight loss compared to a low calcium diet.  The 
HC diet did result in a trend for a greater reduction in waist circumference; however, 
this did not transcribe into an increased loss of total or regional body fat.  
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Chapter 1: Literature Review   
  1.1 Introduction 
Australia is in the grip of an epidemic of obesity and the figures are forecast to rise 
(Ball & Crawford, 2003; The National Obesity Taskforce, 2003). This increase in the 
prevalence of obesity is leading to an explosion of other significant diseases, namely, 
Type-2 diabetes, cardiovascular disease, insulin resistance, non-alcoholic fatty liver, 
hypertension and some cancers (breast, endometrial and colon cancer).  These 
increases in obesity rates are causing considerable financial and functional strain on 
the public health system.  Coincidently, more than 50% of the adult Australian 
population are not achieving the recommended dietary intake (RDI) for calcium.  
Whether calcium intake is linked to body weight regulation and hence obesity, is the 
mainstay of this thesis. Currently, there is strong epidemiological evidence for the 
role of calcium, and in particular dairy calcium, in the regulation of body weight.  
However, evidence from clinical trials is still inconclusive. The backbone of this 
PhD thesis is a novel approach to combating obesity, insulin resistance and 
dyslipidemia, through the increased use of dairy calcium.  While the underlying 
principles of this program are based on the results of cellular, animal and 
retrospective epidemiological data, we address our hypothesis through prospective 
clinical trials.     
 
The observational statements which have provided the foundation for this PhD 
proposal are that:  
 (1) The incidence of adult obesity, glucose tolerance and dyslipidemia is high 
 in the Australian population;  
 (2) simultaneously the dietary intake of calcium is below the RDI;  
 (3) low calcium intakes elevate circulating concentrations of the calcitrophic 
 hormones, parathyroid hormone and 1,25 Dihydroxyvitamin D3;  
 (4) calcitrophic hormones elevate intracellular calcium;  
 (5) high intracellular calcium (Ca2+) directs the flow of dietary fat towards 
 storage rather than oxidation; 
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 (6) an increase in dairy calcium leads to a lower activity of fatty acid synthase 
 (FAS) and enhances lipolysis;  
 (7) calcium is thermogenic.    
 
Collectively, the above arguments lead to the following hypothesis.  
1.1.1 Hypothesis  
Dairy calcium will promote weight loss through increased thermogenesis and 
increased oxidation of ingested fat.  This will result in improved glucose tolerance 
and decreased fasting and postprandial lipemia.  
 
To address this hypothesis, the specific objectives of this PhD proposal are as 
follows:  
 
1.1.1.1 Objectives 
(1) To study the acute (meal related) effects of dairy calcium and pharmaceutical 
calcium on postprandial thermogenesis, substrate oxidation and lipemia in 
overweight and obese adults.  
 
(2) To determine the chronic (dietary) effects of dairy calcium on body composition 
and fat distribution in overweight and obese adults.  
1.2 An Overview of Calcium  
1.2.1 The Role of Calcium in the Body  
Calcium is a divalent cation with an atomic weight of 40 and an equivalent weight of 
20 (Nordin, 1997).  Calcium is the fifth ranked element, behind oxygen, carbon, 
hydrogen, and nitrogen and it makes up 1.9% of the body by weight. Nearly all of the 
body calcium (99%) is in the skeleton; the remainder is in the teeth (0.6%), the soft 
tissue (0.6%), the plasma (0.03%) and the extra-vascular fluid (0.06%). Thus body 
calcium may be regarded as being distributed in three compartments:  firstly in the 
skeleton were it constitutes 25% of dry weight, the extracellular fluid (ECF) where 
the concentration of ionised calcium is maintained by the parathyroid / vitamin D 
 Chapter 1: Literature Review  
3
system within the range 1.15-1.25 mmol/L (equivalent to a total plasma calcium of 
2.30 to 2.50 mmol/L). Thirdly, in the cellular compartment, where the total calcium 
concentration is comparable to that in the extracellular fluid but the free calcium 
concentration is ~10-4 mmol/L  (Favus, 1999).  
 
1.2.1.1 The Functions of Calcium  
The primary function of calcium in the body is to provide human skeleton rigidity, 
this is provided in the form of calcium phosphate, known generally as hydroxyapatite 
(Ca10(OH)2(PO4)6), which is embedded in the collagen fibrils.  The extracellular 
calcium constitutes a pool into which calcium enters from the gut, by absorption, and 
from the bone, by resorption.  It leaves via the gastrointestinal tract, the kidneys, the 
skin, and into the bone for bone formation. Calcium balance in the human body is 
rather complex.   Figure 1.1 gives a simplified diagram of the fate of a calcium intake 
of 800 mg. Only about 300 mg of calcium is absorbed whilst the remaining 500 mg 
is excreted in the faeces.  The calcium that is absorbed into the blood interacts with 
the current body stores, the result being the excretion of 300 mg through the 
intestines, kidneys, and sweat to balance the amount originally absorbed. Many 
neuromuscular and other cellular functions depend on the maintenance of the ionised 
calcium concentration in the ECF. Intracellular calcium has many functions, from 
muscle contraction, including the heart, skeletal muscle, and smooth muscle found in 
the blood vessels. Calcium also activates a number of enzymes; and plays a central 
role in both the synthesis and breakdown of muscle glycogen and liver glycogen; 
helps regulate nerve impulse transmission and blood clotting.  Calcium fluxes are 
important mediators of hormonal effects on target organs through the 
phosphoinositol system and are closely linked with the cyclic AMP systems. The 
intracellular calcium concentration is regulated by a calcium pump, which eliminates 
any calcium which may flow in by diffusion (Nordin, 1997). 
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Figure 1:1 Calcium balance in an adult requiring only 800 mg per day.  
See text for discussion (Williams, 2002).  
 
 
1.2.2 Absorption of calcium   
Absorbability or the availability of calcium for absorption by the intestines is often 
used interchangeably with bioavailability.  However, bioavailability depends on 
absorbability and the incorporation of absorbed calcium into bone.  Hence, it also 
depends on the urinary excretion and faecal loss of endogenous calcium (Guéguen & 
Pointillart, 2000).  As for intestinal absorption of calcium, physiological factors and 
in particular hormones, play a major role in the incorporation of calcium into bone. 
Certain types of foods, namely phosphorous increase the likelihood that calcium will 
be absorbed into bone, whereas, others (sulphate, chloride, chelators, excess sodium 
or protein) increase its excretion in urine.  The bioavailability of calcium may 
therefore be defined as “the fraction of dietary calcium that is potentially absorbable 
by the intestine and can be used for physiological functions, particularly bone 
mineralisation, or to limit bone loss” (Guéguen & Pointillart, 2000).    
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1.2.2.1 Intestinal Absorption  
Calcium must be in a soluble form, generally ionised (Ca2+), at least in the upper 
small intestine or bound to a soluble organic molecule before it can cross the wall of 
the intestine.   Absorption is the result of two processes, active transport across cells, 
mainly in the duodenum and the upper jejunum, and passive diffusion, which occurs 
throughout the small intestine, but mainly in the ileum and very little in the large 
intestine.  
1.2.2.1.1  Active transport  
The active transport system for calcium is saturable and regulated by dietary intake 
and the needs of the body. Active transport involves three stages, which are: entry 
across the brush border of the enterocyte, diffusion across the cytoplasm and 
secretion across the basolateral membrane into the extracellular liquid (Bronner, 
2003).  Calcium enters the cell via a positive electrochemical gradient because the 
calcium concentration in the cytoplasm is very low.  Calcium crosses the membrane 
via calcium channels and via membrane-binding transport proteins (calmodulin and 
membrane calcium-binding proteins).  Calcium may be stored transiently in Golgi 
apparatus, endoplasmic reticulum or mitochondria, but then crosses the cytoplasm 
attached to a calcium binding protein (CaBP or calbindin-D 9K), which is the rate-
limiting factor in active calcium transport. Calcium ions are extruded from the cell 
against an electrochemical gradient by two routes; a small fraction leaves by 
exchanging 3 Na+ for 2 Ca2+, but most leaves via a calcium pump, a Ca-ATPase 
activated by calcium, CaBP and calmodulin.   
 
Vitamin D plays a pivotal part in the active transport of calcium. The active form is 
1,25 dihydroxycholecalciferol (1,25(OH)2D3) or calcitriol), which is produced by 
two hydroxylations of vitamin D. The most significant role of calcitriol is its control 
of the expression of the gene encoding CaBP, causing the synthesis of the protein, 
thereby regulating the migration of calcium across intestinal cells. Calcitriol also has 
a liponomic action, increasing membrane permeability and activating the Ca-ATPase  
(Bronner & Pansu, 1999). Calcitriol acts like a hormone and its renal production is 
regulated by parathyroid hormone (PTH), the secretion of which is stimulated by a 
fall in plasma calcium levels. The PTH-calcitriol system is also involved in bone 
resorption and increases the reabsorption of calcium by the renal tubule. This 
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hormone system therefore controls all the calcium that enters the extracellular pool 
of exchangeable calcium and ensures that the plasma calcium concentration varies 
little from 100 mg/L.  Some of the membrane and cystolic proteins involved in 
calcium transport are not vitamin-D-dependent, one such protein is calmodulin.  
 
Figure 1:2 The Metabolism of Vitamin D3  
Vitamin D3 (cholecalciferol) is formed in the skin by the action of ultraviolet rays in sunlight on 7-
dehydrocholesterol. Vitamin D3 is converted into its biologically active forms, 25-
hydroxycholecalciferol in the liver and into its most active form 1,25 dihydroxycholecalciferol, or 
calcitriol in the kidney (Mahan & Arlin, 1992). 
 
1.2.2.1.2 Passive diffusion  
Passive absorption down an electrochemical gradient occurs via intercellular 
junctions or spaces. It involves the mass movement of water and major solutes, such 
as glucose and sodium. This diffusion is not saturable and therefore increases with 
dietary intake, providing that the calcium is in a soluble form.  Any dietary 
component that keeps calcium in a soluble form or keeps it in solution within the 
ileum would stimulate passive diffusion.  Several molecules can do this namely, 
casein, the amino acids, L-lysine and L-arginine, and lactose. Other dietary factors 
that make calcium irreversibly insoluble by converting it into forms such as 
phosphates, oxalates, phytates and soaps, prevent passive absorption in the ileum.   
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Of great importance is the fact that when dietary calcium intake is low, active 
transcellular calcium transport in the duodenum is up-regulated and a larger 
proportion of calcium is absorbed by the active process than by the passive 
paracellular process, that occurs in the jejunum and ileum (Bronner & Pansu, 2000).  
In contrast to this, when the dietary intake of calcium is high, passive diffusion is the 
main transport mechanism, as down-regulation of active transport occurs.  Because 
of the variability of calcium intakes on absorption levels, Heaney developed the 
“fractional absorption rate”. The fractional absorption rate is highly inversely 
correlated with the logarithm of the calcium load (P<0.001). Hence, the equation can 
be used to predict the actual amount of calcium that will be absorbed from a food 
product (Heaney et al. 1990).  For example; a calcium load of 200 mg would result 
in an absorption rate of 41% and hence, 82 mg of calcium would be absorbed by the 
body.  
Figure 1:3 Absorption Rate Equation  
 
Absorptive fraction (%) = 1.105 – 0.131 lnload + 0.095     
 
 
1.2.2.1.3 Dietary & other factors influencing intestinal absorption  
It is essential that the relative calcium bioavailability from the diet is studied, as it 
has been shown that there is a wide range of absorbance levels between individuals. 
One study by Wolf and associates (2000) indicated that in 142 pre- and 
perimenopausal women, calcium absorption values averaged 35% and ranged from 
17 to 58%. Fractional calcium absorption was positively associated with body mass 
index, dietary fat intake, serum 1,25 dihydroxyvitamin D concentrations and 
parathyroid hormone concentrations, whilst being inversely related to dietary fibre 
intake, total calcium intake, alcohol intake and symptoms of constipation.    
 
More recently, calcium absorptive efficiency has been singled out as being the cause 
of the variability in calcium balance, rather than actual calcium intake itself.  There 
are a number of factors that can affect the absorption rate in a person. Some 
components of the diet can influence the availability of calcium for absorption and 
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the absorption mechanism itself. Some substances can form insoluble complexes 
with calcium, such as the phosphate ion.  However, the dietary phosphorous/calcium 
ratio has to be very high (>3:1), and the phosphorous has to be in an inorganic form 
to significantly affect the absorption of calcium.  Most dietary phosphorous is in 
animal protein and hence not available for combination with calcium.  Other 
elements available in the diet may interfere with calcium absorption, such as phytates 
found in high fibre containing products; bran and most cereals and seeds, oxalates 
(found in spinach, rhubarb) and tannins (tea) can form insoluble complexes with 
calcium, thereby reducing its absorbability.  However, it has been argued that 
phytates may not be that harmful to calcium absorption as they may be hydrolysed 
by phytases in the small intestine (Nordin, 1997).   Calcium absorption has been 
reported to be improved by lactose. The mechanism for this relationship is not well 
understood, but may relate to calcium availability in the lumen or to transit time.    
 
Vitamin D deficiency arising from the lack of exposure to sunlight or any other cause 
lowers the serum calcidiol level which ultimately lowers the calcitriol level (despite 
secondary hyperparathyroidism).  This leads to malabsorption of calcium and, if 
severe and prolonged, to osteomalacia.  This is probably from the loss of a direct 
effect of vitamin D on the calcification process.  More recently a number of studies 
have indicated a relationship between body size and calcium absorption. In cross-
sectional data of 315 girls, aged 5-15 years, overall height was significantly related to 
calcium absorption (corrected for calcium intake, age, Tanner stage and ethnicity) 
(P=0.001). In a similar vein, height-z score was significantly related to calcium 
absorption (P<0.007) (Abrams et al. 2005). In fact Barger-Lux & Heaney (2005), 
state that the magnitude of calcium absorption is determined by body size, such that a 
women 1.8 m in height would absorb 30+% more calcium from a given intake than a 
women 1.4 m tall.   
 
Other factors that can affect adult calcium absorption include age, intestinal 
transition time and oestrogen status. (Heaney et al. 1989; Barger-Lux et al. 1995b).   
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1.2.3 Intake of Dairy Products  
Dairy products account for over 50% of ingested calcium for men and women in 
Australia (Table 1:1) (McLennan & Podger, 1998).  There appears to be a large 
variation in calcium intake amongst nations; however, this is dependent largely on 
their dairy product consumption. In general, it is difficult to achieve dietary calcium 
recommendations without consuming dairy products.  Milk and other dairy products 
contribute substantially to the intake of other micronutrients, namely, phosphorous, 
riboflavin, niacin, vitamin B6 and B12, potassium, zinc, magnesium and vitamin A. 
Full fat dairy products will also naturally contain some vitamin D; the amount will 
vary depending on the season of milk production. In the United States there is 
mandatory fortification of milk and butter/margarine products and voluntary 
fortification of other foods with vitamin D; however, Australia only has a limited 
number of fortified milk products.     
 
Table 1:1 Proportion of calcium intake from commonly eaten foods  
(McLennan & Podger, 1998).  
 Males  
- 19 years and over (%) 
Females 
- 19 years and over (%) 
Milk products and dishes 51.6 53.0 
Dairy milk 29.2 31.5 
Yogurt 2.0 3.7 
Cheese 12.1 11.5 
Frozen milk 
products 
3.0 2.1 
Other dishes where 
milk or a milk 
product is a major 
component 
1.4 1.6 
Flavoured milks 3.3 1.7 
Other – cereal and cereals 13.5 12.3 
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1.2.3.1 Bioavailability of calcium: Supplements versus Dairy  
It appears that there is a wide range of variation between the bioavailability of 
calcium from different calcium preparations. A randomised crossover study of 25 
postmenopausal women  demonstrated a greater bioavailability from a single dose of 
calcium citrate taken with a standard breakfast meal, compared to a calcium 
carbonate supplement (Heller et al. 2000).  This finding has been confirmed in a 
meta-analysis by Sakhaee et al. comprising a data set of 15 studies involving 184 
subjects, the comparison was made between the absorbance of calcium carbonate and 
calcium citrate (1999). This study concluded that calcium citrate is better absorbed 
than calcium carbonate by approximately 22% to 27%, either on an empty stomach 
or co-administered with meals.  Studies seem to imply that it is the greater solubility 
of calcium citrate that results in a greater availability (Levenson & Bockman, 1994).   
 
However, a number of other studies demonstrate no difference in the bioavailability 
between calcium citrate and carbonate. One study found an equivalent calcium 
bioavailability in elderly subjects when 3 high-calcium dietary sources were 
compared.  The sources were orange juice fortified with calcium-citrate malate, skim 
milk, and a calcium carbonate supplement (Martini & Wood, 2002). The comparison 
of these calcium preparations was undertaken in 12 subjects (9 women and 3 men, 
age 70 + 3 and 76 + 6 years) and the acute response to a breakfast meal measured 
over a 4-hour period.  Heaney et al.(2001) study in 24 postmenopausal women, 
similarly, did not find a difference between the same two supplemental preparations.  
These two studies used the measures of rise in serum calcium, increase in urinary 
calcium excretion and suppression of ionised PTH, as a marker of greater 
bioavailability.  Furthermore, Heaney et al. in an earlier study using tracer methods, 
along with calcium supplements at high and low loads, failed to show any difference 
in absorption when taken with food (Heaney et al. 1999). This finding was confirmed 
in an 8-way crossover designed study in 10 postmenopausal women, given a range of 
calcium preparations.  This study failed to find any difference in absorption, when 
measured using the gold standard of dual labelled stable isotope technique (Brink et 
al. 2003).     
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Studies tend to confirm that milk and dairy products have a very similar calcium 
absorption rate compared to calcium supplements (Sibtain Sheikh et al. 1987; 
Guéguen & Pointillart, 2000).  It is generally well accepted that milk and milk 
products are by far the main source of calcium in our diet.  Cow’s milk contains on 
average 1200 mg calcium per one litre.  Of this 20% is bound to casein as an 
inorganic colloid, the remaining 80% is in the mineral form of tri-calcium phosphate 
and phospho-caseinate. The organic or mineral calcium bound to casein is readily 
released during digestion, and therefore its bioavailability is regarded as high 
(Guéguen & Pointillart, 2000).  Milk has additional interesting features, when 
compared to other food sources or supplements. Because it is bound to peptides and 
proteins, milk calcium is more likely to remain in solution when the pH is 
unfavorable, such as achlorhydria.  Milk calcium may also be absorbed in the 
absence of vitamin D, but under the influence of lactose. This can occur in the distal 
small intestine via passive diffusion. Dairy products also lack inhibitors of the 
absorption of calcium, such as phytates and oxalates.  
 
1.2.4 Intake of Dietary Calcium in Australia  
The Australian and New Zealand Nutrient Reference Values (NRVs) (National 
Health and Medical Research Council, 2004) have set the RDIs for calcium intake at 
1000 mg/day for men (19-70 years) and women (19-50 years); and 1300 mg/day for 
men >70 years and women >50 years. Data based on the 1995 National Nutrition 
Survey demonstrated that the mean daily calcium intake for males 19-64 years, males 
64 years and over, females 19-64, and females 64 years and over was, 946, 796, 749 
and 686 mg/day, (McLennan & Podger, 1998). Alarmingly, these figures indicate 
that over 65% of the adult population is not achieving the recommended intake for 
calcium. Low calcium intake can be linked to a reduction of milk consumption 
patterns and an increase in soft drink consumption (Huth et al. 2006), along with the 
belief that milk is fattening (Radak, 2004; Dwyer et al. 2005).    
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  1.3 Obesity: Prevalence and Pathogenesis  
1.3.1 Introduction  
The epidemic of obesity, and its co-morbidities of dyslipidemia, insulin resistance, 
hypertension and cardiovascular disease, is now a global problem. The prevalence of 
obesity in Australia is rapidly rising; in males aged 25-64 years the percentage of 
men who are obese rose from 9 to 17% from 1980 until 2001. Within the same age 
group the prevalence of women who are obese has doubled, from 8 to 20% (Dixon & 
Waters, 2003). Alarmingly, at this rate it is predicted that by 2025, 30-40% of the 
Australian population will be obese (International Obesity Taskforce 2003).  The 
prevalence of overweight is also staggeringly high with 48% of men and 30% of 
women being overweight (National Health and Medical Research Council, 1997).  
Obesity is considered to be one of the most significant public health burdens and is 
estimated to cost the state 1.3 billion dollars annually (The National Obesity 
Taskforce, 2003). The treatment of obesity-related coronary heart disease and 
hypertension contribute about 60 per cent of the cost of obesity.  
 
With the growth in the prevalence of obesity is the increased availability of different 
types of diets and weight loss strategies to overcome this problem.  Although the 
studies are small in number and subject size, it seems that 30-50% of women and 
~40% of men, had dieted to lose weight in the previous year (Vogels et al. 2005). 
The most common method employed is increased exercise and reduced energy 
intake; however, ~20% of female dieters reported to using potentially dangerous 
techniques (including slimming tablets, laxatives, cigarette smoking).  The long-term 
success of weight loss is poor, and with this lack of long-term success comes an 
increase in the use of pharmacological preparations, including appetite suppressants 
and intestinal lipase inhibitors. However, these drugs are not without side-effects and 
so there is continued effort to find effective and above all safe therapies to tackle the 
obesity problem.   
 
The role of macronutrients and weight management has been widely studied 
(Wilkinson & McCargar, 2004; Astrup, 2005; Gumbs et al. 2005; Johnston, 2005; 
Keller & Rastalsky, 2005; Manco & Mingrone, 2005; Schoeller & Buchholz, 2005; 
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Tangney et al. 2005); however, the role of micronutrients has not until recently been 
investigated.  The interest in dietary calcium has arisen from a range of 
epidemiological, animal and more recently human clinical studies.  Heaney (2002) 
states that the increased consumption of calcium could have a significant effect on 
the management of obesity; in fact he predicts that an increase of 300 mg to 
recommended calcium intakes could be associated with a 1 kilogram reduction in 
body fat in children and 2.5-3 kilogram lower body weight in adults, leading to a 
70% reduction in total overweight/obesity. If an increase in dairy and/or calcium 
intake is successful in its goal of aiding fat loss, it could become one of the safest and 
simplest ways to combat obesity. Interest is therefore high in the potential role of 
calcium and /or dairy in the regulation of body weight.    
 
1.3.2 The Regulation of Body Weight in Humans  
There is evidence that the obese population have impaired fat oxidation and this may 
be a primary event in the aetiology of obesity (Blaak & Saris, 2002).  As man exists 
in a post-absorptive state for most of the day, this research is interested in looking at 
the postprandial events as they pertain to thermogenesis, and the use of different 
nutrients as a fuel source.  Weight and body energy content remains quite stable in 
most adults for long periods of time, despite fluctuations in energy intake and energy 
expenditure (Jéquier & Tappy, 1999). To enable this balance to be maintained many 
regulatory processes must be involved. Some of the proposed models for energy 
balance include the set point theory, glucostatic controls of feedings, metabolic 
nutrient-partitioning, adipose tissue signalling and behavioural models (Flatt, 1995a). 
However, in all these approaches, genetics, the environment and psychosocial factors 
cannot be ignored.   
 
1.3.3 Postprandial metabolism and nutrient partitioning 
The maintenance of a constant body weight and body composition requires that 
energy and nutrient balances are achieved. The reasoning behind this comes from the 
fact that the three macronutrients (carbohydrate, protein and fat) are either oxidised 
or stored in their own compartment. The inter conversion of nutrients for storage 
does not represent important metabolic pathways (Flatt, 1988).     
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Energy balance is determined by the macronutrient intake, energy expenditure and 
partitioning in nutrient storage.  Protein and carbohydrate intakes elicit powerful 
autoregulatory adjustments in protein and carbohydrate oxidation, while fat balance 
is less accurately regulated and more easily disrupted (Martinez, 2000).  Most 
individuals reach a state of approximate weight maintenance in which the average 
composition of the fuels they oxidise matches the energy nutrient distribution in their 
diets. It was found that subjects having a higher 24-hour respiratory quotient (i.e. 
those tending to burn more glucose than fat) were at a higher risk of weight gain 
during subsequent years.  It would hence follow that obesity could be avoided if one 
oxidised as much fat as was ingested.  As a corollary, obesity may be a feature of 
those unable to increase their fat oxidation to match fat (Blaak & Saris, 2002).  In 
studies by Marques-Lopez et al. (1998) lean and obese subjects were fed two diets of 
differing macronutrient content. The lean subjects showed a greater glucose 
oxidation and thermogenesis following the high carbohydrate diet compared to the 
high fat diet. However, the obese subjects were less efficient in oxidising fat on the 
high fat diet, and showed de novo lipogenesis whilst on the high carbohydrate diet. 
Thus the postprandial matching of substrate oxidation to the mix of macronutrients in 
the diet plays a crucial role in the short and long term regulation of weight. Unlike 
glycogen and protein stores, fat stores are not tightly regulated in the short term, i.e. 
an increased fat intake does not lead to an equivalent increase in fat oxidation 
(Swinburn & Ravussin, 1993). Instead, an increased intake of fat can lead to a 
positive fat balance, expanding fat stores, and leading to increased adiposity over 
time. An increased capacity to oxidise fatty acids is of significant value as it may 
help maintain fat balance when excess fat is ingested.    
 
1.3.4 Fat balance: a key process in body weight regulation 
Most epidemiological studies show a positive association between fat intake and 
body weight (Lissner & Heitmann, 1995). The fuel mix oxidised may also influence 
body weight regulation.  In certain groups of sedentary individuals, high insulin 
sensitivity was associated with subsequent weight gain; these subjects also have a 
higher mean 24 hour respiratory quotient indicating an increased carbohydrate 
oxidation and a reduced fat oxidation rate. Thus both the excess intake of fat and the 
reduced rate of fat oxidation have a profound effect on the development of obesity. 
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Therefore mechanisms controlling fat oxidation are of great importance in the 
context of body weight regulation.   
 
The rate of glucose and fatty acid oxidation is dependent on their respective 
availability.  More than 30 years ago Randle et al. proposed the concept of the 
“glucose-fatty acid cycle” (Randle et al. 1963; Randle, 1998). According to this 
concept, the release of fatty acids from adipose tissue triaclyglycerol (or from muscle 
triacylglycerol) imposes a limitation on glucose metabolism, by decreasing muscle 
glucose uptake and oxidation, while lipid oxidation is stimulated.  When plasma free 
fatty acid (FFA) levels increase, this mechanism favours muscle FFA uptake, and 
FFA compete with glucose for oxidation. The enhanced FFA oxidation produces an 
increased acetyl CoA to CoA-SH ratio and an increase in cytoplasmic citrate 
concentrations.  This elevated concentration of acetyl CoA activates pyruvate 
dehydrogenase kinase, which phosphorylates and thus inhibits pyruvate 
dehydrogenase (PDH). Glucose metabolism is inhibited at two important steps, 1) the 
increase in cytoplasmic citrate concentrations inhibits phosphofructokinase, which 
results in an increased glucose-6-phosphate concentration, as a consequence, 
hexokinase is inhibited and finally glucose uptake is impaired. 2) Inhibition of PDH 
impairs the entry of pyruvate into oxidative metabolism and thus contributes to 
inhibit glucose oxidation.  
 
In the whole body, the total rate of fat oxidation is dependent on the concentration of 
plasma free fatty acids (Randle et al. 1963; Randle, 1998).  However, the utilisation 
of triacylglycerol deposits in various tissues, such as skeletal muscle, also influences 
total body fat oxidation. A mechanism that tends to increase total body fat oxidation 
is the enlargement of the adipose tissue mass (Schutz et al. 1992). The increase in the 
delivery of free fatty acids into the circulation of obese subjects is not simply related 
to the quantity of adipose tissue.  Levels of plasma free fatty acid concentration have 
been shown to be more elevated in abdominal obesity (Björntorp, 1991).  Abdominal 
obesity is a condition often associated with insulin resistance and hyperinsulinemia. 
The issue in this situation is the presence of a systemic elevation of plasma free fatty 
acids associated with hyperinsulinemia, despite insulin being a very efficient 
inhibitor of free fatty acid mobilisation.  The lipolytic driving forces in patients with 
abdominal obesity dominate the inhibitory action of insulin. Visceral adipose tissue 
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has been shown to be more sensitive to lipolytic stimuli than subcutaneous adipose 
tissue (Rebuffé-Scrive et al. 1989).  Additionally, cells from visceral adipose tissues 
are less sensitive to the inhibitory action of insulin on lipolysis than adipose cells 
from subcutaneous adipose tissue. This seems to be associated with a low density of 
insulin receptors (Bolinder et al. 1996).  As a result of the elevated lipolysis in 
visceral adipose tissue of abdominally obese, the liver is exposed through the portal 
circulation to excess FFA concentrations. This is known to stimulate 
gluconeogenesis, which depends on the oxidation of fatty acids in the liver as an 
energy source; the resulting increased hepatic glucose output reflects insulin 
resistance in the liver (Ferrannini, 1988).   What is of interest is that the high insulin 
secretion and insulin resistance in various tissues are probably secondary to the obese 
state, as most data on individuals who have lost weight show a complete reversal of 
these phenomena.  
 
Body weight in the obese person will eventually reach a near-constant level, in spite 
of an excess of energy and fat intake (Flatt, 1988).  Two mechanisms have been 
attributed to this weight plateau, 1) The co-enlargement of the fat free mass is 
accompanied by an increase in BMR and, therefore an enhanced total energy 
expenditure (Ravussin et al. 1982; Prentice et al. 1986; Jéquier & Schutz, 1988).  2) 
The increase in the fat mass is accompanied by an enhanced rate of FFA release into 
the circulation, which acts to stimulate fat oxidation (Figure 1:4).  Thus the enhanced 
fat oxidation observed in obese individuals in the resting state might serve as a 
lipostatic mechanism. This metabolic adaptation eventually allows fat oxidation to 
rise to a level matching fat intake, thus limiting further weight gain.  Studies on the 
relationship between fat mass and fat oxidation shown that a 10-kg increase in fat 
mass corresponds to a stimulation of fat oxidation of ~20g/day (Schutz et al. 1992). 
Thus the enlargement of body fat stores serves as a mechanism that contributes to 
equilibrate fat balance in individuals with a chronic excess of fat intake.  What needs 
to be determined is whether the signal for the increased fat oxidation is the rise in 
plasma FFA levels or a hormonal message related to adipocyte hypertrophy or 
hyperplasia.  A positive energy balance, particularly due to carbohydrate 
overfeeding, also stimulates sympathetic activity, a mechanism which may contribute 
to increase energy expenditure (Figure 1:4). 
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Figure 1:4 Metabolic consequences of a chronic positive energy balance on fat 
mass and fat-free mass.   
Induced increases in free fatty (FFA) release, FFA oxidation, and energy expenditure eventually leads 
to a new stable body weight, resulting from a new energy balance (Jéquier & Tappy, 1999) 
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1.3.5 The Role for Dietary Calcium in Weight / Fat Loss  
Figure 1:5 Proposed mechanisms contributing to the reduction of fat mass  
 
     
Ø Available energy  
Ç satiety & È spontaneous food intake  
    Calcium binding of Fatty Acid as soaps 
     - Ç faecal fat & energy loss   
Dietary Calcium          
/ Dairy products   × Fat & Energy Utilisation      
    Ç Lipolysis    
    Ç Lipid oxidation 
    È Lipid synthesis 
    Ç Energy expenditure - Thermic effect of a meal 
    Ç Protein synthesis & lean mass accretion   
 
(adapted from (Teegarden, 2005) 
1.3.5.1 Mechanisms mediated by the Calcitrophic hormone 
The link between calcium and body weight has only been fairly recently proposed.  
In 1984 epidemiological data (McCarron et al.) reported an inverse link between the 
intake of calcium and body weight, but it remained an unexplained finding until 
Zemel et al. (2000) reported their research on calcium and body composition. Zemel 
(2000) hypothesised that intracellular calcium was the key to insulin sensitivity, lipid 
storage and synthesis. Interestingly Zemel’s theory of calcium’s role in lipid 
metabolism came from unrelated clinical trials on hypertension, where it was 
observed that increasing the intake of calcium from ~400 mg/day to 1000 mg/day 
resulted in significant weight loss. Zemel  speculated that the increasing calcitrophic 
hormones (PTH, vitamin D3)  secondary to a low calcium intake may stimulated 
adipocyte calcium influx, which in turn stimulates fatty acid synthase activity and 
hence lipid storage (2000). If this is true, increasing calcium intake should lower 
calcitrophic hormones, reduce intracellular calcium and attenuate lipid storage.  It 
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has been hypothesised that high-calcium diets protect against fat gain by creating a 
balance of lipolysis over lipogenesis in adipocytes.   
 
In support of the mechanisms mediated by calcitrophic hormones, data from 
adipocyte culture studies indicate that alterations in intracellular calcium 
concentration may regulate fat metabolism. In vitro,  the intracellular influx of 
calcium, mediated either by parathyroid hormone (PTH) or 1,25-dihydroxyvitamin 
D, was shown to inhibit lipolysis and increase lipogenesis in adipocytes (Zemel et al. 
2000).  Human subcutaneous adipose tissue, in response to 1,25-(OH)2-D or 
parathyroid hormone, showed an increase in intracellular Ca2+. 1,25-(OH)2-D 
treatment also resulted in a 83% inhibition of forskolin-stimulated lipolysis 
(P<0.001).  Similar observations have been made in the aP2-agouti transgenic mouse 
model.  These mice were energy-restricted for 6 weeks where they followed either a 
high dairy (HD) or a low dairy (LD) diet. They exhibited a 79% decrease in 
intracellular adipocyte calcium levels (380 + 43 (HD) vs 79 + 10 (LD) mmol/L). 
Upon refeeding, the low calcium diets resulted in a 4- to 5-fold increase in adipocyte 
[Ca2+]i, whereas there was no increase in adipocyte [Ca2+]i  among the mice fed the 
high-calcium diets (P<0.001) (Sun & Zemel, 2004).           
 
Conversely, the inhibition of PTH and/or calcitriol caused by a higher calcium intake 
and hence a lower intracellular calcium level was the explanation for fat loss due to 
greater lipolysis.  This was supported by work from Draznin’s group which showed 
greater intracellular calcium levels in the adipocytes of obese subjects versus lean 
subjects (1988a). Further support of this mechanism comes from a clinic study 
whereby patients with primary hyperparathyroidism, a condition in which both serum 
PTH and calcitriol concentrations are elevated, have increased body weight (Bolland 
et al. 2005).   
 
Figure 1:6 represents an overview of the mechanisms proposed by Zemel et al. 
(2000).  
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Figure 1:6  Mechanisms whereby Calcium may play a role in reducing fat 
deposits.  
An increase in dietary calcium reduces 1,25-dihydroxyvitamin D [1,25(OH2)D] and PTH 
concentrations, resulting in down-regulation of calcium transfer into adipose and pancreatic cells. 
Inside adipocytes, a reduction in intracellular calcium leads to decreased fatty acid synthase (FAS) 
transcription that results in a lowering of lipogenesis and increased lipolysis. In pancreatic cells, 
reduced intracellular calcium concentrations decrease insulin output, which results in reduced 
lipogenesis and enhanced lipolysis in adipocytes.  In combination, these processes would help reduce 
fat deposition into and storage in adipose tissue.  (Adapted from (Zemel et al. 2000; Zemel, 2003a).   
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1.3.5.2 A specific role for Vitamin D and its effect on Calcium in 
Obesity  
Serum 1,25(OH)2D3 is an important regulator of a large number of genes (DeLuca & 
Zierold, 1998), and many of these genes are either related to fat breakdown and 
storage; namely, hormone sensitive lipase (HSL), glycerol phosphate dehydrogenase 
and fatty acid synthase (FAS) or adipocyte differentiation (peroxisome-proliferator 
activator receptor γ (PPAR-γ) (Barbe et al. 1998; Large et al. 1998; Duque et al. 
2004).  It is well documented that 1α,25-(OH)2-D3  generates biological responses 
via both the genomic and non-genomic pathway. 1α,25-(OH)2-D3  generated 
genomic actions via the binding to a specific nuclear hormone receptor, nuclear 
vitamin D receptor (nVDR) (Figure).  Moreover 1α,25-(OH)2-D3 generates rapid, 
nongenomic signal transduction, including modulation of calcium channels, via a 
putative membrane mVDR in a wide variety of cells (Shi et al. 2002). Zemel’s data 
has previously reported that 1α,25-(OH)2-D3 stimulates adipocyte [Ca2+]i, promotes 
lipogenesis, and inhibits lipolysis via a rapid nongenomic action. Work by Shi et al. 
(2002) further demonstrated that 1α,25-(OH)2-D3 exerts an inhibitory effect on 
adipocyte UCP2 expression via a genomic action.  Papakonstantinou’s group (2003b) 
support the work of Zemel et al. in that male Wistar rats fed control versus high 
calcium diets for 85 days resulted in significant reductions in serum 1α,25-(OH)2-D3, 
following the ingestion of the high calcium diets.  
 
Figure 1:7 1α,25-(OH)2-D3  plays an important role in modulating adipocyte 
lipid metabolism and energy homeostasis via genomic and nongenomic actions  
(Shi et al. 2002).  
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The available data suggests that 1α,25-(OH)2-D3 exerts an inhibitory effect on white 
adipocyte basal, isoproterenol and fatty acid-stimulated uncoupling protein-2 (UCP2) 
expression.  Thus, suppression of 1α,25-(OH)2-D3 and consequent up-regulation of 
UCP2 may contribute to the increased thermogenesis in mice fed high-calcium diets. 
Furthermore this effect along with a decreased lipogenesis and increased lipolysis 
secondary to a decreased [Ca2+]i may contribute to the anti-obesity effect of dietary 
calcium.  1α,25-(OH)2-D3  has also been shown to promote the expression and 
secretion of lipoprotein lipase in cultured adipocytes (Querdeld et al. 1999), which 
indicates that 1α,25-(OH)2-D3 may enhance adipocytes lipid accumulation by 
increasing fatty acid uptake.  A number of studies have also indicated a role for 
1α,25-(OH)2-D3  in human obesity. Ye et al. reported that nVDR gene 
polymorphisms are associated with the susceptibility to obesity in humans with 
early-onset type II diabetes. Ye et al. study states two single polymorphisms in 
nVDR gene intron 8 and exon 9 account for a 9-kg body weight difference, or 4 
kg/m2 (2001). Likewise, human body weight and body mass index have been shown 
to be associated with a restriction site polymorphism in nVDR gene (Barger-Lux et 
al. 1995a). Several studies have also demonstrated changes to the vitamin D-
endocrine system in obese humans, with an increase in circulating 1α,25-(OH)2-D3  
level (Bell et al. 1985; Andersen et al. 1988). In addition two studies have indicated 
that 1α,25-(OH)2-D3-induced hyperinsulinemia may also be involved in the 
development of obesity in humans, as 1α,25-(OH)2-D3 has been shown to stimulate 
insulin release in pancreatic β-cells (Norman et al. 1980; Tanaka et al. 1986).  
However,  in a cross-sectional human study by Parikh and colleagues (2004), 
reported a negative relationship between serum 1,25-vit D and adiposity in obese 
subjects. These authors concluded that an elevation of 1,25 vit-D is unlikely to be an 
important hormonal mechanism for maintaining obesity in adults. 
  
In summary, animal studies indicate that antagonism of 1α,25-(OH)2-D3 on its 
genomic and/or non-genomic pathways may offer a promising approach for obesity 
management. Dietary calcium suppression of 1α,25-(OH)2-D3 levels have been 
shown in several studies (Sanchez et al. 1997; Resnick, 1999). Data from Zemel’s 
animal studies demonstrate that suppression of 1α,25-(OH)2-D3 by increasing dietary 
calcium decreased adipocyte intracellular Ca2+ concentration, stimulated lipolysis, 
inhibits lipogenesis and increased adipocyte UCP-2 expression and core temperature 
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in aP2-agouti transgenic mice.  Dietary calcium not only attenuated diet-induced 
obesity but also accelerated weight loss and fat mass reduction secondary to calorie 
restriction (Zemel et al. 2000; Shi et al. 2001a).   
 
A clear mechanistic pathway between high calcium intake, intracellular calcium 
levels and weight loss is however less clear in humans. It has been demonstrated that 
obese people have greater intracellular Ca2+ concentration levels than non-obese, age 
and sex matched individuals (Draznin et al. 1988b). Furthermore intracellular Ca2+ 
concentration levels have been shown to regulate both lipogenesis and lipolysis in 
human adipocytes (Zemel et al. 2000) and the mouse model (Papakonstantinou et al. 
2003b; Sun & Zemel, 2004), through regulation of the calcitrophic hormones (PTH 
and vitamin D3). Patients with hyperparathyroidism (elevated PTH and calcitriol 
levels) have been shown to be heavier (Bolland et al. 2005) and elevated vitamin D 
levels in humans have been linked with obesity (Norman et al. 1980; Bell et al. 1985; 
Barger-Lux et al. 1995a; Ye et al. 2001).   However, there is no whole body evidence 
that higher intakes of calcium directly influence intra-cellular calcium in humans.  
 
1.3.5.3 Dietary Calcium and its role in Fat Oxidation  
Of great interest is whether an increased intake of calcium can affect substrate 
utilisation towards a greater use of fat as a fuel source.  Zemel’s animal studies have 
investigated this by examining liver carnitine palmitoyltransferase (CPT) activity to 
determine whether the changes in adiposity could be contributable to shifts in liver 
fat oxidation. In the refeeding phase of a study, aP2-transgenic mice where fed ad 
libitum basal (low calcium) diets, or high (cereal) calcium, high (milk) calcium, high 
(yoghurt) calcium or a cereal-based control diet.  The basal (low calcium) and cereal 
(low calcium) diet slightly increased liver CPT activity (44 and 56%), whereas the 
high-calcium diets increased CPT activity by 150% (P<0.05) (Sun & Zemel, 2004).   
 
Zemel’s group have also demonstrated increases in lipolysis in the animal model, as 
measured by incubation of perirenal adipose tissue and measuring the ensuing 
glycerol release into the culture medium (Sun & Zemel, 2004). When the mice were 
a) energy restricted and fed either a basal (low-calcium) diet versus a high-calcium 
cereal meal, lipolysis was decreased by 20% (P<0.05) and b) in a refeeding situation 
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the mice exhibited significantly greater lipolysis on the high-milk-calcium diet 
versus the low-calcium diet (P<0.03).  Inversely, FAS activity and expression was 
decreased in the high-calcium diets. In the energy-restricted mice fed the high-
calcium cereal diet FAS activity and expression reduced by 91 and 99%, 
respectively. Upon refeeding, the high-calcium diet fed mice exhibited lower adipose 
FAS activity and expression, whilst the high-dairy-calcium fed mice had even lower 
FAS activity and expression than the high-calcium diet fed mice (P<0.001).       
 
In a cross-sectional study, Melanson et al. (2003) showed a positive correlation 
(r=0.38, P=0.03) between acute calcium intake and fat oxidation using whole-body 
room calorimetry.  Moreover, in a prospective study of energy restriction, these 
authors showed a greater 24 hour fat oxidation following the short-term consumption 
of high calcium intakes (Melanson et al. 2005). One long-term study has also 
demonstrated a greater fat oxidation rate in subjects who followed a high calcium 
diet for a year (Gunther et al. 2005b). In contrast, Jacobsen et al. (2005) manipulated 
calcium and protein intakes over 2 week periods and did not find any change in 24 
hour energy expenditure nor fat oxidation between diets.  Likewise, in a study of 20 
healthy men where diets were  manipulated for 7 days no significant difference in fat 
oxidation rates over 24 hours was obtained, between high dairy/high calcium, high 
calcium/low dairy and low calcium/low dairy (Boon et al. 2005a).  Furthermore, 
Melanson’s group have recently published the findings from a short-term study 
which contradicts their original findings, in that a greater lipolysis and/or fat 
oxidation was not demonstrated following the 7-day consumption of a high versus a 
low calcium diet (Melanson et al. 2006)(Table 1:9). Clearly, some confirmation of 
findings is required.  In this thesis, we study the acute (single meal) effects of 
calcium from dairy and non-dairy sources on energy metabolism, as part of the focus.   
 
1.3.5.4 Dietary calcium and Thermogenesis 
Since the initial discovery of the brown adipose tissue (BAT) mitochondrial 
uncoupling protein (UCP), namely UCP2, much interest has gathered and research 
into the role in energy metabolism.  Since lipogenesis is dependent upon 
mitochondrial ATP production (Kopecky et al. 2001), mitochondrial uncoupling in 
adipocytes may contribute to control of lipid metabolism. Work from Zemel’s 
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laboratory (discussed above) has demonstrated a role for intracellular calcium 
([Ca2+]i) in regulating adipocyte energy metabolism (2000).  The work in human 
adipocytes and agouti-transgenic mice has demonstrated that an increase in ([Ca2+]i) 
stimulates the expression of and activity of fatty acid synthase (FAS), a key enzyme 
in de novo lipogenesis, and inhibits basal and agonist-stimulated lipolysis in both 
human and murine adipocytes (Xue & Zemel, 2000; Shi et al. 2001a). Furthermore 
Zemel’s group demonstrated in 3T3 L1 adipocytes using mitochondrial uncouplers; 
that, mitochondrial uncoupling increases ([Ca2+]i) and down-regulates lipolysis via a 
calcium-dependent mechanism. Alternatively, mitochondrial uncoupling up-regulates 
FAS expression via a calcium-dependent mechanism, and suppression of FAS 
activity via a Ca2+-independent mechanism (Sun & Zemel, 2003).  
 
In the aP2-agouti mouse study by Sun and Zemel (2004), obesity was induced by a 
high-fat/high-sucrose diet followed by energy restriction on a high-calcium diet. The 
animals were then provided ad libitum basal (low calcium) diets, or high (cereal) 
calcium, high (milk) calcium, high (yoghurt) calcium or a cereal control diet. The 
animals on the low-calcium diet regained all the weight whereas the high-calcium 
diet animals reduced fat gain by 55%. All the high-calcium diets stimulated adipose 
tissue uncoupling protein (UCP2) and skeletal muscle UCP3 expression (P<0.001).  
Interestingly, only the high dairy diets showed a marked (>10-fold, P<0.001), 
increase in skeletal muscle peroxisome proliferator-activator receptor-α expression 
(PPAR-α) (a transcriptional factor that regulates cellular lipid metabolism). These 
mice also exhibited some trend towards an increase in core temperature (an indirect 
metabolic index associated with thermogenesis) in the high-calcium fed mice.  This 
increase was demonstrated without a difference in food intake during the refeeding 
and is suggestive of a shift in energy metabolism from energy storage to 
thermogenesis.  
 
Shi et al. (2001b) fed aP2-agouti transgenic mice a medium-dairy or a high-dairy 
diet.  They observed that the animals core temperature was raised by 0.48, 0.57 and 
0.67oC, respectively (P<0.05) across the 3 groups.  Further evidence of changes in 
energy metabolism was further demonstrated by the increase in PPAR-α, which was 
10-fold higher in the mice refed with high dairy-calcium diets compared with the 
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low-calcium diets. Similarly mice refed the high-calcium diets exhibited significantly 
lower adipocyte PPAR-γ expression than those refed the low-calcium diets (P<0.03), 
suggesting that dietary calcium may also inhibit fat mass regain by suppressing 
adipogenesis (Sun & Zemel, 2004).     
 
1.3.6 The Control of Food Intake  
1.3.6.1 Hunger, Satiation and Satiety  
Most people who maintain a stable body weight spontaneously adapt their energy 
intake to a large range of energy expenditures through accurate mechanisms of 
control of food intake. Appetite involves a complex sequence of interactions amongst 
the peripheral and central mechanisms. The gastrointestinal tract contains chemo-and 
mechanoreceptors that relay the information about its nutrient content to the brain 
mainly via the vagus nerve. Impairment of appetite or satiety may arise from 
peripheral or central mechanisms. The amount of energy ingested over 24 hours 
depends on two major variables: the size of individual meals and the frequency with 
which meals are ingested.  These two variables are regulated by distinct mechanisms. 
Hunger can be defined as the sensation felt by an individual that drives them to 
search for, and ingest food.  This sensation is elicited after a variable period 
following the absorption of the nutrients ingested with the previous meal. Although 
its mechanisms remain poorly understood, it has been observed that a light drop in 
plasma glucose concentration precedes the initiation of food intake in both rats and 
humans. After the ingestion of a certain amount of food, a suppression of hunger 
occurs that will lead to the termination of food intake. This process is referred to as 
satiation, and the mechanisms that underlie it are the major determinants of meal 
size.  The time of satiation is followed by a period of variable duration that is 
characterized by the absence of hunger; this is referred to as satiety. Termination of 
the period of satiety coincides with resurgence of the feeling of hunger, leading to 
consumption of the next meal, thus resuming the cycle of food intake. The 
mechanisms that promote satiation are different from those that determine the 
duration of satiety. Thus meal size and meal frequency are controlled by different 
factors.  
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The overall process of food intake control is governed by complex mechanisms. The 
macronutrient composition, size, and caloric density, along with their organoleptic 
properties (sight, smell, taste and texture), play an important role in the determination 
of satiation.  In has been shown that subjects that are voluntarily energy restricted or 
energy overfed to lose and gain weight, respectively; once they are resumed on an ad 
libitum diet, initial body weight is soon reinstated. Thus, it is clear that whilst 
nutrient composition is important to regulation food intake, chronic body weight and 
composition play a more influential role in the control of food intake. What is 
becoming more evident is that food intake is now becoming more linked to social 
activities, and not necessarily linked to the hunger response.   
 
1.3.6.1.1 Effect of Nutrients on Food Intake  
The influence of nutrients on subsequent food intake has been extensively studied by 
providing blinded meals with differing food composition or energy content and 
observing the changes in the subsequent food composition of the next meal.  It has 
generally been observed that an acute deficit in energy intake is rapidly compensated 
in the subsequent meals. Although the results of numerous studies are not conclusive, 
it is the general opinion that if one of the major macronutrients is in deficit at one 
meal, there is not a compensatory increase in the intake of that macronutrient but 
rather a compensatory ingestion of an equivalent number of calories from a mixed 
meal (Blundell, 1995; Blundell et al. 1995; Blundell et al. 1996).  In contrast, 
excessive intake of nutrients generally decreases subsequent food intake.  There is a 
hierarchy regarding the ability of the various macronutrients to suppress subsequent 
food intake. It is well-documented that kJ for kJ, protein is more satiating than 
carbohydrate or fat (Robinson et al. 1988; Hill & Blundell, 1990; Blundell et al. 
1995; Stubbs et al. 1996; Hellstrom & Naslund, 2001; Hu, 2005). Evidence also 
suggests a hierarchy in macronutrient oxidation rate during the postprandial state 
with the sequence protein > carbohydrate > fat (Flatt, 1988; Flatt, 1995b; Stubbs et 
al. 1995).  This line of research has therefore lead to the suggestion that a high 
satiating efficiency of a macronutrient may be related to its oxidation rate.  It has also 
been documented that different protein sources have a different satiating capacity, 
with whey protein shown to be more satiating than casein (Hall et al. 2003).  This is 
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of particular interest with regards the dairy and weight loss story, due to milk and 
milk-containing products having a higher whey content (see discussion below).   
 
 1.3.6.1.1.1 Dairy intake and it’s effect on Food Intake  
It has been suggested that it is the whey protein content of milk and dairy products 
that may regulate food intake. It was first suggested by Mellinkoff (1956) through his 
aminostatic concept, that the digestion and absorption of proteins could influence 
their satiating properties.  The digestion and absorption of whey and casein differ 
quite considerably.  Whey protein rapidly enters the jejunum in the form of intact 
protein, whereas casein is slow to appear and is mainly in the form of degraded 
peptides.  This difference between the two proteins is mainly due to the greater 
clotting of casein in the stomach, giving it larger exposure to the gastric peptic 
hydrolysis (Mahe et al. 1996). As a result the over-all gastric emptying time for 
casein is longer and there is a smaller postprandial increase in plasma amino acids 
compared with non-coagulating whey protein. Whey proteins therefore elicit a 
greater satiating power as this protein empties faster from the stomach and has a 
higher postprandial excursion of plasma amino acids.  
 
The data of Hall et al. (2003) confirms some aspects. A whey preload led to greater 
AA levels compared to casein, though clear cut differences in gastric emptying (as 
judged by paracetamol absorption test) could not be confirmed. Importantly, buffet 
meal food intake was significantly suppressed following the whey pre-load (Hall et 
al. 2003). 
 
Another possible effect of whey proteins on satiety is the postprandial release of the 
hormone cholecystokinin (CCK).  An increase in CCK has been associated with a 
meal-induced satiety.  This has been demonstrated by Schneeman et al. whereby 24 
men and women who were given either a high dairy or non-dairy breakfast meal 
(providing the same energy value and similar polyunsaturated to saturated fat ratios), 
consumption of the high dairy meals resulted in an enhanced CCK response (2003). 
This was also demonstrated by Hall et al. in subjects fed isocaloric liquid breakfast 
meals, the high whey meal elicited a 60% greater postprandial plasma CCK increase 
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(2003).  In this study it was also demonstrated that the whey pre-load also increased 
two other hormones known to contribute to satiety, namely glucose-dependent 
insulinotrophic polypeptides and glucagon-like peptide-1, greater than the casein pre-
load. One other proteolysis product that is important to food intake is 
caseinomacropeptide (CMP). CMP is the first digestion product of casein to be 
released from the stomach (Ledoux et al. 1999). It has been suggested that CMP may 
act as an appetite suppressant, in rats (Pedersen et al. 2000), CMP has been 
demonstrated to stimulate pancreatic secretion (a marker of CCK release) and in 
humans it has been reported to a potent stimulant of CCK release; however, clinical 
studies are limited (Gustafson et al. 2001).    
 
If dairy products are to have an effect on weight reduction through mechanisms of 
greater satiety it would be anticipated that less food be ingested following the 
consumption of a high dairy meal. In our laboratory we have demonstrated a 
significant reduction in food consumption of human subjects following a high dairy, 
high vitamin D breakfast meal (HCB) versus a low dairy, low vitamin D meal 
(LCB). The differences in consumption were -444 kJ consumed during an ad libitum 
buffet meal (immediately post-testing), this difference widened to -765 kJ at the 
evening meal and there was less food consumed 24 hours after the experiment on the 
HCB (7143 + 431 kJ vs. 8484 + 699, P<0.02) (Ping-Delfos et al. 2004).  Findings by 
Barr et al. (2000)  have also hinted at a compensatory decrease in energy intake 
following dairy intake. In their randomised, controlled open trial, 101 subjects were 
advised to increase their intake of skim or 1% milk intake by 3 serves per day and 
compared to subjects advised to maintain their usual intake. This protocol was 
followed for 12 weeks. The milk group gained 0.6 kg more than the control group 
(P<0.01) but interestingly, the predicted weight gain due to an increase in energy 
intake of 200 to 250 kcal/day (836–1046 kJ) over a 12-week period should have been 
of least 2.5 kg.  
 
Besides the other factors discussed in this thesis, food intake may be an additional 
facet of the calcium/dairy story. We therefore wished to examine the effects of 
calcium (pharmaceutical) and dairy calcium on feelings of hunger/satiety and 
subsequent food intake, as part of our studies.      
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1.3.7 Change in Fat Absorption   
Another proposed mechanism by which calcium may impact body weight is that 
increased dietary calcium seems to bind more fatty acids in the colon, thereby 
inhibiting fat absorption. Welberg et al. in a small 1994 study (1994), showed that 
calcium supplementation increased the percentage of excretion of total fat as related 
to fat intake. The calcium supplementation in this study was either 2 or 4 g. Denke et 
al. (1993) supplemented 13 men with approximately 2 g of calcium per day. The 
percentage of dietary fat excreted per day increased from 6% to 13% with calcium 
supplementation. The Nestle Company supplemented chocolate with 900 mg of 
calcium and tested the faecal fat content of 10 men in a double-blind crossover study 
(Shahkhalili et al. 2001). Calcium supplementation of chocolate increased faecal fat 
from 4.4 to 8.4 g per day (P < .0001). These studies show a small effect of calcium 
on fat absorption that probably contributes to the antiobesity effects but does not 
explain it entirely. The degree of faecal fat loss in these studies of high calcium 
supplementation is only approximately 3% of that induced by medications such as 
orlistat. 
 
1.4 Evidence to date: The Role of Dietary Calcium in 
Weight Loss  
1.4.1 Introduction  
Since the early work by Zemel and the initial epidemiological study by McCarron 
(1984) there has been much interest in the area of dietary calcium and weight loss.  
There are now at least 18 review studies published (Zemel, 2001; Heaney et al. 2002; 
Zemel, 2002; Barr, 2003; Parikh & Yanovski, 2003; Teegarden & Zemel, 2003; 
Zemel, 2003a; Zemel, 2003b; Elwood et al. 2005a; Harkness & Bonny, 2005; Harris, 
2005; Ilich, 2005; Sakhaee & Maalouf, 2005; St-Onge, 2005; Teegarden, 2005; 
Zemel, 2005b); only two of which are systematic reviews (Barr, 2003; Trowman et 
al. 2006).  However, what many of these authors agree on is that there is a lack of 
well-controlled randomised controlled studies of dairy and/or calcium-containing 
products on weight loss.  The next section will discuss the evidence to date from 
 Chapter 1: Literature Review  
31
animal studies through to cross-sectional and longitudinal data to randomised 
controlled trials (refer to Tables 1:4-1:9).  Each study has been graded on the 
National Health and Medical Research Council levels of evidence (2000) (Table 
1:2). In a review of the data, expert consensus statements and evidence from 
experimental studies with animals and/or cells may provide valuable information and 
are given a rating of level V.     
 
Table 1:2 National Health & Medical Research Council - levels of evidence 
NHMRC level of evidence  
I Evidence obtained from a systematic review of level II studies  
II Evidence obtained from at least one properly designed randomised 
controlled trial  
III-1 Evidence obtained from well-designed, pseudo-randomised 
controlled trials  
III-2 Evidence obtained from comparative studies with concurrent 
controls and allocation not randomised, cohort studies, case-control 
studies or interrupted time series with a control group   
III-3 Evidence obtained from comparative studies without concurrent 
controls, a historical control study, two or more single arm studies, 
or an interrupted time series without a control group   
IV Evidence obtained from case series, either post-test or pre-test/post-
test 
V Evidence provided by expert consensus statements, experimental 
animal and cell studies 
 
1.4.1.1 Animal Studies  
The first animal studies to be conducted came from Metz and colleagues, and 
demonstrated a reduction in body fat mass in 2 strains of hypertensive rats with 
higher calcium intake (1988).  Spontaneously hypertensive rats and Wistar Kyoto 
rats were randomised to 2%, 1% and 0.1% calcium (CaCO3) intakes, they exhibited a 
significant reduction in body weight (P<0.05) between the high and low calcium 
diets (evidence level-NHMRC V-animal study).  
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Much of the knowledge to date regarding the role of dairy and/or calcium has come 
from Zemel’s work with the aP2-agouti transgenic mouse.  Agouti is an obesity gene 
expressed in both rodents and human adipocytes, these mice exhibit a normal pattern 
of leptin expression and activity similar to that found in humans and exhibit a human 
pattern (adipocyte-specific) of agouti expression. These mice are a useful model to 
use as they are not obese when consuming a standard A1N-93G diet, but develop 
mild-to-moderate obesity when fed high-sucrose and/or high-fat diets (Zemel et al. 
2000).  In a three-phase study obesity was induced in these agouti-mice with a high-
fat/high-sucrose diet (phase I), energy was then restricted using a high-calcium 
(1.3%) diet for 6 weeks to induce fat loss (phase II). After this 6 week period the 
mice group (n=50) were randomised into 5 groups and given free access to either a) a 
low-calcium (0.4%) diet b) a high-calcium (1.3%) cereal, c) milk plus the high-
calcium cereal (1.3% calcium), d) yoghurt plus the high-calcium cereal (1.3% 
calcium) or e) a cereal-control diet (0.4% calcium) for 6 weeks. Re-feeding of the 
low-calcium diet to the mice caused a regain of all the weight and fat, whereas the 
high-calcium diets reduced weight gain by 55% (P<0.01) (Sun & Zemel, 2004) 
(evidence level-NHMRC V-animal study).  Interestingly, fat pad weight was 
significantly affected in that the low-calcium diets had a 487% increase in fat pad 
mass, further the dairy-based, high-calcium diets were more effective than the high-
calcium cereal diets, as the high-dairy diets prevented 85% of the fat gain compared 
to preventing 55% of the fat regain in the high-calcium diets.       
 
Shi et al. (2001b) have fed agouti-mice with low calcium (0.4%) or high calcium 
(CaCO3, 1.2%), or medium or high dairy calcium (non-fat dry milk, 1.2% or 2.4% 
calcium) diets.  Energy restriction on the low-calcium diet resulted in an 11% body 
weight loss (P<0.001), compared with the ad libitum control (evidence level-
NHMRC V-animal study).  However, much greater weight reductions of 19%, 25% 
and 29% were observed in the high-calcium, medium-dairy and high dairy groups, 
respectively (P<0.01, vs. basal energy-restricted group). Consistent with these 
findings, the energy-restriction caused only an 8% decrease in fat pad mass on the 
low-calcium diet (NS), compared to the basal diet ad libitum group. However, on the 
energy-restricted diet with the high-calcium intake a 42% fat pad mass decrease was 
observed (P<0.001), which was further reduced by 60% and 69% for the medium and 
high-dairy groups, respectively (P<0.001, versus the basal energy-restricted group). 
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Similar results were reported by Papakonstantinou (2003b), whereby male Wistar 
rats were fed a control versus a high calcium diet for 85 days. It is important to note 
that unlike the Agouti mouse used by Zemel’s group, the Wistar rat does not have 
any genetic mutations that have the potential to modify energy balance, but it is 
susceptible to dietary obesity (Papakonstantinou et al. 2003a). Rats fed the high-
calcium diet gained less weight than the control (310 + 10 g versus 335 + 12 g, 
P=0.04), and had 29% less body fat than the controls. This finding was; however, 
contributable to the greater faecal fat content and hence significantly less digestible 
dietary energy provided to the high-calcium diet fed mice (evidence level-NHMRC 
V-animal study).  
 
Not all findings from animal studies are in agreement. Zhang and Tordoff (2004) 
(evidence level-NHMRC V-animal study), have demonstrated no effect of differing 
concentrations of  calcium in normal weight and obese, Sprague-Dawley rats and 
C57BL/6J mice. These animals were fed a dietary mix with 0.2, 0.6 or 1.8% of 
calcium. Interestingly, with this group of animal models, they were already obese, 
rather than young animals that were growing and obesity was induced, as in the three 
previously mentioned studies.  Zhang and Tordoff found in their studies that when 
the Sprague-Dawley rats were fed ad libitum high versus low calcium diets, they ate 
significantly less on the high calcium diet (P<0.00001), indicating a lack of 
palatability of the diet. It has been suggested by these authors that in the studies on 
animals supplemented with higher calcium diets (Shi et al. 2001b; Papakonstantinou 
et al. 2003b; Sun & Zemel, 2004), the animals are simply smaller due to eating less 
of the unpalatable diet and this is restricting their growth and hence body fat, rather 
than the high calcium diets causing less gains in body fat.  It is also important to note 
that differences in the results observed between animal species can be due to the fact 
that the initial observations that led to the current hypothesis were made in an agouti 
mouse model. When ectopically expressed, the agouti gene increases intracellular 
calcium in proportion to its level of expression in that tissue. This primary event 
leads to varying degrees of insulin resistance and obesity. Consequently, lowering of 
intracellular calcium, through high calcium diets, reverses these effects. The human 
homologue of agouti is expressed in human adiposites, and Zemel’s group have 
shown that recombinant agouti protein increased adipocyte intracellular Ca2+([Ca2+]i) 
and thereby stimulated lipogenesis and inhibited lipolysis in a coordinated manner. 
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In other animal models of dietary obesity (C57BL/6J mice or Sprague-Dawley rats), 
dramatic changes in intracellular calcium are not the primary phenomenon leading to 
obesity. Hence the beneficial effects of dietary calcium may not be so clear cut. 
 
1.4.1.2 Cross-sectional Observational Studies 
(Refer to Table 1:4)  
The first study to show a link between calcium intake and body weight was an 
analysis of the National Health and Nutrition Examination Survey I (NHANES-I) by 
McCarron et al. (1984) (evidence level-NHMRC IV).  However, the lack of any 
plausible explanation for this finding merely relegated it to mild interest or a chance 
finding.  Furthermore, Zemel et al. (2000) (evidence level-NHMRC IV) analysis of 
data from the NHANES III showed a strong inverse association for relative risk (RR) 
of obesity and calcium intake.  These data showed that after controlling for energy 
intake, RR of high body adiposity decreased as calcium intake increased. The RR for 
women was 0.75. 0.40 and 0.16 for the second, third and fourth quartiles, 
respectively, with a similar inverse relationship shown in males (refer to Figure 1:8). 
Underreporting of dietary intake in overweight and obese subjects is a major 
confounder in dietary interventions (Black & Cole, 2001; Livingstone & Black, 
2003). Hence in studies that employ reported dietary intakes, this confounding 
cannot always be fully controlled.   
Figure 1:8 Relative Risk – highest adiposity quartile versus quartile of reported 
dietary calcium intake  
   
 
 
 
 
 
 
 
 
(n=380, P<0.0009) (Zemel et al. 2000) 
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Since these two studies were published a range of cross-sectional studies from 
around the world have supported these findings.  
 
Davies et al. (2000) (evidence level-NHMRC IV), re-analysed the results from 5 
clinical studies looking at dietary calcium and bone mineral changes. The subjects’ 
age was clustered towards the 3rd, 5th and 8th decade and results showed a 
significant negative association between calcium intake and weight for all age 
groups. However, it is pointed out by Davies, that weight/fat loss was not the end 
point in these studies.  Jacqmain et al. (2003) (evidence level-NHMRC IV) analysing 
data from part II of the Québec Family Study (235 females and 235 males). After 
adjustment for age, daily energy intake, percentage dietary fat and protein, and 
markers of socio-economic status, there were negative correlations between daily 
calcium intake and percentage body fat, BMI, fat mass and waist circumference. 
Comparative trends were observed in men, but not after adjustment for the same 
covariates. Similarly, a negative inverse correlation was found between the intake of 
dietary calcium and abdominal obesity in 63 year old Swedish men (Rosell et al. 
2004) (evidence level-NHMRC IV).   This same relationship was found in black and 
white men and white women (but not in black women) (Loos et al. 2004) (evidence 
level-NHMRC IV). In a longitudinal study of milk intake and ishaemic heart disease 
and stroke in males from Wales, cross-sectional data at baseline indicated that men 
who drank at least one pint of milk (500 ml) had a BMI of 25.4 kg/m2, whereas those 
who drank little or no milk had a BMI or 26.7 kg/m2 (P<0.001) (Elwood et al. 2004) 
(evidence level-NHMRC IV). A similar relationship has also been demonstrated 
from an examination of the data from the National Nutrition Survey 1995 of 
Australia. Soares et al. (2004) showed that Australian men and women with higher 
calcium intakes, had lower BMIs as well as waist circumferences (data controlled for  
various confounders) (evidence level-NHMRC IV). 
 
Three more recent studies have also demonstrated the link between dairy 
consumption and body composition. In the Tehran Lipid and Glucose Study (223 
males, 239 females) a negative association was observed between dairy consumption 
and BMI (Mirmiran et al. 2005)(evidence level-NHMRC IV). This association was 
also demonstrated in Portugese men and pre-menopausal (Marques-Vidal et al. 2006) 
(evidence level-NHMRC IV) and pre-menopausal African-American women, who 
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described  themselves as lactose-intolerant (and hence had a low calcium intake) had 
(Buchowski et al. 2002) (evidence level-NHMRC IV).  Finally a number of studies 
that have addressed the link between calcium and/or dairy intake and risk of heart 
disease/stroke have cross-sectionally analysed the data at baseline and have 
concluded that a higher dairy intake (Shaper et al. 1991; Abbott et al. 1996; Bostick 
et al. 1999)  or calcium intake (Van der Vijver et al. 1992; Iso et al. 1999) is 
associated with a reduced BMI (evidence level-NHMRC IV).  
 
Only three reported studies have found no association between high and low tertiles 
of milk intake and BMI (Ness et al. 2001; Kamycheva et al. 2003; Venti et al. 2005) 
(evidence level-NHMRC IV).    
 
Although a large number of cross-sectional studies from around the world are in 
agreement that there is an association between calcium and/or dairy in body 
composition, these studies do not indicate a causal link. In many of these studies 
dairy intake is often used as a surrogate measure for calcium intake; because dairy 
calcium comprises the primary source of dietary calcium in the US and Australian 
diet. It is also important to note that a low calcium intake may be associated with a 
less healthy lifestyle, diet or lower socio-economic status (Barger-Lux et al. 1992; 
Teegarden, 2005).  It should also be noted that these types of studies use “reported 
dietary intake” and underreporting of dietary intake in overweight and obese subjects 
is a major confounder in these types of studies (Black & Cole, 2001; Livingstone & 
Black, 2003).  It has also been suggested that dietary calcium may only have an 
effect under certain circumstances, such as during weight loss of obese subjects or in 
subjects with a vitamin D insufficiency. Likewise, it may be that there is a threshold 
effect for calcium, and epidemiological studies are not sensitive enough to pick up 
these effects.       
 
1.4.1.3 Longitudinal Observational Studies   
(Refer to Table 1:5) 
Heaney et al. (2003) reanalysed data already published by Davies et al. (2000) from 
2 cohorts of women studied from 1984 to 1985 and 1995 through to 1997. In total 
564 women were enrolled in the studies examining calcium intake and bone density 
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(348 were studied once, 70 were studied for 8.5 years and 146 were studied for 22 
years). The young women at the 25th percentile of calcium intake for the group had a 
15% prevalence of being overweight, whereas when the women with the highest 
quartile for calcium intake (equivalent to the American Recommended Daily 
Allowance (RDA) had only a 4% prevalence of being overweight.  In the analysis of 
women in midlife, women at the 25th percentile of intake of calcium gained weight 
on average of 0.42 kg per year; whereas the RDA of calcium was consumed there 
was a weight loss of 0.011 kg per year. Heaney goes on to conclude that although 
calcium intake only explains a small fraction of the variability in weight or weight 
gain, an increase of calcium intake across the population could reduce the prevalence 
of obesity by as much as 60-80%.   
 
In the Amsterdam Growth and Health Longitudinal Study, subjects were tracked 
from age 13 years (1977) to age 36 (2000) (Boon et al. 2005b).  The authors found a 
weak inverse relation of calcium intake to body composition. They also report no 
differences between the middle (800-1200 mg/day) and high (>1200 mg/day) groups 
of calcium intake, which may suggest that there is a threshold effect whereby greater 
than 800 mg / day has no additional benefits on body composition. 
 
Two longitudinal studies in young adults (18-30 years) followed for 10 years 
(CARDIA Study) (Pereira et al. 2002) and a 2 year exercise study in young women  
(Lin et al. 2000) have shown similar results.  In the CARDIA study at baseline, 
overweight individuals consumed dairy products less frequently than their normal 
weight counterparts (P=0.01). After a 10 year period the incidence of developing 
obesity in subjects who were overweight at baseline was 64.8% for those in the 
lowest quintile of dairy intake, compared with 45.1% for those in the highest quintile 
of dairy intake (P<0.001). When a BMI of 30 kg/m2 and a WHR of 0.90 (men) and 
0.85 (women) were evaluated separately, the odds of developing both conditions 
were lower (OR 0.81 for BMI and OR 0.89 for WHR) with each daily increment of 
total dairy intake over ten years in those who were overweight at baseline. In Lin et 
al. (2000) exercise study when calcium was adjusted for energy intake there was a 
negative relationship with the 2 year changes in total body weight and body fat and  
the young women with higher intakes of calcium gained less fat over the two years. 
Another study in young women who had followed a one-year dairy intervention (no 
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fat mass change at one-year); however, at 18 months of follow-up the high dairy 
group had maintained an elevated calcium intake compared with the control group. 
Using regression analysis the high calcium group also predicted a negative change in 
fat mass, controlled for BMI (Eagan et al. 2006).    
 
Newby et al. (2004a)  study looked at 459 men and women and assessed dietary 
intake (using 7-day food diaries) and changes in body composition were assessed 
over 25 months. Using a multivariate adjusted models in which highest and lowest 
quintiles for food pattern 1 (reduced fat dairy products, fruit and fibre) were 
compared; factor 1 was inversely associated with an annual change in BMI in women 
and inversely associated with waist circumference in both sexes. A sample of 
subjects from the Quebéc Family Study were measured twice ~6 years apart. 
Consumption of two food patterns (whole fruit intake and skimmed milk and partly 
skimmed milk) were negatively correlated with the changes of waist circumference 
and percentage body fat (Drapeau et al. 2004).  Again using retrospective data it was 
demonstrated that middle-aged women (but not men) who habitually consumed 
greater than 500 mg of calcium per day, had less of a weight gain than non-calcium 
consumers over 10 years (Gonzalez et al. 2006).  
 
More recently, Rajpathak and colleagues (2006)  found no association between 
calcium, dairy intake or supplemental calcium and body weight changes over 12 
years follow-up data from the Health Professional Study, which is a prospective 
cohort of men aged 40-75 years.  Although the findings were that the men with the 
greatest increase in total dairy intake gained slightly more weight than did the men 
who decreased their consumption; it must be noted that this is likely contributable to 
the mens increased consumption of high-fat dairy foods.     
 
All the above mentioned studies have been given a NHMRC level of evidence of IV. 
Although they are all prospective in nature, these studies are not intervention based, 
have no control group and merely determine predictions of weight / fat gain based on 
dietary calcium intake measured at certain time-series.  
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1.4.1.4 Randomised Clinical Trials 
As the idea of calcium and in particular dairy calcium is a fairly new area of 
research, to date there have only been a limited number of well-designed randomised 
control trials. Some of the studies have been designed with weight loss as the 
primary outcome and hence the diet plans were hypocaloric, versus studies designed 
to address body composition changes whilst following eucaloric intakes, these two 
areas have therefore been divided into separate sections. Similarly, there has been 
interest in the effect of calcium supplements versus dairy; again these two topics will 
be covered separately.   
 
1.4.1.4.1 Randomised Clinical Trials – adequate dairy intake versus       
inadequate dairy intake during energy restriction  
(Refer to Table 1:6) 
One of the first RCT that involved dairy foods and weight loss was a study designed 
to test a novel, but simple weight loss design versus a standard energy-restricted diet 
in obese outpatients. The outcome from this study was a greater weight loss on the 
milk (and unsweetened yoghurt) only diet (11.2 kg (SD 5.2) versus 2.6 kg (SD 4.1) 
on the standard diet. At the time this was an unexpected outcome; however, the 
authors contributed the result to the novelty and simplicity of the diet that the 
subjects had to follow (Summerbell et al. 1998) (evidence level-NHMRC II).  More 
recently three clinical studies that were designed to specifically address the 
hypothesis of dairy calcium intake and body composition were undertaken by 
Zemel’s group that have all shown a high dairy calcium diet has an enhanced effect 
on weight and fat loss particularly from the abdominal region, with a preservation of 
lean tissue mass (Zemel et al. 2004; 2005a; 2005b).  In their 2004 study, Zemel et al. 
randomised 32 obese subjects to a standard calorie-deficient diet alone, a calorie-
deficient diet supplemented with calcium or a calorie-deficient diet supplemented 
with dairy products. As was expected all subjects lost weight, the control group lost 
6.4% of their body weight, the high-calcium group lost 26% more weight (8.6%), 
whilst the high dairy group lost 70% more weight (10.9% of body weight) (P<0.01). 
More interestingly greater fat was lost from the trunk region, this was 19% of total 
fat loss on the low calcium diet and this fraction was increased to 50.1% and 66.2% 
(P<0.001) on the high-calcium and high-dairy diets, respectively (Zemel et al. 2004) 
 Chapter 1: Literature Review  
40
(NHMRC – level of evidence III-I). In their second study, obese subjects were 
randomised to a control diet or a high-dairy (from yoghurt) diet on an energy-
restricted 12-week weight loss study. As with the previous study, the high-dairy 
group lost significantly more fat (-4.43 kg versus -2.75 kg), whilst lean tissue was 
reduced by 31% on the yoghurt diet. Again trunk fat loss was augmented on the 
yoghurt versus the control diet and this was reflected by a greater reduction in waist 
circumference  (Zemel et al. 2005a) (NHMRC – level of evidence III-I). 
 
Zemel et al. third RCT was looking at weight loss and maintenance (discussed 
below) in African-American adults (2005b). Twenty-nine subjects were randomised 
to a low dairy (LD) (~500 mg calcium) versus a high dairy (HD) (~1300 mg of 
calcium) diet with calorie restriction of 500 kcal per day, the subjects followed this 
protocol for 6 months. Subjects achieved significant weight loss on both arms of the 
study; however, the HD diet achieved a 2-fold greater weight loss (LD -5.954 kg, HD 
-11.02 kg P=0.01), the loss of lean body mass was also markedly reduced with the 
HD diet (LD -1988 g, HD -148 g, P=0.001) (NHMRC – level of evidence III-I).   
     
Not all data supports the findings of Zemel’s group, a recent study by Harvey-Berino 
and colleagues (evidence level-NHMRC III-I), replicated the design of Zemel’s 
weight loss studies. Fifty-four subjects were randomised onto a calorie restriction 
diet of 500 kcal/day and either following a low dairy or high dairy diet (2005).  As 
would be expected from a weight-loss trial both groups lost a significant amount of 
weight or body fat at the end of the 6-month period; however, there was no 
significant difference between the dietary groups for weight (P=0.56) or body fat 
(P=0.37).  Similarly, a study by Thompson et al. (2005) (evidence level-NHMRC III-
I)  comparing a moderate (not low) dairy calcium diet (800  mg Ca/d) with a high 
dairy calcium diet (~1400 mg Ca/d) and found no difference between the groups for 
weight or body fat.  A lack of significant change in weight or body fat loss was also 
found in Bowen et al. study (2005) (evidence level-NHMRC III-I). It is important to 
note that this study; however, was manipulating the protein content of the diet, as 
well as calcium. The diets provided either a high-dairy protein, high-calcium diet 
(2400 mg Ca/d) versus a high mixed protein, moderate calcium (500 mg Ca/d) for 12 
weeks of weight loss followed by 4 weeks of weight maintenance.  
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1.4.1.4.2 Randomised Controlled Trial – Calcium supplementation & weight 
loss  
To date, there are limited RCT that have attempted to address the question of calcium 
supplementation and its effect on weight and fat loss in humans. Most of the studies 
found with weight loss end-points, were studies designed with bone mass or fracture 
rate incidence in mind.   
 1.4.1.4.2.1 Supplementation with energy restriction  
In brief, four studies have included a supplemental protocol with restriction of calorie 
intake (Ricci et al. 1998; Jensen et al. 2001; Shapses et al. 2004; Major et al. 2007), 
whilst one study supplemented the subjects with calcium whilst they consumed an 
isocaloric diet (Reid et al. 2002). 
 
Shapses et al. (2004) pooled the results from 3 separate, randomised, placebo-
controlled trials, with subjects receiving 1 g of supplemental calcium (subjects were 
100 pre- and post-menopausal women), followed for 25 weeks. Results showed no 
differences between body weight or fat between the supplemented versus the placebo 
group. Similarly, no differences in weight loss between groups following weight loss 
for 3 months (strict liquid formula diet)  (Jensen et al. 2001), or in the supplemented 
group (provided with dietary counselling for calorie restriction) when measured at 
the end of 6-months (Ricci et al. 1998).   In a more recent study conducted in 63 
overweight/obese subjects, a 700 kcal/d energy-restricted diet was followed, and 
supplemented with 1.2 g/day of elemental calcium (plus  400 IU vitamin D) or a 
placebo, there was no difference between the groups for weight, fat mass or waist 
circumference (Major et al. 2007).   Barr’s (2003) review paper found 12 studies that 
provided information on calcium supplementation and weight loss end-points, a 
further 5 studies were included that weight loss end points could be obtained from 
the study authors.  There was a strong conclusion that in 16 of these studies, the 
calcium supplemented group did not elicit greater weight loss than the placebo 
group.  The one study that did find a reduction in weight (or lesser weight gain) in 
the supplemented group, was in a long-term (>4 yr) study, without energy restriction.  
The only other study that found greater reductions in weight, fat mass and trunkal fat,  
was Zemel’s group, with one of his weight loss arms being given a supplement of 
800 mg of calcium (total intake ~1300 mg) (2004).   
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1.4.1.4.2.2 Supplementation without energy restriction  
In Reid et al. study (2002), subjects were provided with a 1 g/day calcium 
supplement or placebo, without changes to usual dietary intake. Subjects were 
assessed at 30-months; the results indicated no difference in weight lost or changes in 
fat mass.  
 
In summary, only two of the above mentioned studies were able to demonstrate a 
relationship between a higher supplemental calcium intake and greater weight or 
body fat loss.  However, it must be noted that all of studies, except Major et al. 
(2007) and Zemel et al. (2004), were designed with bone measures as end-points and 
therefore were possibly not powered to pick up differences in anthropometrical 
measurements.  Similarly, in all but the two previously mentioned studies, the 
subjects did not follow strict dietary protocols for calorie restriction, but were rather 
provided with behaviour modification and general instructions on moderately 
reducing food intake. This throws open the question of compliance in such studies, 
especially when the length of the studies are considered.  
 
1.4.1.4.3 Randomised Control Trial – weight maintenance  
(Refer to Table 1:8) 
More recently Zemel has suggested that the benefits of dairy on body composition 
can be achieved without energy-restriction. In his original trial, investigating the 
antihypertensive effect of calcium in obese African-Americans, it was observed that 
the group provided with 2 cups of yoghurt per day (increasing calcium from ~400 to 
1000 mg /d) for a year resulted in a 4.9 kg reduction in body fat (Zemel et al. 2000). 
In his latest study (Zemel et al. 2005b), 34 obese African-Americans were 
maintained on a low calcium/low dairy diet (LD) or a high-dairy diet (HD) with no 
change in energy intake. Body weight remained stable for both groups; however, the 
high-dairy group had significant reductions in body fat (LD -0.169, HD -2.158, 
P<0.01), and trunk fat (LD -0.357, HD -1.026, P<0.01) and an increase in lean mass, 
whereas there were no significant changes in the low-dairy group (LD 0.283, HD 
1.08, P<0.04).            
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The above findings were not replicated in Gunther et al. study (2005a) (evidence 
level-NH&MRC III-I). They studied 155 normal-weight young women, randomly 
assigned to one of 3 groups (1. control: maintain dietary intake; 2. medium-dairy: 
increase dairy intake to achieve 1100 mg calcium and isocaloric intake; 3. high-dairy 
group: substitute dairy products to achieve 1300 mg calcium and an isocaloric diet). 
The authors of this study did not find any weight loss differences between the three 
dietary groups at the end of the one-year period.  
 
In an interesting review paper by Barr (2003) a MEDLINE search (1966-2001) 
(Table 1:9) located nine articles examining dairy supplementation and body weight 
or composition. In seven of these studies, no significant differences in the change in 
body weight or composition were detected between treatment and control groups. 
However, two studies conducted in older adults detected a significantly greater 
weight gain in the dairy treatment group.  However, in interpreting these results, it is 
important to add that these studies did not instruct the participants to reduce their 
energy intake to compensate for the increase in energy from a high dairy intake. In 
fact one of the studies reported that although there was a greater weight gain on the 
dairy treatment group, the weight gain was not as much as would be expected from 
simply adding milk to the usual diet (Barr et al. 2000).      
 
1.4.1.5 Pitfalls of current RCT Studies   
What is clear from the studies previously mentioned is that there is a lack of 
consistency of study endpoints.  Only, one group of researchers have been able to 
draw clear and significant conclusions for a role for calcium and dairy calcium in 
weight/fat loss (Zemel et al. 2004; 2005a; 2005b), or dairy alone (Zemel et al. 
2005a).  Other studies, which have looked at only the role of dairy calcium on weight 
loss, have failed to show any significant difference between the treatment groups 
(Bowen et al. 2005; Harvey-Berino et al. 2005; Thompson et al. 2005).  Reasons for 
these discrepancies may include the following:   
 
1. Lack of a true placebo-controlled experimental arm 
The role of dairy and its effect on weight loss had become a very popular news item 
with the media (West Australian, Jan 22, 2003; Today Tonight, February 2003), 
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especially during the recruitment phase of our studies.  The design of a true placebo-
controlled study is required to eliminate bias form subjects not on the “dairy-rich” 
diet. Subjects who realise they are allocated to the “control” diet, can reduce their 
compliance and adherence to the study protocol.  
 
2. Does calcium have an effect without vitamin D? 
This was the first Australian study to test Zemel’s hypothesis, and hence the use of a 
typical Australian diet meant the reliance on calcium-rich products that are not 
vitamin D enriched, as in the United States.  
 
3. Does amount of fibre in the diet matter? 
We also provided diets closer to the RDI for fibre; there were two reasons for this: 
(a) to ensure the diets were closer to usual/recommended intakes and (b) It has also 
been reported that higher intakes of calcium can lead to constipation (Arnaud & 
Sanchez, 1990; Soffer, 1999), to avoid this we ensured that the diets meet fibre 
recommendations ~28 g / day. Zemel’s et al. studies gave only 8-12 g / day of fibre; 
however, they make no comment on symptoms reported by the subjects. 
 
 
4. Energy deficit based on empirical kJ reduction or on body size 
considerations?  
A fixed energy deficit (500 kcal or more) to all subjects means that, depending on the 
study design (see below), some would loose more and some less weight as it would 
tax different proportions of energy requirement.  Our study was the first to utilise 
indirect calorimetry methods to determine BMR and hence fix the energy 
requirements of the subjects at the same plane of nutrition. This is not only a more 
accurate method, compared to using energy equations, but allows for greater control 
based on body size.  
 
5. Study design consideration  
Most studies have utilised an open parallel design which necessitates greater control 
of potential confounders between groups.  No reported study has indeed made a good 
attempt to examine their data after controlling for confounders. Our study bypassed 
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these limitations by employing a with-in subject, cross-over designed study.  Further 
our analysis will account for period, sequence and treatment effects.  
 
1.4.1.6 Studies conducted in Children  
The majority of dairy-weight loss studies have been conducted with adults; however, 
several longitudinal and cross-sectional studies are now emerging that have found an 
association between dairy in promoting a healthy weight or preventing an unhealthy 
weight gain among children and adolescents. As the focus of this thesis was utilising 
the adult population, only a brief overview of the studies carried out in children will 
be discussed.    
 
A study in 8 year old children by Skinner et al. (2003) used statistical modelling to 
demonstrate that children could reduce their body fat by 0.4% simply by drinking an 
extra 200 ml glass of skim milk or 200 g of low-fat yoghurt each day. Similarly, 
Carruth and Skinner (2001) looked at the longitudinal food consumption of 
preschoolers aged 24-60 months and related the findings to body composition at 70 
months. They concluded that higher intakes of calcium and servings of dairy were 
associated with lower body fat levels. Similar results have been found in a recent 
study of children aged 6 followed yearly until 13 years of age. These results 
concluded that children in the lowest sex-specific tertile of dairy intake at preschool 
(<1.25 serves per day for girls and <1.70 serves per day for boys) had significantly 
greater gains in body fat during childhood (as measured by sum of 4 skinfold 
measurements). In addition, by the time the cohort reached early adolescence, those 
in the lowest tertile of dairy intake had higher BMIs by ~2 units and an extra 25 mm 
of subcutaneous fat (Moore et al. 2006).  Cross-sectional data by Novotny et al.  
(2004) indicates that total calcium and dairy-calcium intake were negatively 
associated with both iliac skinfold thickness and weight,  and these associations were 
greatest in girls of Asian ancestry than Caucasian girls.  A complex relationship was 
found in a cross-sectional and longitudinal study of hypercholesterolemic (HC) and 
normo-cholesterolemic (NC) children (Dixon et al. 2005).  After adjustment for age, 
sex, energy intake and percentage energy from fat, calcium intake was inversely 
associated with BMI, sum of skinfolds, and trunk skinfolds at baseline and over 1 
year in 7-10 year old non-HC children. An inverse relation was also found between 
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dairy food intake and measures of obesity at baseline in these children; however, 
calcium and dairy food intake was not associated with measures of obesity in HC 
children or in the 4- to 6-year old non-HC children.  A large cohort (884) of Italian 
children (mean age 7.5 + 2.1 years), had their height and weight measured along with 
lifestyle and dietary habits assessed, as part of a survey on childhood obesity.  The 
frequency of consumption of milk was inversely and significantly associated (t=-
2.964, P=0.003) with age-and sex-specific BMI z-scores when controlled for sex, 
age, physical activity, birth weight and parental overweight and education (Barba et 
al. 2005). Likewise, in cross-sectional data of 1701 children, a significant association 
was found between obesity and low intakes of dairy products (Olivares et al. 2004).    
 
Several studies have now emerged that have found no association between dairy 
consumption and body weight/BMI. One was a prospective cohort study of 1,345 
children (from low income families) aged 2 to 5 years (Newby et al. 2004b).  
Secondly, a longitudinal study in adolescents that found no association between dairy 
or calcium consumption and BMI-z score or percentage body fat (Phillips et al. 
2003).  Likewise, in cross-sectional data from an eating-behaviour study of 78 Pima 
Indian children (aged 10.4 + 0.3 years),  height, weight and DEXA measurements 
were taken and food intake measured by 24-hour recall, with assistance from parents. 
There were no significant associations between calcium intake and body weight 
(r=0.04, P=0.73), body fat (r=0.12, P=0.42) or body mass index (r=0.04, P=0.77) 
(Venti et al. 2005).  
 
To date, only three randomised controlled trials have been conducted in children.  It 
is important to note that whereas the adult studies have been interested in weight 
loss, in this group of subjects who are still growing (and hence gaining weight), the 
subjects have been supplemented with additional calcium and the difference in 
weight gain noted.  The first study by Chan et al.  (1995) divided 48 pubertal girls 
(age 11 years) into two groups of either consuming their usual dietary intake or 
supplemented with dairy foods to achieve ~1200 mg calcium per day. There were no 
differences between the total energy or fat intake between the groups and no 
differences between the groups for body weight or body fat levels; however, it is 
important to note that the main study outcome was bone mineral content and density 
rather than body composition changes. Similarly, in a 24-week study by Lappe’s 
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group (2004), there were no differences in weight gain in pubertal (mean age 9 
years), although the girls in the treatment group had consumed nearly twice as much 
dietary calcium. The increase in calcium came primarily from dairy foods, which had 
resulted in a ~150 calorie (628 kJ) greater consumption per day; however, they did 
not have greater increases in body weight, BMI or fat mass compared to girls 
consuming their usual dietary intake providing ~900 mg calcium per day.  In a study 
by Lorenzen’s group (2006) 110 girls (mean age 13.3 years) were assigned to two 
groups, either a medium or low calcium intake,  based on their habitual calcium 
intake.  The girls were then randomised to receiving 500 mg calcium carbonate or a 
placebo for one year. These researchers found that the girls habitual calcium intake 
was inversely associated with body fat (r=-0.242, P=0.011). However, calcium 
supplementation had no effect on height, body weight, or percentage body fat.   
 
Only one study, that the author is aware of, reported a negative response of dairy and 
or calcium intake in children.  Berkey et al. (2005) followed a cohort of 12,829 
children aged 9 to 14 years. Annual weights and heights were recorded and food 
frequency questionnaires were completed to determine the past years food intake.  
The authors concluded that the children who drank more milk gained more weight.  
It is important to note, that the weight gain was probably due to excess calorie intake 
by the group who drank more milk.  Interestingly, dietary calcium, skim and 1 % 
milk were associated with weight gain, but dairy fat was not.          
 
1.4.1.6.1 Summary – Dietary Calcium’s role in Weight Loss  
Some animal studies (NHMRC – level of evidence V) have demonstrated a role for 
dairy / calcium and weight loss (Zemel et al. 2000; Sun & Zemel, 2004); however, 
these findings have not always been consistent (Zhang & Tordoff, 2004).  
Epidemiological studies (McCarron, 1983; Davies et al. 2000; Heaney, 2003; 
Jacqmain et al. 2003; Parikh & Yanovski, 2003; Soares et al. 2004; Azadbakht et al. 
2005) support a clear role for calcium, and in particular, dairy foods in the regulation 
of weight. However, these types of studies do not indicate a causal link and it has 
been suggested that low calcium intake may also be associated with less healthy 
lifestyles, diet or other social status indicators (Barger-Lux et al. 1992; Teegarden, 
2005).  These types of observational studies in this review were allocated a NHMRC 
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level of evidence of IV.  RCT are expected to provide a high level of evidence for a 
cause-effect link; however, due to the novelty of this topic the research to date is 
very limited.  Only two reviews of RCT, one non-systematic (Barr, 2003) and the 
other a systematic review (Trowman et al. 2006) have concluded that there was no 
association between calcium supplementation and a reduction in body weight.  
However, with both these reviews, the data was drawn from studies that did not 
begin with weight regulation/ loss as an endpoint.  To date, there are only five RCT 
designed specifically to relate dietary calcium/dairy to weight loss.  Three of these 
studies, all from the same laboratory, have found a positive role of dairy calcium in 
augmenting weight loss  (Zemel et al. 2004; Zemel, 2005a; Zemel, 2005b). Due to 
the limitation of blinding such studies (parallel design) the level of evidence 
(NHMRC) given to these studies was III-I.  Two more recent RCT have replicated 
the design of Zemel’s weight loss studies and found no difference between the 
groups for weight or body fat (Harvey-Berino et al. 2005; Thompson et al. 2005).  
Both these studies were given an NHMRC level of evidence of III-I.  It is clear from 
the evidence to date, that there is a paucity of well-designed RCT, with NHMRC 
level of evidence II designed studies. The RCT’s discussed above are parallel in 
design, which can lead to many confounding errors (see section 1.4.1.5). In an 
attempt to avoid such pitfalls our weight loss study was designed as a cross-over 
design in which the subjects were truly “blinded” to the dietary intake.  
 
1.4.2 Dairy and Weight: other bioactive compounds  
Along with the calcium component of dairy products there is growing evidence that 
there may be other bioactive compounds, which could be responsible for 
improvements to health outcomes. Milk contains approximately 5% lactose, 3.2% 
protein, 4% lipid and 0.7% mineral salts. It is these components that gives milk and 
milk products their nutritional value (Shah, 2000).   
1.4.2.1 Whey  
Whey proteins comprise approximately 20% of total milk proteins. β-Lactoglobulin 
represents half the total protein in the whey of cows’ milk.  Whey has been 
recognised as a rich source of bioactive compounds (Shah, 2000); and it has been 
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suggested by Zemel that they may act independently, as well as, synergistically with 
the calcium in milk to attenuate lipogenesis and accelerate lipolysis (Zemel, 2003b).   
 
One of these health benefits seems to stem from the insulinotrophic effects that milk 
may elicit. The potential health aspects of the insulinotrophic effects of milk remain 
unclear. Hyperinsulinemia, mediated from hyperglycemia seems to be a risk factor 
for diseases that are collectively called the Metabolic Syndrome. It has been shown 
that experimentally induced hyperinsulinemia under normoglycemic conditions 
decreased insulin sensitivity in healthy subjects. Recent research seems to suggest 
that milk proteins, in particular the whey fraction have a stimulating effect on insulin 
secretion in healthy subjects (Nilsson et al. 2004). The mechanism for this 
stimulatory effect is unclear, but it has been suggested that specific insulinogenic 
amino acids or other bioactive peptides that are originally present in the whey or 
formed during digestion could promote these effects. Research by Nilsson’s group 
has indicated that the incretin hormones seem to be involved, in particular glucose-
dependent insulinotrophic polypeptide (GIP), which has been shown to significantly 
increase in plasma following the ingestion of a whey-based meal. Furthermore, 
glucagon-like peptide (GLP-1) is known to have insulinotrophic properties during 
normal plasma glucose concentrations (Vilsboll et al. 2003).  A recent study has 
shown that the same elevated insulin response with a consequential reduction in the 
postprandial blood glucose area under the curve was observed in diabetic subjects 
when administered whey protein at a breakfast and lunch meal based on high 
glycemic foods (Frid et al. 2005).        
 
As discussed previously in section 1.3.6.1.1.1, whey protein has a greater effect on 
food intake due to its faster absorption rate and hormonal response, compared to 
casein. Whey consumption leads to higher plasma concentrations of factors known to 
contribute to satiety including amino acids, glucose-dependent insulinotrophic 
polypeptides, GLP-1 and CCK.  Whey proteins also contain significant angiotensin-
converting enzyme (ACE) inhibitory peptides (see section 1.4.2.5).    
1.4.2.2 Branched chain amino acids (BCAA) 
The BCAA’s leucine, isoleucine and valine, but especially leucine plays a specific 
metabolic role in the regulation of energy metabolism and muscle protein synthesis.  
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In skeletal muscle, leucine stimulates protein synthesis and inhibits protein 
catabolism.  Leucine stimulates protein synthesis through the mammalian target of 
rapamycin (mTOR) pathways, 70-kDa ribosomal protein S6kinase activity and 
enhances eukaryotic initiation factor (elF)4E-binding protein phosphorylation and 
the association of elF4E with elF4G.  Accordingly the three BCAA’s are relatively 
abundant in the food supply, with dairy products being a particular rich source 
(Layman, 2003).       
 
Layman (2003) proposes that leucine has a metabolic role in maintaining glucose 
homeostasis and stimulating protein synthesis, particularly when subjects are energy 
restricted with exercise. Layman’s study had subjects following a high protein (1.5 
g/kg body weight) and 10 g leucine/kg for 16 weeks with a 5-day/ week exercise 
protocol, versus a low protein diet and the same exercise.  The high-protein diets 
elicited a greater weight loss, primarily from body fat; in addition to this at week 4, 
10 and 16, the subjects on the high-protein protocol had higher lean body mass. 
These findings are consistent with other studies in that leucine appears to have a 
protein sparing effect under energy-restriction, weight-loss diets (Skov et al. 1999; 
Layman et al. 2003). However, the mechanism for this finding is yet to be 
established.  
1.4.2.3 Vitamin D 
Without adequate vitamin D, the small intestine absorbs no more than 10-15% of 
dietary calcium. In a person with vitamin D sufficiency, the small intestine absorbs, 
on average 30% of dietary calcium during growth, lactation and pregnancy, with the 
efficiency increasing to 80% (Holick, 2004).   According to Bell et al. (1985) obesity 
is often associated with vitamin D deficiency.  It has been shown that whether the 
vitamin D is ingested in the diet or obtained from sunlight, it becomes stored in the 
large body fat stores in obese subjects and is not bioavailable (Wortsman et al. 
2000).  In the US there is mandatory fortification of milk and butter/margarine 
products with vitamin D; whereas only a limited number of  milk products are 
presently vitamin D fortified in Australia.      
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1.4.2.4 Conjugated Linoleic Acid (CLA) 
Conjugated Linoleic Acid (CLA) refers to a group of polyunsaturated fatty acids that 
exist as positional and stereoisomers of conjugated dienoic octadecadienate. The 
predominate isomer found in foods is the cis-9, trans-11-CLA isomer, and this is 
found mostly in ruminant animals, and in particular dairy products (Belury et al. 
2003).  Park et al.  were the first to report that incorporating 0.5% CLA in the diets 
of mice reduces body fat by ~60% (1997). These findings have since been supported 
by other mice studies (Park et al. 1997; West et al. 1998; Terpstra et al. 2002). The 
body-fat lowering effect of CLA has been reported in other experimental animals, 
such as pigs, rats, hamsters and chickens, but the effect has been less striking in mice 
(Terpstra, 2004).  A review by Terpstra (2004), of eight human studies reported that 
none of the studies found a significant reduction in body weight, and only 2 studies 
showed a significant, but small body-fat lowering effect. Similarly, a RCT testing 
two CLA isomers on weight loss in 81 middle-aged men, failed to find a significant 
change in body composition (Malpuech-Brugére et al. 2004). Likewise, in Larsen et 
al. (2006), a study of 101 men who were assigned to the ingestion of 3.4 g/d of CLA 
or placebo of olive oil, with a modest calorie restricted diet, (following a lead-in of 
>8% weight loss for 1 year), the supplementation of the CLA failed to prevent 
weight or fat mass regain. Wahle et al.  states that studies in humans are sparse and 
contradictory. They report a number of reasons for these differences in results; 
namely, lower dosages of CLA (g/kg bodyweight) are used in humans studies 
compared to the animal studies, and also growing animals may be more responsive 
than the mature human. It has been suggested that the CLA could be activating 
brown tissue in young animals. Brown adipose tissue is lost in older animals and 
humans (Wahle et al. 2004). It has also been reported that the CLA isomer that is 
involved in the body fat-lowering effect is the trans-10, cis-12 isomer, whereas > 
90% of the total CLA intake from food in humans is accounted for by the cis-9, 
trans-11 isomer.  It is also stated that CLA is only found in high fat containing dairy 
products and as all of the RCT studies that have found a positive effect of dairy on 
changes in body composition have used low-fat/non-fat milks and yoghurts (Zemel et 
al. 2004; 2005a; 2005b);  it is unlikely to be the CLA content of these foods that is 
the significant contributor to the weight loss observed.   
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1.4.2.5 Angiotensin-Converting Enzyme (ACE) Inhibitory activity  
The rennin-angiotensin-aldosterone system is a target for blood pressure control. 
Cleavage of angiotensinogen by rennin produces angiotensin I which is subsequently 
hydrolysed by angiotensin-I-converting enzyme (ACE), to angiotensin II, which is a 
potent vasoconstrictor. Milk proteins, both casein and whey, are a rich source of 
ACE inhibitory peptides (FitzGerald et al. 2004).   The milk proteins contain ACE 
inhibitory peptides encrypted within their primary structures, these peptides can be 
released by enzymatic hydrolysis either during gastrointestinal digestion or during 
food processing.  The ACE inhibitory activity is generally more associated with a 
antihypertensive effect; however, it has been reported that adipocytes have an 
autocrine/paracrine rennin-angiotensin system (RAS), and it has been suggested that 
adipocyte lipogenesis is regulated, in part by angiotensin II (Engeli et al. 2003; 
Zemel, 2003b; Abuissa et al. 2005).  Animal studies support this theory that the 
inhibition of RAS mildly attenuates obesity in rodents (Reckelhoff & Fortepiani, 
2004); however, limited human clinical studies support this (Zorad et al. 1995; 
Barton et al. 2003).    
 
1.5 Dietary Calcium and its Other Health Benefits  
The intake of dietary calcium has long been associated with the prevention of 
osteoporosis and there are a myriad of studies from all around the world to 
demonstrate this (Nordin, 1997; Reid, 1998; Heaney, 2000; Cosman, 2005; Nieves, 
2005).    However, dairy is now becoming more widely investigated for its links with 
improvements in other areas of health, namely lowering blood pressure, and 
improvements in the blood lipid parameters, along with reducing the risk of 
developing diabetes.  
 
1.5.1.1 Hypertension and the role of dairy calcium   
Hypertension is similarly a serious public health issue as it greatly increases the 
incidence from stroke and coronary heart disease.  Recent Australian data quotes the 
prevalence of hypertension in Australia to be ~29% (Briganti et al. 2003).  There is a 
direct positive relationship between overweight and hypertension, and it has been 
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estimated that the control of obesity may eliminate 48% of the hypertension in 
caucasians (El-Atat et al. 2003).  Evidence that dietary calcium can have an impact 
on blood pressure first emerged with the publication of McCarron’s paper in the 
early 1980s (McCarron et al. 1984). McCarron & Reusser (1999), in their paper 
“Finding consensus in the Dietary Calcium-Blood Pressure Debate” state that there is 
evidence from meta-analyses of 23 observational studies and 42 randomised 
controlled trials that identify statistically significant reductions in hypertension risk 
through an adequate calcium intake.  Findings from these meta-analyses seem to 
demonstrate considerable diversity in the blood pressure responses.  It seems that 
some of this diversity in results could be attributable to a possible “threshold effect”. 
 
1.5.1.2 Cardiovascular Disease 
Cardiovascular disease risk factors along with risk factors for the Metabolic 
Syndrome and Type II diabetes are closely tied in with obesity, this section will be 
given considerable expansion.   
 
Dairy consumption and in particular milk, have long being considered an important 
factor in coronary heart disease, because of the contribution it makes to the dietary 
intake of saturated fats. This belief that milk is a factor in heart disease along with 
weight gain, appears to have led to a decline in milk consumption in many countries 
(Elwood et al. 2005a), including Australia (Dairy Australia, 2005). For a brief 
overview of some of the available studies refer to Table 1:11.     
 
A cross-sectional study of 470 men and women taking part in the Québec Family 
Study, found that daily calcium intake was negatively correlated with plasma low 
density lipoprotein (LDL) cholesterol, total cholesterol, and total:HDL cholesterol in 
both sexes, and after adjustment for variations in body fat mass and waist 
circumference (P<0.05) (Jacqmain et al. 2003).  Similarly, in a study of 291 healthy 
men (age 62-64 years), with a range of insulin sensitivities, the subjects were divided 
into tertiles of percentage contribution of small dense-LDL (sd-LDL).  It was found 
that individual fatty acids, typically found in milk products, were associated with a 
more favourable LDL profile (i.e. fewer sdLDL particles) (Sjogren et al. 2004).  
However, this was not the case in a cross-sectional study of 12,610 Japanese men 
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(age 30-69 years), the cohort was divided into dairy consumers (Yes) versus non-
dairy consumers (No), based on a simply question “Do you drink a glass of cow’s 
milk (180-200 ml) everyday”. Multivariate models correcting for five confounding 
factors, demonstrated higher serum triglyceride levels (P<0.001) and LDL-
cholesterol (P<0.001) in the dairy-consuming group (Nagaya et al. 1996).    
 
In several further cross-sectional studies no difference or at least an insignificant 
change has been reported in blood lipid levels (Abbott et al. 1996; Barr et al. 2000; 
Ness et al. 2001; Elwood et al. 2004).   
 
An early randomised controlled cross-over study (Steinmetz et al. 1994) showed that 
after a 6-week consumption of either a background diet, following the 
recommendations from the American Heart Association, with either skim milk or 
whole milk, that total cholesterol was lowered in both diets,  but with a ~7% greater 
reduction on the skim milk versus the whole milk diet. Likewise, mean LDL-C were 
~11% lower on the skim milk versus the whole milk diet. A randomised controlled 
trial in 13 healthy men with moderate hypercholesterolemia, who had randomly been 
administered a low calcium diet (410 mg / day) versus a high calcium (2200 mg / 
day)  demonstrated a greater dietary saturated fat excretion per day (6 to 13%) with 
the calcium fortification.  The high calcium diet significantly reduced total 
cholesterol by 6%, LDL cholesterol by 11% and apolipoprotein A1 by 7% (P<0.05) 
when compared with the low Ca diet (Denke et al. 1993).  A review article by St 
Onge et al. (2000)  seems to confirm overwhelmingly, that milk and dairy products 
have a cholesterol lowering effect.  
 
A number of RCT looking at the effects of a high-dairy diet on weight loss have 
failed to show significant changes in blood lipids between the control and high-dairy 
diet.  Two of Zemel et al. studies, one with a -500 kcal/day deficit diet and using 
yoghurt as the dairy source (2005a) and secondly, a 24-week weight loss trial, 
standard low dairy/calcium diet, a high dairy and a high calcium diet (Zemel et al. 
2004),  reported a significantly greater weight loss in the high dairy/calcium group; 
however, neither of these studies found any differences in blood lipids, between the 
diet groups.  Similarly, in a weight maintenance trial in African-American subjects 
(Zemel et al. 2005b), where a significantly greater body fat reduction achieved in the 
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high dairy group, was 5.4%, P<0.01, no difference in blood lipids (total cholesterol, 
HDL-C or LDL-C) were reported.      
 
Two further RCT that manipulated the calcium content of the diets, but did not report 
greater weight losses between the dietary interventions, also did not see differences 
in the blood lipid levels (Bowen et al. 2005; Thompson et al. 2005).  Similarly, in a 
randomised-double-blind trial in 193 male and female subjects, given a calcium 
supplement of 1 or 2 g of calcium per day for 4 months, no significant differences 
between the high calcium versus the placebo groups for total cholesterol or high-
density lipoprotein-cholesterol (Bostick et al. 2000).  Barr et al. performed an open 
trail of 204 healthy subjects given advice to increase their milk intake to 3 cups per 
day, versus maintaining their usual diet for 12 weeks, no difference was found 
between the groups for total cholesterol, LDL-C, or the ratio of total cholesterol to 
HDL-C. However, triglyceride levels increased by 8%, but still within the normal 
range for the milk group, and remained stable for the control group (Barr et al. 
2000).            
 
The results from the research to date are mixed, but in summary it seems that no 
negative conclusion can be drawn between only milk intake and an increased risk 
from coronary heart disease.  A recent review paper highlighted the results from 10 
cohort studies and 2 case-control studies. The studies had been selected from a 
search on MEDLINE (using the key words: milk, dairy and dietary calcium and a 
range of words appropriate to vascular disease). The results from the 10 prospective 
studies were pooled, addressing the relative odds for ischaemic heart disease in the 
subjects with the highest milk intakes, compared to those with the lowest intakes, 
0.87 (0.74-1.03) and for stroke the pooled estimate is 0.83 (0.77-0.90). A pooled 
estimate of the odds for a vascular event in the 10 prospective studies, either heart 
disease of stroke, is 0.84 (0.78-0.90). The results were reassessed using energy intake 
as a confounding factor; the results still gave similar estimates, namely 0.85 (0.70-
1.03) (Elwood et al. 2004).   
 
In a recently published paper from data using a sub-population of the original 
Caerphilly Cohort study (commenced 1979-1983); subjects were asked to weigh and 
record their food intake for 7 days, to assess total milk intake. The results indicated 
 Chapter 1: Literature Review  
56
that the relative odds of an event in the men whose milk consumption was the 
median or higher, relative to those with lower intakes of milk, were 0.52 (0.27-0.99) 
for an ischaemic stroke and 0.88 (0.56-1.40) for an ischaemic heart event. These 
results are in line with the previous pooled results from Elwood et al. (2005b).    
 
In a Swedish case-control study to address whether intake of milk-fat influences 
cardiovascular risk, it was found that the intake of milk-fat was not negatively 
associated with cardiovascular disease and that the consumption of milk-fat did not 
increase the risk of a first acute myocardial infarction (Warensjö et al. 2004).  
Similar results were found in two other case-control studies, Gramenzi et al. (1990) 
in a retrospective case-control study, 287 women with acute myocardial infarction 
and 649 control women (with other acute disorders) who were admitted to hospital 
during 1983-89, were questioned about the frequency and amount of various foods 
consumed prior to the onset of symptoms of infarction. The odds ratio for the risk of 
myocardial infarction in the third of women with the highest consumption of milk, 
compared with the third with the lowest consumption, was 0.9. (1990).   Similarly, in 
Tavani et al. (2002) data from a case-control of non-fatal acute myocardial 
infarctions (AMI) conducted in Milan, Italy, versus a control group who were 
admitted to hospital for acute conditions unrelated to known or likely AMI risk 
factors.  Information on the diet was based on a validated food frequency 
questionnaire to determine prior consumption of milk and other dairy products.  The 
odds ratio for infarction in patients who drank seven or more cups of milk per week, 
compared to patients who drunk no milk, as 0.78 (0.58-1.08) after adjustment for 
numerous possible confounding factors.      
 
It is clear from these studies that dairy consumption, and in particular milk, does not 
cause an increase in blood lipid levels. And there does not appear to be a positive 
association between milk consumption and coronary heart disease risk.  
 
1.5.1.3 Metabolic Syndrome & Type 2 Diabetes 
If dairy calcium can be shown to improve weight or fat loss, an additional benefit 
may be seen by a concomitant reduction in insulin resistance.  Insulin resistance is 
associated with several metabolic disorders, such as, impaired glucose tolerance, type 
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2 diabetes mellitus, central obesity, hypertension and dyslipidemia, which together 
constitute the metabolic syndrome or insulin resistant syndrome (Reaven, 1988; 
Reaven, 2002). The Metabolic Syndrome can be diagnosed according to guidelines 
established by the World Health Organisation (WHO) in 1998-99, or more recently 
published diagnostic criteria by the National Cholesterol Education Program Adult 
Treatment Panel III (NCEP ATP III) in 2001 (Table 1:3) (Alberti & Zimmet, 1998; 
Scheen & Luyckx, 2003).  The central role of insulin resistance in the metabolic 
syndrome was established in the Bruneck Study, which evaluated the prevalence of 
insulin resistance in 888 subjects between the ages of 40-79 years (Bonora et al. 
1998).  The homeostasis model assessment method (HOMA), which takes fasting 
insulin and glucose levels into account, was used to estimate the level of insulin 
resistance. Insulin resistance was most prevalent in subjects with 
hypertriglyceridemia (TG > 2 mmol/L) (84.2%), low HDL cholesterol levels (HDL 
cholesterol < 1 mmol/L) (88.1%) and non-insulin dependent diabetes mellitus 
(NIDDM) (83.9%), and to a lesser degree hypercholesterolemia.   
Table 1:3 Diagnostic criteria for the metabolic syndrome according to the WHO 
and NCEP ATP III guidelines.  
Abbreviations: HOMA, homeostatic model assessment; BMI, body mass index; IGT, impaired 
glucose tolerance; WHO, World Health Organisation; NCEP ATP III, National Cholesterol Education 
Program  Adult Treatment Panel III.       
Risk Factor WHO 
Defining level 
NCEP ATP III 
Defining level 
Waist-to-hip ratio >0.9 - 
Waist circumference (cm) - Men >102 
Women >88 
HDL cholesterol (mmol/L) <0.9 Men <1.03 
Women <1.29 
Triglycerides (mmol/L) >1.7 >1.69 
Blood pressure (mmHg) >160/90 >130/85 
Fasting glucose (mmol/L) - >6.1 
HOMA >2 - 
BMI (kg/m2) >30 - 
Number of risk factors 
required for diagnosis 
>2 plus IGT and/or insulin 
resistance 
>3 
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A cross-sectional study of 2537 women and 2439 men assessed the habitual intake of 
several major food products, including dairy, by a food frequency questionnaire.  
They concluded that in men there was an inverse association with the presence of the 
metabolic syndrome (Mennen et al. 2000).  More recently, a cross sectional study in 
827 Tehranian adults, looked at several measures of the metabolic syndrome and 
concluded that those subjects in the highest quartile of dairy consumption had lower 
odds of having enlarged waist circumferences (p for trend <0.001), hypertension  (P 
for trend <0.02) and the metabolic syndrome (p for trend <0.02) (Azadbakht et al. 
2005).  A large observational study over ten years in overweight adults, identified a 
link between dairy consumption and a reduced risk (72% risk reduction) for 
developing insulin resistance (Pereira et al. 2002).   
 
The latest results from the ongoing Health Professionals Follow-Up Study have 
added some interesting findings on the relationship between dairy consumption and 
the risk of developing type 2 diabetes in men (Choi et al. 2005).  This study involved 
longitudinal monitoring of the dietary intake and health status in 41,254 male health 
professionals for 12 years, after an initial dietary assessment using a semi-
quantitative food frequency questionnaire. They concluded that there is a clear link 
between consuming more dairy foods (which included milk, yoghurt, cheese, ice 
cream and cream), and having a lower risk of developing type 2 diabetes over the 
following 12 years.  After adjusting for 14 confounding variables, it was found that 
those in the two highest quintiles of dairy consumption were 23-25% less likely to 
develop the disease than those in the lowest quartile (P=0.003). The research 
suggested that for each single serve increase in dairy consumption per day, the risk of 
developing diabetes was reduced by 9%.  The authors conclude that the protective 
effect of dairy is likely to be due to the lowering of risk factors from type 2 diabetes, 
such as body weight, hypertension and abnormal glucose homeostasis.  
 
Of the several RCT that have been specifically designed to address the issue of dairy 
calcium intake and weight/fat loss, only two of the studies by Zemel’s group 
indicated improvements in glucose function. Zemel et al. study  (2004), giving 3 
groups a -500 kcal deficit diet with either a low dairy (LD), high dairy (HD) or high 
calcium (HC) intake.  Glucose tolerance was not significantly different at baseline; 
however, the HD group exhibited a significantly improved glucose tolerance at 24 
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weeks and a 27% reduced area under the postprandial curve for glucose following a 
standard glucose load (P<0.01). Fasting plasma insulin levels also showed a 44% 
decrease in the HD group (P<0.01). Neither the LD nor the HC group exhibited any 
difference with regards to glucose or insulin levels. In Zemel’s study of African-
American obese subjects either following a weight reduction or weight maintenance 
diet, along with either a LD or HD diet, the weight loss arm of the study the subjects 
from both groups exhibited decreases in circulating insulin levels; however, the HD 
group had significantly greater reductions than the control (P<0.05).  Similarly, on 
the weight maintenance study, the HD group had significantly greater reductions in 
circulating insulin levels (P<0.05) (Zemel et al. 2005b).  Not surprisingly, it would 
appear that these results were obtained due to a greater weight or fat loss from the 
HD groups in Zemel’s studies, as Thompson et al. (2005) study comparing a 
moderate dairy calcium intake (~800 mg/day) versus a high dairy calcium intake 
(~1200 mg/day), they found no significant weight difference between the groups and 
although there were significant decreases in glucose and insulin levels, there was no 
treatment effect (P=0.44, P=0.89, for glucose and insulin, respectively).  Likewise 
Bowen et al. reported a similar weight loss for subjects following a high protein 
(dairy) diet versus a moderate protein (low dairy) diet,  fasting insulin levels 
decreased by the end of a 12 week (weight loss), and 4 week (weight maintenance), 
but was independent of treatment group. There was also no difference in an oral 
glucose tolerance test between dietary groups (Bowen et al. 2005). However, in Barr 
and colleagues study of a RCT–open trial of subjects instructed to increase their milk 
intake or maintain their usual intake, a small, but significant weight gain was 
reported in the milk intake group. Interestingly, the authors report that this modest 
weight gain of 0.6 kg was significantly less than expected for the additional energy 
intake. They reported a reduction of insulin in both groups, irrespective of treatment, 
a stable haemoglobin A1c; however,  there was a significantly (P<0.01) difference 
between groups for changes in glucose, the milk group had a less than 2% increase in 
glucose, whilst the control group had a reduction in glucose, but by less than 1% 
(Barr et al. 2000).  
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1.5.1.4 Bone Health  
The Weight Loss industry is now a billion dollar business, with a wide array of diet 
programs and weight-loss centres to chose from (Weight Watchers, Jenny Craig 
Weight Loss Centres, Cohen’s Lifestyle Clinics, SureSlim Wellness Clinics, to name 
a few).  Along with these weight loss centres is a range of popular diets, often given 
much attention and hence promotion through the media, namely, The Atkin’s Diet, 
South Beach Diet, SugarBusters, Scarsdale diet, the list goes on. The problem with 
many of these diets is that their, energy-restriction is often extreme and leads to 
nutrient deficiencies (Dwyer et al. 2005).  In fact many of these diets advocate the 
use of nutritional supplements to ensure adequate nutrient intake. It is common 
amongst dieters to limit or avoid calcium rich foods, particularly the dairy products, 
as these are perceived as high fat foods (Radak, 2004; Dwyer et al. 2005).   Recent 
guidelines for obesity treatment state that “During weight loss, attention should be 
given to maintaining an adequate intake of vitamins and minerals; maintenance of 
the recommended calcium intakes of 1,000 to 1,500 mg/day is especially important 
for women who may be at risk of osteoporosis” (National Institutes of Health, 1998).  
Studies have indicated that weight loss is associated with elevated calcium 
requirements; it would seem that even normal intakes of calcium during energy 
restriction can result in an inadequate calcium absorption which can ultimately 
compromise calcium balance and bone mass (Cifuentes et al. 2004).   Several studies 
have indicated that the provision of at least 1 g/day of calcium (through a high 
calcium diet or calcium supplement) is likely to reduce loss of bone mineral and alter 
markers of bone resorption (Bowen et al. 2004; Radak, 2004). Some have suggested 
that a higher amount may be required to offset the weight loss associated bone 
changes (Riedt et al. 2005).  Therefore, with or without, conclusive evidence that a 
high dietary calcium diet aids weight loss; it seems prudent and above all ethical to 
ensure that at least 1 g of calcium per day is achieved.      
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1.6 Concluding remarks  
1.6.1 Summary   
Australia like the rest of the developed world is in the grip of an epidemic of obesity. 
To date the role of macronutrients and weight management have been widely 
studied; however, the role of micronutrients have not until recently been investigated. 
A large number of cross-sectional and longitudinal studies from around the world are 
in agreement that there is an association between calcium and/or dairy in body 
composition; however, these studies can not be used to elicit a causal link.  It is 
important to note that dairy intake is often a surrogate measure for calcium intake; 
because dairy calcium comprises the primary source of dairy intake in the US and 
Australian diets. In addition, a low calcium intake may be associated with a less 
healthy lifestyle, diet or social status.   
 
As the concept of calcium, and in particular dairy calcium is a fairly new area of 
research, to date there have only been a limited number of well-designed randomised 
control trials.  We would conclude from these studies that there is a lack of 
consistency of study endpoints. Only, one group of researchers have been able to 
draw consistent and significant conclusions of a role for calcium and dairy calcium in 
weight / fat loss (Zemel et al. 2004; 2005a; 2005b), or dairy alone (Zemel et al. 
2005a; 2005b). Other studies, which have looked at only the role of dairy calcium on 
weight loss, have failed to show any significant difference between the treatment 
groups (Harvey-Berino et al. 2005; Thompson et al. 2005).  We propose that there 
are some flaws in the methodology of these studies which may explain an 
inconsistency in results. These are lack of a true placebo-controlled experimental 
arm, the addition of vitamin D as well as calcium as the treatment, methodology used 
for determining energy deficiency (empirical versus measured) and the lack of 
control of confounders in the parallel-designed studies.      
 
Therefore, by addressing some of the limitations currently present in the literature, 
our research adds invaluable knowledge towards the presently inconclusive link 
between dietary calcium and its role in weight and fat loss in the overweight/obese 
adult  population. 
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Table 1:4 Cross-Sectional data from observational studies investigating the effects of dairy and /or calcium intake on body weight and 
adiposity  
NH&MRC levels of evidence were only give to studies relating to main thesis topic of weight or fat change. Source: (National Health and Medical Research Council, 2000). 
NHMRC level Authors Details of study   Results / Conclusion  
IV McCarron et al.  
1984 
NHANES I data  
13,671 adults 18-74 years 
US data 
Dietary calcium was negatively associated with BMI; r = -0.59, 
P<0.001 
IV Shaper et al.  1991  Prospective study of 7,735 men 
UK data 
The proportion of men with a BMI >28.0 kg/m2 was 27% in the 
quintile with the lowest milk intake and 16% in the quintile with 
the highest intake at baseline.   
IV Van der Vijver et al.  
1992 
Prospective study from 1953-1954 data of 
general health examination of 1,340 men 
and 1,265 women  
Calcium intake was assessed by 1-week 
food frequency recall  
Dutch data  
Baseline BMI in men was 1.2 kg/m2 greater in those in the lowest 
quintile of dietary calcium intakes (<585mg/d), compared with 
those is the highest quintile of calcium intake (>1245 mg/d). 
Similar patterns were obtained with corresponding figures of 2.0 
kg/m2 (low < 445 mg/d versus > 850 mg/d). 
IV Abbott et al.  1996  Prospective study 
Honolulu Heart Program 
3150 men (55 – 68 years) 
Food intake assessed by 24-hour recall  
Baseline BMI was 0.8 kg/m2 (25% of SD) greater in those in the 
lowest quintile of milk intakes compared with those in the highest 
quintile of milk intake. 
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NHMRC level Authors Details of study   Results / Conclusion  
IV Bostick et al.  1999 Prospective study  
34,486 postmenopausal women (55 – 69 
years) 
US data 
Baseline BMI was 1.0 kg/m2 greater in those in the lowest 
quintile of daily calcium intake (<696 mg/d) compared with those 
in the highest quintile of intake (>1,425 mg/d). 
IV Iso et al.  1999 Prospective study from 1980 data from 
Nurses’ Health Study (age 34-59 years) 
85,764 women 
US data 
At baseline, 0.3% (9% of SD) more women had a BMI>29 kg/m2 
in the lowest quintile of milk intakes, compared with those in the 
highest of dietary calcium intake (dietary intake included calcium 
from multivitamin supplements but not specifically calcium 
supplements). 
IV Zemel et al.  2000 Re-examination of NHANES III data  (US 
data) 
(1988-1994) Body composition was 
assessed using anthropometric and 
bioelectrical impedance. Odds ratios for 
%BF and corresponding 95% CI were 
calculated.   
The odds ratio of being in the highest quartile of body fat was 
markedly reduced from 1.00 (1st) to 0.75, 0.40, 0.16 (2nd, 3rd, 4th) 
in adult women. Males represented an inverse relationship 
between calcium and dairy intakes and body fat. These data 
demonstrate a reduction in the odds of being in the highest 
quartile of adiposity with increases in the intake of calcium and 
dairy product intakes. 
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NHMRC level Authors Details of study   Results / Conclusion  
IV Davies et al.  2000  Re-evaluation of 5 clinical studies (primary 
outcomes were skeletal end points)  
All subjects were women clustered around 
3 main age groups:- 3rd, 5th and 8th decade 
(n=780) 
4 studies were observational (2 cross 
sectional – BMI was regressed against 
entry level calcium and 2 longitudinal – 
change in weight over time was regressed 
against calcium intake, 1 double blind RCT 
– calcium supplementation)   
Significant negative associations between calcium intake and 
weight were found for all three age groups, and the odds ratio for 
being overweight (BMI > 26 was 2.25 for the young women in 
the lower half of calcium intake (P<0.02). Relative to placebo, 
the calcium-treated subjects in the controlled trial had a greater 
weight loss, across 4 yr.  Estimates of the relationship indicate 
that a 1000 mg calcium intake difference is associated with an 8 
kg difference in mean body weight & that calcium intake explains 
~3% of the variance in body weight.      
IV Ness et al.  2001 Prospective study 5,765 men (35-64 years) 
UK data 
No difference – baseline BMI was 0.3 kg/m2 greater in the 
highest tertile of milk intake, compared with the lowest tertile of 
milk intake (P=0.50) 
IV Kamycheva et al.  
2002 
Cross sectional study 
9252 (males) and 9662 (females)  
1994-95 completed food-frequency and 
lifestyle factor questionnaires 
Norwegian data  
Ca intake and BMI had no correlation, but after correcting for the 
other variables with age, there was a +ve relation in men 
(P<0.001). No association was found in women. Dairy products 
supply ~75% of total calcium intake in Norway. 
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NHMRC level Authors Details of study   Results / Conclusion  
IV Buchowski et al.  
2002 
50 pre-menopausal African-America 
women 
US data 
Lactose intolerant women (had a low dairy intake) had a higher 
BMI than lactose tolerant women (P<0.001). Calcium intake was 
negatively with BMI (R2 = 0.470) 
IV Jacqmain, 2003 Cross-sectional study  
Quebec Family study (age 20- 65 years) 
235 males, 235 females 
Canadian data 
Subjects divided into 3 group based on 
calcium intake 
1) <600 mg, 2) 600-1000 mg, 3) >1000 mg  
After adjusting for age, daily energy intake, % dietary fat, dietary 
protein and markers of socioeconomic status, there were –ve 
correlations between daily calcium intake and % BF (r  = -0.19, 
P<0.01), BMI (r = -0.14, P=0.05), fat mass (r = -0.17, P=<0.05) 
and waist circumference (r = -0.15, P<0.05).  Comparative trends 
were observed in men, but not after adjusting for the same 
covariates.  Dairy supplied 62% and 60 % of daily calcium intake 
for women and men respectively.   
IV Loos et al.  2004  HERITAGE Family study  
362 men (109 black, 253 white) 
462 women (201 black, 261 white) 
Groups divided into tertiles of energy-
adjusted Ca intake 
US data 
 
At baseline, calcium intake was inversely associated with 
measures of adiposity in black men and white women. Black men 
in the top tertile of energy adjusted calcium intake had a BMI 3.3 
kg/m2 lower than those in the lowest group (P=0.01). In white 
women there was a –ve association between energy adjusted 
calcium intake and BMI (P<0.02) and white men in the highest 
tertile of energy adjusted calcium intake had lower body fat than 
those in the lowest tertile (P=0.04). No significant associations 
were found with black women. 
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NHMRC level Authors Details of study   Results / Conclusion  
IV Rosell et al.  2004  Cross-sectional study  
301, healthy males (age 63 years) with 
different degrees of fasting-insulin 
concentrations 
Sagittal abdominal obesity (SAD), dietary 
intake from 7 day food records, fatty acid 
composition in serum phospholipids and 
adipose tissue were measured. Under-
reporters (UR) and non under-reporters 
(non-UR) were identified  
Swedish data 
The intake of dairy fat (g/100 g fat) was inversely correlated with 
SAD (this was only observed in UR). The intake of calcium was 
inversely related in UR and non-UR. The intake of dairy fat was 
inversely correlated in the UR group.  
Calcium intake (g/10 MJ) was negatively correlated with 
abdominal obesity (r = -0.22, P<0.001).  
IV Elwood et al.  2004 Observational data from Caerphilly Cohort 
Study (1979-1983) 
2512 men (45 – 59 years) 
Food intake assessed by semi-quantitative 
food frequency questionnaire 
UK data  
At baseline, the BMI of men who drank at least 1 pint (500 ml) 
per day was 25.4 kg/m2, whereas those who drank little or no 
milk had a BMI of 26.7 kg.m2 (P<0.001).  
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NHMRC level Authors Details of study   Results / Conclusion  
IV Soares et al.  2004 
(unpublished report) 
Cross sectional data from the 1995/6 
National Nutrition Survey 
Australian data 
After controlling for age, energy intake, fat and protein intake, 
reporting bias and socio-economic status, both men and women 
in the top tertile of dietary calcium intake had significant lower 
BMI and waist circumference than those in the lower groups.   
IV Marques-Vidal et al.  
2005 
Cross sectional data  
17,771 men and 19,742 women (>18 years) 
Portugal data 
In men, milk intake was inversely related to BMI (r = -0.10, 
P<0.001), whereas the relationship in women was weaker (r = -
0.06, P<0.001).  In both genders the relevance of milk consumers 
increased with decreasing BMI – in men 62,68,71% in obese, 
overweight and normal weight men (P<0.001); in women the 
corresponding numbers were 71,72 and 76% (P<0.001).  No 
relationship was found in women > 55 years.  
IV Azadbakht, 2005 Population-based cross-sectional  
357 men, 470 women (age 18-74 years)  
Usual dietary intake was defined by 168-
item semiquantitative FFQ 
Quartile cut-offs 1-4: <1, 1-<1.8, 1.8-<2.7 
and >2.7 servings of dairy per day 
Iranian data 
Subjects in highest quartile for dairy consumption had lower odds 
of having a larger waist circumference (1, 0.89, 0.74, 0.63 
P<0.001).  
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NHMRC level Authors Details of study   Results / Conclusion  
IV Mirmiran et al.  
2005 
Cross sectional study  
223 males, 239 females (age >16 years) 
randomly selected from the Tehran Lipid & 
Glucose Study.  
Dietary data collected from means of a 
FFQ for 1 y and 2 x 24-h dietary recall.  
Iranian data 
After adjusting for confounding variables (age, energy intake, 
carbohydrate intake, fat intake, protein intake, dietary fibre intake 
and physical activity levels) men and women in the top quartile 
for dairy consumption had lower chances of being overweight 
(OR 0.78, 95%CI 0.43-0.92 for men and OR 0.89, 95%CI 0.53-
0.95 for women) or obese (OR 0.73 95%CI 0.40-0.83 for men 
and OR 0.69 95%CI 0.34-0.80 for women) P<0.05.   
IV Venti et al.  2005 Cross-sectional study 
35 men, 30 females (age 33+8 years) 
participating in a study of eating behaviour 
Height and weight measured, body 
composition (by DEXA) 
Food intake assessed using the Block 1998 
Food questionnaire  
US (Pima Indian) data  
There was no significant associations between calcium intake and 
body weight (r=0.05, P=0.71), body fat (r=0.16, P=0.19) and 
body mass index (r=0.01, P=0.97). One explanation for the lack 
of association may be that the high-fat, high-energy diet 
consumed by the subjects, overwhelmed the anti-obesogenic 
effect of calcium.  
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NHMRC level Authors Details of study   Results / Conclusion  
IV Murakami et al.  
2006 
Cross sectional study  
1905 female dietetic students (age 18-20 
years) 
Dietary intake was assessed over a 1-mo 
period, using diet history questionnaire and 
BMI (assessed by self-reported weight and 
height).  
Japanese data  
Intakes of calcium and dairy products were not significantly 
associated with BMI (adjusted means in the lowest and highest 
quartiles were 20.7 and 20.8 for calcium, P for trend = 0.48 and 
20.6 and 20.6 for dairy products, p for trend = 0.81). these results 
were also observed after excluding 481 energy under and over-
reporters for calcium (20.4 and 20.5, respectively, P for trend 
=0.73) and dairy products (20.3 and 20.4, respectively, P for 
trend =0.73).    
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Table 1:5 Longitudinal data from observational studies investigating the effects of dairy and/or calcium intake on body weight and 
adiposity  
NH&MRC Authors Details of study   Results / Conclusion  
IV Lin et al.  2000 Two year prospective exercise study  
54 (normal weight females, age 18 – 31 
years)   
US data 
Total calcium/kcal –vely predicted changes in body wt. (R2 = 
0.19) and body fat (R2 = 0.27).There was an interaction of 
calcium and energy intake in predicting changes in body wt, such 
that at the lower energy intakes, calcium intake (not adjusted for 
energy) predicted changes in body weight. In subjects with higher 
energy intakes, calcium had no impact on changes in body weight 
or body fat.  
IV Pereira et al.  2002 CARDIA Study  
10 year prospective study of 3,157 young 
adults (age 18-30 years) 
Food intake measured by diet history 
interview 
US data 
 
At baseline, overweight individuals consumed dairy products less 
frequently than their normal weight subjects (P<0.01).  
The 10-year cumulative incidence of developing obesity in 
subjects who were overweight at baseline was 64.8% for those in 
the lowest quintile of dairy intake, compared with 45.1% for 
those in the highest quintile of dairy intake (P<0.001). 
The odds ratio for adults who were overweight to become obese 
10 years later were 0.84 (95% CI 0.73-0.97) for regular-fat dairy, 
0.84 (0.70-1.02) for reduced-fat dairy and 0.82 (0.72-0.93) for all 
dairy products, per 1 daily eating occasion.  
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When BMI of 30 kg/m2 and a WHR of 0.90 for men and 0.85 for 
women were evaluated separately, the odds of developing both 
were lower (OR 0.81 for BMI and OR 0.89 for WHR) with each 
daily increment of total dairy over ten years in those who were 
overweight at baseline.  
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NH&MRC Authors Details of study   Results / Conclusion  
IV Heaney, 2003 Re-evaluation of Davies et al.  2000 data, 
focusing on distribution of values around 
the regression lines relating Ca intake to 
BMI. 
564 women (348 were studied once, 70 
studied 8.5 years and 146 were studied for 
22 years)    
US data 
At the 25th%ile of Ca intakes, 15% of young women were 
overweight, this fell to 4% at Ca intakes in the range of current 
recommended values. Obesity prevalence also fell within this 
cohort from 1.4 to 0.2% across the same differences in Ca intake. 
At midlife women in the 25th%ile of intake gained 0.42 kg/y, this 
gain dropped to –0.011 kg/y at recommended Ca intake levels. 
Although Ca intake explains only a small fraction of the 
variability in weight or wt gain, shifting the mean of the 
distribution downwards by increasing calcium intake can be 
estimated to reduce the prevalence of overweight and obesity by 
60-80%.    
IV Newby et al.  2003 Baltimore Longitudinal Study of Aging – a 
prospective study 
219 women and 240 men were followed for 
25 + 7 months 
Food intake was assessed by 7-day dietary 
records.  
US data 
Six food patterns were derived from 40 food groups,  Factor 
1(reduced fat dairy products, fruit and fibre). Factor 1 was 
inversely associated with annual change in BMI (β = -0.51; 95% 
CI -0.82—0.20, P<0.05) in women and inversely associated with 
annual change in waist circumference (β = -1.06 cm; 95% CI -
1.88 — 0.24 cm, P<0.05) in both sexes.  
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IV Drapeau et al.  2004 A sample of 248 volunteers from the 
Quebec Family Study were measured twice 
(1, 1989-1994 and 2, 1995-2000) 
3-day food diaries were completed at visit 
1 and food-based questionnaires indicating 
changes in the consumption of 10 food 
categories. 
Canadian data 
Increases in the consumption of whole fruit, skimmed and partly 
skimmed milk were the two food patterns that negatively 
correlated with the changes in each body weight-related indicator; 
change in waist circumference (β = -0.23, + 0.09 P = 0.02); 
change in percentage body fat (β = -0.14, + 0.06 P = 0.02).  
IV Boon et al.  2005 Amsterdam Growth and Health 
Longitudinal Study  
followed men (296)  and women (333) 
from age 13 (1977) until age 36 (2000)  
Dutch data 
For men, in the age-adjusted model, a 1000 mg per day higher 
dietary calcium intake was related to a 0.21 cm lower sum of four 
skin folds (P=0.04). For women, the highest dietary calcium 
intake group (>1200 mg/d) had a significantly lower sum of four 
skinfolds than the group consuming less than 800 mg/d (β = -
0.28; 95% CI -0.56—0.01 P=0.04) when adjusted for age. These 
effects disappeared after adjustment for dietary energy, fibre 
intake, and habitual physical activity.  No difference were 
observed between the middle calcium intake (800-1200 mg/d) 
and high calcium intake (>1200 mg/d), suggesting a threshold of 
~800 mg/d above which calcium intake has no additional 
beneficial effect on body composition.  
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IV Rajpathak et al.  
2006  
Data from the Health Professionals Follow-
Up Study 
Prospective data from men aged 40-75 
years in 1986.  
Data on lifestyle factors and diet updated 
biennially, with self-administered 
questionnaires. Participants reported their 
weight in 1986 and 1998. Multi-variant 
linear regression analysis used to examine 
how baseline calcium intake (n=23 504) 
and change in calcium intake (n=19 615), 
were associated with weight change. 
Similar associations were determined with 
dairy foods.    
When adjustments were made for confounders, baseline or 
change in intake for calcium, dairy or supplemental calcium and 
changes in weight. The men with the largest increase in dairy 
intake gained slightly more weight than did the men who 
decreased intake the most (3.14 compared to 2.57 kg , P for trend 
= 0.001). This association was primarily due to an increase in 
high-fat dairy intake. Low-fat dairy intake was not significantly 
associated with weight change.   
IV Eagan et al. 2006 In a previous study 154 young women were 
randomised to a control (<800 mg Ca/d), 
medium dairy (1000 mg Ca/d) or high 
dairy (1300-1400 mg Ca/d) for a year trial. 
51 women recalled 6 months post-study 
and dietary intake assessed and body 
HD group maintained elevated Ca intake. Mean Ca intake 
predicted a negative change in fat mass (P=0.04).  
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composition    
IV Gonzalez et al. 2006 Retrospective data in 10,591 men & 
women aged >45 yr. Assessment of the 
relationship between calcium intake & 
weight gain over 10 years.  
Women with a Ca supplement dose of > 500 mg had a 1.8 kg less 
weight gain than non-users (P=0.001).  
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Table 1:6 Randomised Controlled Studies investigating the effects of dairy with energy restriction on body weight and body fat 
NH&MRC Authors Details of study   Results / Conclusion  
II Summerbell et al.  
1998 
3 arm randomised trial  
16 week intervention  
1) 3.4 MJ (control), 2) isocaloric milk only, 
3) milk plus designated food only 
45 patients (outpatient clinic) 
BMI > 27 
Wt loss for each group was 1) 1.7 kg (95% CI -0.3-3.7), 2) 9.4 kg 
(5.9-12.9), 3) 7.0 kg (2.7-11.3). Dietary treatment can achieve as 
much wt loss in obese outpatients as has been reported with any 
drug treatment. But compliance is poor unless the diet is novel 
and simple. 
III-I Zemel et al.  2004  Parallel design 
32 obese subjects (BMI 30 – 39.9 kg/m2) 
(27 men, 5 women, age 49 + 6 years) 
24 week intervention 
3 groups 1. low dairy (400-500 mg Ca) + 
placebo (n=10) 2. high-calcium diet 
(supplemented with 800 mg Ca) (n=11) or 
3. high-dairy group (1200-1300 mg dietary 
calcium + placebo) (n=11).  
Energy-deficient –500 kcal/d  
Weight loss 1. 6.60 + 2.58 kg, 2. 8.58 + 1.60 kg, 3. 11.07 + 1.63 
kg (P<0.01). Fat loss 1. 4.81 + 1.22 kg, 2. 5.61 + 0.98 kg, 3. 7.16 
+ 1.22 kg (P<0.01). Trunk fat change 1. 1.38 + 0.60, 2. 2.94 + 
0.73, 3. 3.74 + 0.64 kg (P<0.01).   
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III-I Zemel et al.  2005a Parallel design 
34 obese subjects 
Two groups, both energy deficit (-500 
kcal/d)  
1. 400-500 mg Ca/d (n=16, 14 women, 2 
men, age 42 + 6) 2. 3 serves yoghurt 1100 
mg Ca/d (n=18, 13 women, 5 men, age 39 
+ 10) 
12 week intervention  
Weight loss was greater on the yogurt diet (1. 4.99 + 0.5 kg, 2. 
6.63 + 0.6 kg, P<0.01) 
Fat loss greater by 61% on 2. (1. -2.75 + 0.73 kg, 2. -4.43 + 0.47, 
P<0.005). Less reduction in LBM on 2. (1. -1963 g, 2. 1361g, 
P<0.05). Greater waist circumference loss on yogurt diet (1. -0.58 
+ 1.04 cm, 2. -3.99 + 0.48, P=0.001) 
III-I Zemel et al.  2005b  Parallel design 
29 African-American  
Two groups, both energy deficit (-500 
kcal/d)  
1. 400-500 mg Ca/d (n=12, 11 women, 1 
man, age 42 + 2.7) 2. 3 serves dairy 1000 
mg Ca/d (n=17, 14 women, 3 men, age 42 
+ 2.9) 
24 week intervention   
Weight loss was greater on high dairy diet (1. -5.954, 2. -11.02 
kg, P<0.01).  Fat loss was also greater on the high dairy diet (1. -
3.97, 2. -9.08 kg, P<0.01) and trunk fat (1. -0.849, 2. -4.177 kg, 
P<0.01). Less reduction in LBM on high dairy diet (1. -1988, 2. -
148 g, P<0.001).  
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III-I Harvey-Berino et al.  
2005  
Parallel design 
54 overweight & obese (44 completers) 
Energy-deficit -500 kcal/d (calculated from 
7-day food record.  
1. Low dairy - 1 serve dairy (26 women, 2 
men, age 45 + 6.5 years)  
2. High dairy - 3-4 serves of dairy (23 
women, 2 men, age 45 + 7.0 years) 
Encouraged to expend 1000 calories/wk in 
PA   
1 year intervention   
No difference in weight lost between groups 
(1. -9.6 + 6.5, 2. -10.8 + 5.9 kg, P=0.56) at 1 year and fat loss at 6 
months (1. -9.0 + 3.8 kg, 2. -10.1 + 3.6 kg, P=0.37).  
III-1 Bowen et al.  2005 Parallel design  
50 overweight & obese (30 women, 20 
men) 
1. high dairy protein/high calcium (DP 
2400 mg/d) (age men 49 + 3.2, women 47 
+ 2.4 years) 
2. high mixed protein /moderate calcium 
(MP 500 mg/d) (age men 49 + 4.2, women 
46 + 2.6 years 
Weight loss or fat loss was not different between treatments. 
Weight change (men 1. -9.4 + 1.3 kg, 2. -12.0 + 1.5 kg, females 
1. -9.4 + 1.0 kg, 2. -7.8 + 0.6 kg). Fat mass (men 1. -7.5 + 1.0 kg, 
2. -9.6 + 1.1 kg, women 1. -9.2 + 0.9 2. -7.1 + 0.5).  
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III-I Thompson et al.  
2005 
Parallel study 
72 completers, obese subjects 
Randomised into 1 of 3 groups, all with -
500 kcal/d energy restriction 
1. Control: 30% fat, 20% protein, 50% 
carbohydrate,  provided average of 932 mg 
calcium & 16.2 g fibre (n=26) 
2. as 1. with addition of 4 serves of dairy (2 
serves from milk) (n=22) 
3. as 2. additional fibre (from wholegrain, 
fruit, veg) and GI foods less than 100 
encouraged (n=24) 
48 week intervention  
None of the 3 dietary groups achieved significantly greater 
weight loss. Weight loss (1. 10.0 + 6.8 kg, 2. 11.8 + 6.1 kg, 3. 
10.6 + 6.8 kg) and fat loss (1. 7.5 + 6.6 kg, 2. 9.0 + 6.0 kg, 3. 8.5 
+ 7.8 kg).  
* Weight loss arm of study 
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Table 1:7 Randomised Controlled Studies investigating the effects of calcium supplements with energy restriction on body weight and 
body fat 
This table does not include studies that were reviewed in Barr, 2003 (obtained from a Medline search 1966-2001). The majority of those studies did not set out to establish the 
hypothesis that a greater intake of calcium would elicit a greater weight / fat loss. In a number of the studies the results had to be obtained by personal communication).  
NH& MRC Authors Details of study   Results / Conclusion  
III-I Ricci et al.  1998 31postmenopausal women (BMI 28-42 
kg/m2), subjects had <800mg/d Ca.  
6 month intervention  
Randomised to 1 g Ca citrate or placebo, 
along with calorie restriction (behaviour 
modification).  
Both groups had similar weight loss (-9.0 (Ca) vs.-8.8 (placebo) 
kg), BMI (-3.3 (Ca) vs. -3.3 (placebo) kg/m2), and fat mass (-7.3 
(Ca) vs. -7.3 (placebo) kg).  
III-I Jensen et al.  2001 62 overweight & obese women,   
6 month intervention (3 month 4.2 MJ 
supplemental diet, 3 months advised to eat 
normal diet with calorie reduction) in 
additional randomised to Ca supplement 
group (1 g) or placebo.    
Both groups lost similar amounts of weight (5.6% (Ca supp) 
versus 5.5% (placebo). Ca supplementation should be encouraged 
during weight loss to prevent bone loss.  
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III-I Zemel et al.  2004  Parallel design 
32 obese subjects (BMI 30 – 39.9 kg/m2) 
(27 men, 5 women, age 49 + 6 years) 
24 week intervention 
3 groups 1. low dairy (400-500 mg Ca) + 
placebo (n=10) 2. high-calcium diet 
(supplemented with 800 mg Ca) overall 
1200-1300 mg/d (n=11) or 3. high-dairy 
group (1200-1300 mg dietary calcium + 
placebo) (n=11).  
Energy-deficient –500 kcal/d  
Weight loss 1. 6.60 + 2.58 kg, 2. 8.58 + 1.60 kg, 3. 11.07 + 1.63 
kg (P<0.01). Fat loss 1. 4.81 + 1.22 kg, 2. 5.61 + 0.98 kg, 3. 7.16 
+ 1.22 kg (P<0.01). Trunk fat change 1. 1.38 + 0.60, 2. 2.94 + 
0.73, 3. 3.74 + 0.64 kg (P<0.01).   
 
III-I Shapses et al.  2004 Data combined from 3 x 25-week RCT of 
1000 mg Ca supplementation 
100 pre- and post-menopausal women 
(initial research with bone mineral change 
outcomes).  
Energy requirements based on Harris 
Benedict equation, added activity factor 
and subtracting  2100 kJ   
No difference in weight change between calcium and placebo 
group (placebo –6.2 + 0.7 kg, calcium –7.0 + 0.7 kg). The mean 
change in body weight and fat were not significant different 
between calcium and placebo treatments in any of the studies.      
III-I Major et al. 2007 RCT- parallel design No treatment effect on weight or body fat levels 
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63 overweight/obese women, daily Ca 
intake <800 mg. 
Energy-restricted diet (700 kcal/d) 
1. Elemental Ca 1200 mg + 400 IU vit D 
2. placebo supplement  
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Table 1:8 Randomised Controlled Studies investigating the effects of dairy with energy balance on body weight and body fat 
NH&MRC Authors Details of study   Results / Conclusion  
g Zemel et al.  2000  11 African-American men (age – not 
reported) 
Consumed 2 cups of yoghurt daily  
1 year intervention 
Weight change – not reported. High dairy group lost 4.9 kg body 
fat (no control group).  
III-I Gunther et al.  2005 135 healthy weight females (age 18-30 
years).  
Followed isocaloric intakes and divided 
into 1 of 3 groups. 1) control (n=22) 2) 
medium-dairy to achieve 1100-1200 mg Ca 
(n=23) 3) high-dairy to achieve 1300-1400 
mg Ca (n=22)  
1 year intervention 
No significant change in body weight or fat mass between the 1), 
2) or 3)  
(BW: 0.8 + 2.8, 0.7 + 3.0, 1.5 + 4.1 kg, P=0.45;  FM: -0.5 + 2.5, 
0.3 + 2.7, 0.5 + 3.5 kg, P=0.26) 
III-I Zemel et al.  2005b 
** 
Parallel design 
34 African-American  (11 men, 23 women) 
Two groups, weight maintenance   
1. low dairy - 500 mg Ca/d  
2. high dairy - 3 serves dairy 1200 mg Ca/d  
24 week intervention   
There was no significant change in body weight (1. 0.2 + 0.5, 2. 
0.4 + 0.6 kg).  However, significant decrease in body fat in the 
high dairy group (1. -0.169, 2. -2.158 kg, P<0.01), trunk fat (1. -
0.357, 2. -1.026 kg, P<0.01), with an increase in lean body mass 
in the high dairy group (1. 0.283, 2. 1.08 g, P<0.04).  
g The details of this study are not reported, NH&MRC levels of evidence – unable to determine    ** Weight maintenance arm of study   
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Table 1:9 Randomised Controlled Studies where energy intake was not controlled but subjects were given additional dairy  
(1-6 adapted from Barr, SI, 2003) 
Authors Details of study   Results / Conclusion  
Baran et al.  19891  37 premenopausal women (age 30-42 years) 
3 year randomised trial of increased dietary 
calcium (+610 mg/d) vs. usual diet 
Women in dairy supplement group were asked to 
increase their calcium intake (500-600 mg/d) by 
substituting low-fat high-calcium foods and 
eliminating unnecessary calories.    
The control group gained 3.4 kg, the dairy group gained 4.2 kg 
(significance not reported) 
Prince et al.  19952 168 postmenopausal women (mean age 63 years) 
2 year randomised trial of 1. placebo 2. milk 
powder (1 g Ca/d) and two other interventions. 
Due to the extra kilojoules from the milk powder 
subjects were asked to reduce their energy intake 
by 1200 kJ by avoiding high fat foods.  
No change in BMI in the dairy group, not reported in the control group.  
Storm et al.  19983 60 postmenopausal women (age > 65 years) 
2 year randomised trial of addition of 250 ml/d 
milk or placebo (or 1 other intervention) 
No significant change differences in change in weight or body composition 
among treatment groups.  
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Barr et al.  20004 200 (129 women and 71 men) (mean age 65 
years) 
Randomised to ~2 cups/d low fat milk or usual 
diet. Milk group instructed to add 3, 240 ml 
servings of skim or 1% milk to their diet and to 
follow their usual diet.  
12 week intervention 
Men gained 1.0 kg, women 0.4 kg (control), and men gained 1.6 kg, women 
1.9 kg (dairy). Overall the dairy group gained 0.6 kg more weight than the 
control (P<0.01). However the weight gain was less than predicted from the 
addition of the dairy calories (~2.5 kg may have been expected).   
Lau et al.  20015 185 Chinese women (age 55-59 years), > 5 yr 
postmenopausal.  
2 year intervention of addition of 50 g/d high-
calcium, low fat milk powder. No mention of 
substitution or addition – milk powder provided 
175 kcal/d.   
There was a significant gain in weight in the dairy group (control -0.26, 
dairy +0.52 kg, P<0.001). Fat change (control -0.14, dairy +0.42 kg) and 
lean change (control +0.2, dairy +0.3 kg). 
Cleghorn et al.  20016 115 Australian women < 5 year postmenopausal 
2 year open-crossover 3 litres/week of calcium 
fortified milk (1 year on milk, 1 year off). Women 
were asked to drink an additional 3 litres of milk 
without changing their usual diet.  
There was a 0.06 kg difference between the on/off added dairy products 
(95% CI: -0.71 to 0.83 kg, NS).  
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Table 1:10 Fat oxidation studies in Humans   
NH&MRC  Authors Details of study   Results / Conclusion  
IV Melanson et al. 
2003  
35 (21M, 14F) non-obese, healthy adults 
(age 31 + 6 y, weight 71.2 + 12.3 kg, BMI 
23.7 + 2.9 kgm2, fat% 21.4 + 5.4 %).  
Cross sectional data was collected on 24 h 
energy expenditure, macronutrient 
oxidation using whole room indirect 
calorimetry, habitual Ca intake (4 day food 
records); acute ca intake estimated from 
measured food intake during 24 h stay in a 
room calorimeter.     
Acute Ca intake was positively correlated with fat oxidation over 
24 hr (r = 0.38, P=0.03), during sleep (r = 0.36, P=0.04) and 
during light physical activity (r = 0.32, P=0.07).  Acute Ca intake 
was inversely correlated with 24-h RQ (r = -0.36, P=0.04) and 
RQ during sleep (r = -0.31, P=0.07). After the adjustment for fat 
mass, fat free mass, energy balance, acute fat intake, & habitual 
fat intake, acute Ca intake explained ~10% of the variance in 24-
h fat oxidation. In backwards stepwise models, total Ca intake 
was a stronger predictor of 24 h oxidation than dairy Ca intake.       
g  Melanson et al. 
2004 (abstract) 
18 subjects (10M, 8F), age 33 + 8 yr, BMI 
27.6 + 3.2 kgm2, %fat 31.4 + 11.7%) 
consumed a low dairy (500 mg) or high 
dairy (1400 mg), isocaloric diet for 7 d. 
Each dietary condition was performed 
twice with a 1-3 week wash-out.  RMR was 
measured on day 5 or 6 of the diet.     
RMR did not differ between diets (1676 + 214 kcal/d HD, 1650 + 
212 kcal/d LD, P=0.75). Similarly, there was no difference 
between RQ (0.78 + 0.05 HD, 0.78 + 0.03 LD, P=0.96).  
Conclusion – modifying dietary calcium intake between 500 and 
1400 mg/d, has no effect on resting energy expenditure and 
substrate oxidation.  
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II Boon et al. 2005  12 healthy men (28 + 2 yr, BMI 25.2 + 
0.06) given isocaloric diets (high 
calcium/high diary H/H, high calcium/low 
dairy H/L, low calcium/low dairy L/L) in a 
cross-over design, for 7 d. At the end of 7d 
measured 24-h energy expenditure, 
substrate metabolism, fat biopsies to 
determine mRNA expression in genes 
involved in lipolysis & lipogenesis.    
24-h energy expenditure was 11.8 + 0.3, 11.6 + 0.3, and 11.7 + 
0.3 MJ/24 h in the H/H, H/L, and L/L conditions. Fat oxidation 
did not differ significantly, 108 + 7, 105 + 9, 100 + 6 g/24 h 
(H/H, H/L, and L/L, respectively).  1,25(OH)2D3 changed from 
175 + 16, 138 + 15, 181 + 23 to 159 + 19, 164 + 13 and 198 + 19 
pmol/L in the H/H, H/L, and L/L condition, this was significantly 
different between the H/H and the L/L conditions (P=0.05). There 
was no difference in the gene expression for any of the measures 
taken.     
II Gunther et al. 2005  Normal weight women (age 18-30 y) were 
assigned to a low (<800 mg/d, n=10) or 
high (1000-1400 mg/d, n=9) dietary 
calcium group of 1 y. Whole body fat 
oxidation was assessed after the subjects 
consumed 2 isocaloric liquid meals 
containing 100 or 500 mg Ca at baseline 
and 1 y. Fasting PTH was also measured at 
baseline and 1 y.   
The mean 1 y change in fat oxidation was higher in the HC than 
the LC group after the consumption of a low calcium meal (0.10 
+ 0.05 versus 0.005 + 0.04 g/min, P<0.001) and a high calcium 
meal (0.06 + 0.05 versus 0.03 + 0.04 g/min, P<0.05). 1 y change 
in serum log PTH was negatively associated with the 1y changing 
in postprandial fat oxidation after a high calcium meal (partial r=-
0.46, P<0.04) when controlled for the 1 y change in total body fat 
mass. Conclusion: the chronic consumption of high diary, 
calcium diet increases whole body fat oxidation from a meal, and 
increases in fasting serum PTH relate to decreases in postprandial 
whole body fat oxidation.  
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II Jacobsen et al. 2005 10 subjects followed an isocaloric diet for 1 
week either: low calcium/normal protein 
~500 mg/d (LCNP), high calcium/ normal 
protein~1800 mg/d (HCNP) or high 
calcium/high protein~1800 mg/d (HCHP). 
Diets were provided in a randomised, 
crossover design.  
The calcium intake had no effect on 24-h energy expenditure or 
fat oxidation. Faecal fat excretion increased 2.5 fold during the 
HCNP diet compared with the LCNP and HCHP diets (14.2, 6.0 
and 5.9 g/d, respectively, P<0.05).  The HCNP diet also increased 
faecal energy excretion as compared with the LCNP and HCHP 
diets (1045, 684, 668 kJ/d, respectively, P<0.05). There were no 
effects on blood cholesterol, free fatty acids, triglycerides, 
insulin, leptin, or thyroid hormones.   
II Melanson et al. 
2005 
19 subjects (10 M, 9 F), consumed a low 
dairy (~500 mg/d), LD or high dairy 
(~1400 mg/d) energy balanced diet for 1 
week. On the 7th day, subjects were studied 
in a room calorimeter under one of four 
conditions (in a cross over design).  Each 
dietary condition was performed under 
energy balance and energy restricted 
conditions. The energy restriction was only 
given to the subject within the 24 hr testing 
period and was achieved by energy 
restriction and exercise.  
Under energy balance conditions, there was no effect of dietary 
treatment on RQ or 24 hour macronutrient oxidation. Under 
energy deficit conditions, 24 hr fat oxidation was significantly 
increased  on the HD diet (HD 136 + 13 g/d, LD 106 + 7 g/d, 
P=0.02). Conclusion: consumption of a HD, energy restricted diet 
increased 24 hr fat oxidation. It is hypothesised that these effects 
are due to an increased fat oxidation during exercise.  
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II Melanson et al. 
2006 (abstract) 
10 subjects (4 F, 6 M), consumed a low 
dairy calcium (LDC) ~500mg/d or high 
dairy calcium (HDC) ~1400mg/d diet for 7 
days. On the 7th day, pre-exercise (30 
mins), exercise (50% max capacity, 60 
mins) and post-exercise (120 mins) 
measures of palmitate & glycerol kinetics 
& substrate metabolism were made 4.5 
hours following consumption of a standard 
breakfast (crossover design).  
Fasting 1,25-vit D trended lower on the HDC diet (P=0.06). RQ 
did not differ significantly before, during or after exercise. There 
were no differences in circulating glucose, insulin, FFA 
concentration or glycerol/palmitate kinetics at any time point.  
This study does not support the hypothesis that lipolysis and FOX 
are increased short-term after the consumption of a HDC diet, 
despite a decrease in 1,25-vit D.   
g The details of this study are not reported, NH&MRC levels of evidence – unable to determine    
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Table 1:11  Studies of dietary calcium / dairy in relation to cardiovascular risk factors and vascular outcomes  
Abbreviations: IHD - Ischemic Heart Disease, CHD - Coronary Heart Disease, FA - Fatty Acids, sd - small dense, AHA - American Heart Association 
Authors Details of study   Results / Conclusion  
Steinmetz et al. 1994 Randomised controlled study  
8 healthy males (age 20-36 years) 
Subjects were given 236 ml of either skim or 
whole milk within a background diet according to 
the AHA recommendations.   
Plasma lipid were analysed at baseline, week 3 
and 6.   
After 6 weeks total cholesterol mean was 4.47 (skim) and 4.80 (whole) 
mmol/L (P<0.001) (~7% lower in skim than whole milk diet). Mean LDL-C 
were 2.64 (skim) and 2.96 (whole) mmol/L (P<0.001)(~11% lower in skim 
than whole milk diet). Mean apolipoprotein B decreased with skim milk and 
increased with whole milk.  
Nagaya et al. 1996 Cross-sectional data 
12,610 Japanese men (age 30-69 years) 
Cohort divided into dairy consumers (Yes) versus 
non-dairy consumers (No) based on a simply 
question of “Do you drink a glass of cow’s milk 
(180-200 ml) everyday”. 
Regardless of age the “Yes” group had higher levels of serum TC, HDL-C 
and LDL-C than the “No” group (P<0.001); except for the age group 50-54. 
Multivariate models correcting for five confounding factors (age, body 
mass index, habitual exercise, smoking and drinking habits), demonstrated 
higher serum triglyceride levels (+1.5%, 5.280 vs. 5.201 mmol/L, P<0.001) 
and LDL-cholesterol (+2.0%, 3.382 vs. 3.316 mmol/L, P<0.001).  
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Bostick et al. 1999 Prospective cohort  
34,486 postmenopausal women 
Age 55-69 years (without a history of IHD)  
Completed semi-quantitative food frequency 
questionnaire (1986) quartiles for calcium intake: 
1 <696 mg, 2 696-1051 mg, 3 1052-1425 mg, 4 
>1425 mg) 
8 year follow-up  
US data  
Relative Risks for highest versus the lowest quartiles of total calcium 0.67 
(95% CI: 0.47-0.94,P for trend 0.09) and 0.94 (95% CI:0.66-1.35, P for 
trend 0.68) for milk products  
Shaper et al.  1991 Prospective cohort 
7735 men  
Age 40-59 years (1981) 
Questioned about milk intake and milk taken on 
cereal (divided into none milk drinkers, < ½ pint, 
<1 pint and > 1 pint) 
9.5 year follow up   
UK data  
Men with lower milk intake had higher rate of heart attack than high milk 
drinkers at baseline. There were big differences between the groups, and 
when background characteristics were adjusted for no significant 
association could be seen between the groups.    
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Mann et al. 1997 10802 male & female vegetarians  
Aged 16–79 years 
13 year follow up 
UK data  
The ratio of deaths from all causes in subjects who drank > ½ pint of milk 
per day, compared to < ½ pint, was 0.87 (0.68-1.13). Only 63 (16%) of 
deaths has been certified as due to ischaemic heart disease and the ratio in 
these was 1.50 (0.81-2.78) for the subjects in the highest milk consumption 
group, relative to the low-consumption group.  
Elwood et al. 2004  Caerphilly Prospective study (set up in 1979-
1983) 
2512 men  
Age 45-59 years 
Semiquantitative food frequency questionnaire 
used to assess usual intake  
Group followed for 20-24 years and incidence of 
IHD and stroke events identified  
UK data 
The hazard ratio in men with a milk consumption of 1 pint or more (0.57 
L), relative to men who stated they consumed no milk, is 0.71 (0.40-1.26) 
for IHD and 0.66 (0.24-1.81) for ischaemic stroke.  
Iso et al. 1999 Nurses Health Study (commenced 1976, followed 
up 1994) 
85 764 women (no evidence of CHD) 
Aged 34-59 years 
Completed dietary questionnaires, calcium intake 
was assessed, US data  
Women in the highest quartile of calcium intake had an adjusted relative 
risk of ishaemic stroke of 0.69 (95%CI, 0.50-0.95, P for trend 0.03) 
compared with those in the lowest quartile (this result was not restricted to 
milk, but observed for yoghurt, hard cheese and ice cream.  
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Ness et al. 2001 5765 men (commenced 1970), 25 year follow up  
Aged 35-64 years 
Completed health and lifestyle questionnaires 
which asked about daily milk consumption 
UK (Scotland) data  
Men who drank more than 1 1/3 pints of milk per day had an adjusted risk 
of death from CHD, relative to men who drank < 1/3 pint  
Kinjo et al. 1999 223170 men and women  
Asked about no. of times drank milk in a week 
25 year follow up  
Japanese data  
There were 3084 deaths due to cerebral embolism and thrombosis. Risk 
ratios, adjusted for confounding (sex, age, area, smoking, alcohol and 
occupation), were inversely associated with milk consumption. The relative 
risk in subjects who drank milk more than four times a week compared with 
those who drank milk less than once a week was 0.85 (0.77-0.92).   
Abbott et al. 1996 Baseline data from Honolulu Heart Program  
3150 men (age 55-68 years) 
Reports baseline dietary calcium intake on stroke 
risk in 22 years follow up 
US data (Japanese ancestry) 
Men who were non-drinkers of milk experienced stroke at twice the rate 
(P<0.05) of men who consumed >2 cups of milk / day. While the rate of 
stroke decreased with increasing milk intake, the decline in stroke risk with 
increased consumption was modest for those who consumed less than 2 
cups. Intake of dietary calcium was also associated with a reduced risk of 
stroke (P<0.01), although its association was confounded with milk 
consumption.   
Snowdon et al. 1984 8724 men , 15048 women (age 40-65 years) 
Half of subjects were lacto-vegetarian; milk intake 
divided into 2 glasses or more per day.  US data 
In subjects with an intake of milk >2glasses the relative risk of coronary 
death in the following 20 years, compared with those that drank no milk, 
was 0.94 men and 1.11 in women (no confidence intervals available).  
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Vijver et al. 1992 Data obtained from the General Health 
examination in 1953-1954, 1340 men and 1265 
women (40-65 years)  
Calcium intake was assessed at baseline by a 1-
week food frequency recall, compared subjects in 
top fifth of total calcium intake vs. bottom fifth 
Cardiovascular deaths identified over the 
following 28 years 
Adjusted odds ratios for cardiovascular disease in the fifth of subjects with 
the highest calcium intakes, compared with the lowest, were 0.77 (0.53-
1.11) and 0.91(0.55-1.50) for males and females, respectively.  
Barr et al. 2000 Randomised, controlled open trail  
204 healthy men & women  
Age 55-85 years 
Advised to increase skim or 1% milk intake by 3 
cups / day (n=101) or to maintain usual diet 
(n=103) for 12 weeks after a 4-week baseline 
period.   
Total and low-density lipoprotein cholesterol levels and the ratio of TC to 
HDL-c were unchanged. Triglyceride levels increased within the normal 
range in the milk group (P=0.002).   
Elwood et al. 2005a  Caerphilly Cohort, population sample of men age 
45-59 years, 665 men completed 7 day food intake 
and milk consumption was determined. 
UK (Wales) data  
The relative odds of an event in the men whose milk consumption was 
median or higher, relative to those with lower intakes of milk, were 0.52 
(0.27-0.99) for an ishaemic stroke and 0.88 (0.56-1.40) for an ishaemic 
heart disease event.  
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Jacqmain et al. 2003  Cross-sectional data from phase 2 of Québec 
Family Study 
Adults age 20-65 years (235 men, 235 women) 
Subjects divided into 3 groups based on daily 
calcium intake A. <600 mg, B. 600-1000 mg, C. 
>1000 mg 
Daily calcium intake was negatively correlated with plasma LDL 
cholesterol, total cholesterol, and total:HDL cholesterol in women and men 
after adjustment for variations in body fat mass and waist circumference 
(P<0.05).   
Sjogren et al. 2004  Cross-sectional data 
291 healthy men,  age 62-64 
Individuals completed 7-d dietary records, and 
fasting plasma insulin, lipid and lipoprotein 
concentrations as well as serum and adipose tissue 
FA composition were determined.  Subjects were 
divided into tertiles of percentage distribution of 
sdLDL. 
Small dense LDL was positively related to plasma triacylglycerol and 
fasting insulin concentrations (P<0.001) and inversely related to HDL 
cholesterol (P<0.0001).  No strong relations were found between sdLDL 
and the reported intake of SFA, monounsaturated fatty acids or PUFA. 
Individual FAs typically found in milk products were associated with a 
more favourable LDL profile. This was shown for 4:0-10:0 and 14:0 in the 
diet (P<0.05), 15:0 and 17:0 in serum phospholipids (both P<0.05), and 
15:0 in serum nonesterified FA (P<0.01).    
Denke et al. 1993  Randomised controlled trial, single-blind 
13 healthy men with moderate 
hypercholesterolemia 
Comparison of a low-calcium diet (34% fat, 13% 
SFA, 410 mg calcium) versus a fortified diet 
(2200 mg calcium / day – calcium citrate malate).  
The percentage of dietary saturated fat excreted per day increased from 6 to 
13% with calcium fortification.  The high Ca diet significantly reduced total 
cholesterol 6% (5.99 to 5.66 mmol/L), LDL cholesterol 11% (4.13 to 3.67 
mmol/L), and apolipoprotein A1 7% (P<0.05) when compared with the low 
Ca diet.  
 Chapter 1: Literature Review  
96 
Authors Details of study   Results / Conclusion  
Bostick et al. 2000 Randomised, double-blind, placebo controlled 
trial 
Outpatient clinic 
193 (men & women, age 30-74 year) 
Subjects supplemented with 1 or 2 g elemental 
calcium vs. placebo over a 4-month period 
(cholesterol outcomes)  
US data 
Because of no apparent difference between the 1 and 2 g supplemented 
group these data were pooled and a comparison made with the placebo 
group. Mean cholesterol level dropped 0.07 mmol/L (1.3%) (P=0.43) more 
and the mean HDL-C level dropped 0.01 mmol/L (1.1%) (P=0.71) less in 
the calcium group than in the placebo group. Among participants without a 
history of hypercholesterolemia, the mean cholesterol level dropped 0.18 
mmol/L (3.3%) (P=0.01).  and the HDL-C level dropped 0.02 (1.5%) 
(P=0.61) more in the calcium group than in the placebo group.     
Barr et al. 2000  Randomised, controlled open trial 
240 healthy men & women (age 55-85 years) 
Who consumed < 1 ½ serves dairy per day – from 
6 US academic health centres.  
Provided with advice to increase skim milk or 1% 
milk by 3 cups per day (n=101) or maintain usual 
diet (n=103) for 12 weeks after a 4 week baseline 
period.  
Total and LDL-C and the ratio of TC to HDL-C were unchanged. 
Triglycerides increased within normal range in the milk group (P=0.002).   
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Bowen et al. 2005 Parallel design  
50 overweight & obese (30 women, 20 men) 
1. high dairy protein/high calcium (DP 2400 
mg/d) (age men 49 + 3.2, women 47 + 2.4 years) 
2. high mixed protein /moderate calcium (MP 500 
mg/d) (age men 49 + 4.2, women 46 + 2.6 years 
Subjects all subjects given 5.5 MJ/d (inc. to 7 
MJ/d if active) 
12 weeks energy restriction - ER (4 week energy 
balance - EB) 
Fasting plasma levels of lipids changed throughout the study, with no 
differences between dietary groups or gender. Overall, TC decreased by 
0.62 + 0.11 mmol/L during ER, and increased by 0.21 + 0.10 mmol/L 
during EB, resulting in a net reduction in TC (-0.41 + 0.07 mmol/L; 
P<0.001). LDL-C decreased 0.60 + 0.10 mol/L after 12 weeks of ER 
(P<0.001), at week 16, LDLD-C remained 0.36 + 0.10 mmol/L below 
baseline (P<0.001). Fasting triglycerides decreased by 0.35 + 0.06 mmol/L 
during ER, by week 16, there was a 0.24 + 0.06 mmol/L decrease in 
triglyceride concentration compared to baseline (P<0.001). Fasting HDL-C 
remained unchanged during the ER and EB phases.   
Thompson et al. 2005 Refer to table 1.6   Each group showed a significant increase in HDL-C and significant 
reductions in total cholesterol, LDL-C and triglycerides - but there were no 
differences between the groups (P=0.71, TC; P=0.24, HDL-C; P=0.77, 
LDL-C; P=0.40, triglycerides) 
Zemel et al. 2004  Refer to table 1.6  No significant treatment effect on TC, HDL-C or LDL-C (no values 
reported) 
Zemel et al. 2005a Refer to table 1.6  No significant treatment effect on circulating lipids (no values reported) 
Zemel et al. 2005b  Refer to table 1.6  No significant treatment effect on circulating lipids (weight maintenance) 
Not reported on the weight loss (phase 2) study 
Major et al. 2007 RCT- parallel design After 15 wk intervention > decrease LDL (P=0.05)and LDL:HDL (P<0.01) 
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63 overweight/obese women, daily Ca intake 
<800 mg. 
Energy-restricted diet (700 kcal/d) for 15 wk 
1. Elemental Ca 1200 mg + 400 IU vit D 
      2. placebo only  
in treatment group independent of changes in wt and fat loss.  
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Chapter 2: General Materials & Methods   
2.1 Materials  
• Bio-Rad 550 microplate reader  
• Blood pressure machine: Datex-Engstrom Cardiocap™ II  and Model T8, 
Omron, Japan 
• Calcium fortified milk powder: NatraCal™, Murray Goulburn Co-
Operative Ltd.  Brunswick, VIC, Australia    
• Calcium tablets: Citrical, Mission Pharmacal Australasia, Sydney, Australia  
• Cholesterol and triglyceride enzymatic colorimetric kit: TRACE Scientific 
Ltd, Melbourne, VIC, Australia 
• Dual energy X-ray absorptometry (DEXA):  Hologic QDR-4500A, version 
8.6, Bedford, MA, USA 
• Dietary Scales: Philips electronic scales, VIC, Australia  
• Digital Scale: Tanita System 502, Tokyo, Japan 
• Glucose (finger prick – acute study only): ACCU-CHEK Active blood 
glucose strips, Roche Diagnostics, NSW, Australia  
• Glucose colorimetric assay kit (chronic study): Randox Laboratories Ltd.  
Ardmore, Co.Antrim, UK  
• Glycerol kit: Randox Laboratories Ltd.  Ardmore, Co.Antrim, UK 
• Indirect calorimetry: Deltatrac II metabolic monitor, Datex Ohmeda, 
Finland 
• Insulin ELISA kits: DAKO Diagnostic, Cambridgeshire, UK  
• Medi-swab alcohol swabs: Smith and Nephew, Mount Waverley, VIC, 
Australia 
• Microplates 96-well: NUNC, Naperville, USA 
• Milk products: Murray Goulburn Co-Operative Ltd.  Brunswick, VIC, 
Australia   
• Non-esterified fatty acid kit: Wako Pure Chemical Industries, Ltd. Osaka, 
Japan 
• Polyjoule: Nutricia, Mount Wellington, New Zealand 
  
Chapter 2: General Materials & Methods  
100
• Skinfold Calipers: Harpenden brand, Diagnostic Instruments Pty. Ltd. 
Victoria Park, West Australia  
• Syringes: Terumo, Elkton, USA 
• Tape measure: Rosscraft Pty. Ltd.  Vancouver, Canada 
• Urinary calcium: Atomic Absorption Spectrometer, Avanta Σ, GBC 
Scientific Equipment Pty Ltd.  VIC, Australia 
• Urine containers: 4 litre stock bottles, Viscount Plastics, Canning Vale, 
West Australia   
• Vacutainer adaptors: Becton Dickinson, Franklin Lakes, USA  
• Vacutainer EDTA collection tubes: Greiner bio-one, Kremunster, Austria  
• Vacutainer SST (sera) collection tubes: Greiner bio-one, Kremunster, 
Austria 
• Winged-infusion sets: Terumo, Tokyo, Japan  
 
2.2 Methods 
2.2.1 Subjects and experimental protocol  
The investigation into the effect of dairy calcium consumption on weight and fat loss 
was conducted in the acute and chronic setting. The details concerning the specific 
characteristics of the subjects recruited and the experimental protocol of the 
respective studies will be described in subsequent chapters.  This chapter will cover 
specific methods which were used for both the acute and chronic studies. 
2.2.1.1 Measurements of Body Composition  
2.2.1.1.1 Body weight and height 
Body weight was measured after an overnight fast on each occasion, immediately 
after voiding, with subjects wearing underwear and a light surgical gown, on a digital 
balance (Tanita System 502, Tokyo, Japan) and recorded to the nearest 100 g. 
Standing height was measured using a stadiometer fixed to the wall and recorded to 
the nearest 0.1 cm  
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2.2.1.1.2 Waist and hip circumferences 
Waist and hip circumferences were measured as described by Norton and Olds 
(2000).  The waist measurement is taken at the level of the narrowest point between 
the lower costal (rib) border and the iliac crest. If there is no obvious narrowing then 
the measurement was taken at the mid-point between these two landmarks.  Each 
measurement was taken at the end of a normal expiration with the arms relaxed at the 
sides.  The waist was measured twice and a mean value recorded for each subject.  
Waist circumference measurements were only taken by the chief investigator. 
Unpublished repeatability measurements of 25 overweight/obese clinical patients 
gave a CV% of 1.1. The hip measurement was taken at the level of the greatest 
posterior protuberance of the buttocks.  The measurer stood by the side of the subject 
and measured with the tape in a horizontal plane.      
2.2.1.1.3 Dual Energy X-ray absorptometry 
Body composition was determined by Dual energy X-ray absorptometry (DEXA) 
(Hologic QDR-4500A, version 8.6, Bedford, MA, USA) and were performed at an 
accredited DEXA centre off-site but close to Curtin University Bentley Campus. The 
scan mode used was Array. Daily scanning of the anthropometric spine phantom 
were conducted (using the Hologic protocol).  In addition a daily reading is checked 
using Shewart Multi-rule Charts and Cusum plots (Lu et al.  1996). In addition a 
weekly step phantom is analysed to enable standard body composition measurements 
to be compared. An abdominal region of interest (ROI) was delineated as previously 
described by Ley et al. (1992), in brief, it is between the upper part of the body of 
T12 and the iliac crest and its sides lateral to any trunk soft tissue.  The software 
system used was the Hologic Dos Version. CVs for the measurement of a total body 
scan were >4%.   
 
2.2.2 Measurement of blood pressure  
In all studies subjects were measured under standardised conditions, this included,  
an overnight fast (of at least 12 hours), and having rested in a supine position for at 
least 1 hour. 
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2.2.2.1 Acute Study  
During the acute studies the Blood Pressure machine (Datex-Engstrom Cardiocap™ 
II) was used. The subjects were lying in a supine position, as for the measurement of 
energy expenditure. The blood pressure measurement was taken during the last 5 
minutes of measurement, to ensure that subjects were relaxed during measurements. 
Three blood pressure measurements were taken, with a minute rest in between and 
the mean of the three measurements recorded for each subject.  
  
2.2.2.2 Chronic Study  
During the weight loss study systolic and diastolic blood pressure were measured at 
baseline, week 6 and at the end of each diet period, using the Omron blood pressure 
machine (Model T8, Omron, Japan).  Three blood pressure measurements were 
taken, with a minute rest in between and the mean of the three measurements 
recorded for each subject.  
 
2.2.3 Using Indirect Calorimetry  
Since Basal Metabolic Rate (BMR) constitutes up to 70% for the total energy output, 
is reasonably stable and easily measurable, it is appropriate that the energy needs of 
man are based on measures of BMR as an approximate for the total energy output 
(Soares et al.  1989).  Resting Metabolic Rate (RMR) is usually used as synonym to 
BMR, but is conceptually different. BMR measurements need to be conducted 
immediately after the subject wakes up, but are not feasible when overnight facilities 
are not available. However, Soares et al. have shown that these two methods yield 
similar results, when proper rest periods are observed (1989).   
 
There are several ways of measuring energy expenditure. The accurate, but invasive 
way is the whole body calorimetry or direct calorimetry. This method involves the 
subject being placed in a thermically isolated chamber, where the heat that he/she is 
dissipating is accurately collected and precisely measured (Ferranini, 1988).  In the 
present studies RMR was measured by indirect calorimetry using a Deltatrac II 
metabolic monitor (Datex Ohmeda, Finland); an open-circuit ventilated canopy 
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measurement system.  Indirect calorimetry is a non-invasive method, by which the 
type and rate of substrate utilisation and energy metabolism are estimated in vivo 
starting from gas exchange measurements (measurements of oxygen consumption 
and carbon dioxide production).  The background behind the indirect calorimetry is 
that the main goal of nutrient metabolism is to produce energy, involving the 
extraction of the chemical energy of a substrate (being carbohydrate, protein and fat) 
via complete oxidation to carbon dioxide and water.  The heat produced by these 
biological combustions is used to maintain body temperature.  The concept 
mentioned above is based on the assumption that all the oxygen is used to oxidise 
degradable fuels, and that all the carbon dioxide evolved by this means is recovered, 
therefore making it possible to calculate the total amount of energy produced 
(Ferranini, 1988).  Energy produced means the conversion of the chemical free-
energy from nutrients into energy of adenosine triphosphate (ATP) plus some energy 
loss during the oxidation process. O2 and CO2 concentrations were measured by 
means of a paramagnetic O2 analyser and infrared CO2 analyser. Humidity 
measurements are also performed for correction to standard temperature and pressure 
(STPD).  The flow meters were set at 46.4 L/min to account for the size of an adult 
subject, and the gas analysers are manually calibrated before each use by a 
calibration gas mixture (see below). The measurements of VO2 and VCO2 are used to 
calculate Respiratory Quotient (RQ) using the equation VCO2/VO2 and Resting 
Energy Expenditure using the following equation by Ferranini (1988).  
 
 
 
Where N is the total nitrogen excreted in the urine.  
 
 
 
 
 
 
 
 
 
Energy expenditure (kJ/hr): (3.91 x VO2/1000) + (1.1 x VCO2) – (3.34 x N) x 60 
x 4.184  
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Figure 2:1 Overview of Patient Connections in Canopy Mode  
1. Mixing chamber inlet, 2.  Canopy hose, 3. Canopy, 4. Flow generator inlet, 5. 
Sampling line, 6. & 7. Canopy outlet fittings, 8. Plastic seal    
  
 
Figure 2:1 demonstrates the direction of the air flow when the Deltatrac II is used for 
indirect calorimetry measurements. Atmospheric air enters the canopy at 6. as the 
person breathes in, and the exhaled air exits through tube 2. A sample of air is taken 
through tube 1, as well as a sample of exhaled air and they are analysed separately by 
the Deltatrac II.  
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Figure 2:2 Subject during testing phase   
  
2.2.4 Calibration of Deltatrac II  
The Deltatrac II was allowed to warm-up for 30 minutes each morning of testing, 
followed by a calibration protocol.  The calibration protocol allows for the automatic 
calibration of the gas supply. The Datex calibration gas contains 95% oxygen and 
5% carbon dioxide, in the automatic mode the monitor compares the measured gas 
concentration with calibration gas values stored in the monitor memory, and adjusts 
the measurement accordingly.  The adjustment value will not allow a greater than 3% 
variance, and will require re-calibrating if this arises. Performance of the instrument 
was also checked at regular intervals during the study period by monitoring the ratio 
of carbon dioxide produced to oxygen consumed, during a 30-minute ethanol burn. 
During all PhD experiments the mean (SD) ratio for ethanol burns was 0.664 (0.007) 
with a CV of 1.5 %.  
 
2.2.4.1 Measurement of  Resting Metabolic Rate    
The measurement was conducted under standardised conditions, as in previous 
studies (Piers et al.  2002a) with subjects lying (a) at complete physical rest; (b) in a 
thermally neutral environment; (c) 12-14 hours after their last meal and a minimum 
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of 8 hours of sleep; (d) awake and emotionally undisturbed; and (e) without disease 
and fever. The within-subject coefficient of variation (CV) in RMR was 3.3%.    
 
2.2.5 Diet Induced thermogenesis  
Diet induced thermogenesis (DIT) was measured as described previously (Piers et al.  
2002a). In brief, twenty minutes into each postprandial hour, subjects returned to the 
supine position and rested for 10 minutes. The canopy was then placed over their head 
and measurements made for the last 30 minutes of the hour. The first 5 minutes was 
not included in subsequent data analysis. In between measurements subjects were 
allowed to sit up in bed and listen to music, or read.  Some elected to sit at a table close 
to the bed, where they did craft work or read a book. An intermittent measurement 
protocol provides accurate postprandial data relative to that obtained by continuous 
minute-to-minute measurement over the postprandial period (Piers et al.  1992).  
Results were expressed in absolute values (kJ/h) and as a percentage of the energy in 
the breakfast meal.   
 
Whole-body substrate oxidation rates were calculated at rest (fasting), and for every 
hour up to 5 hours (6 hours – acute studies) postprandially, using measures of oxygen 
consumption (VO2), carbon dioxide production (VCO2) and urinary nitrogen 
excretion in that postprandial phase. The equations of (Ferrannini, 1988) were used 
to calculate energy expenditure and substrate oxidation rates (see next page). 
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2.2.5.1 Calculation for Fat, Carbohydrate & Protein Oxidation 
Figure 2:3 Equations for the calculation of protein, fat and carbohydrate 
oxidation  
Where N is the total nitrogen excreted in urine (g/hr), VO2 is the oxygen 
consumption (L/hr) and VCO2 is the carbon dioxide produced (L/hr) (Ferranini, 
1988).  
 
Indirect calorimetry measurements are very delicate, and consequently there are a 
number of conditions that need to be fulfilled in order to obtain accurate results.  
 
1. Reduction of Physical Activity at least 36 hours prior to the experiment: In a 
review by (Granata & Brandon, 2002) they showed that strenuous physical activity 
has been demonstrated to increase resting energy expenditure for as long as 24 to 48 
hours. Also physical activity increases fat oxidation and decreases glucose 
metabolism rates for up to 24 hours. To achieve the most accurate indirect 
calorimetry results, it is recommended that subjects refrain from strenuous physical 
activity 36 hours before the test day.  
2. Controlling emotional state: Glucose metabolism has been demonstrated to be 
elevated during stressful situations by the increased secretion of the counter-
regulatory hormones (to insulin), cortisol, catecholamines and glucagon.  Elevation 
of these hormones results in the elevation of endogenous glucose production which is 
secondary to accelerated hepatic gluconeogenesis (Weissman, 1999).  The increased 
glucose production, together with the peripheral tissue resistance to insulin, results in 
Protein oxidation (g/hr) =  
6.25 x N 
 
Fat oxidation (g/hr) =  
1.67 x (VO2 – VCO2)/1000 – (1.92 x N) x 60   
 
Carbohydrate oxidation (g/hr) =  
(4.55 x VCO2/1000)–(3.21 x VO2/1000)–(2.87 x N) x 60 
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reduced glucose utilisation and triggers hyperglycaemia.  In this situation insulin 
levels are within normal or mildly elevated range, but not high enough to counteract 
the hyperglycaemia. In addition to the hyperglycaemia, fat oxidation is also increased 
and glucose oxidation is decreased. The fatty acids released via lipolysis undergo β-
oxidation, which in a stressed person is the main ATP-production pathway.  Hence it 
is essential a subject is well-rested prior to the test day, and is familiar with the 
equipment used for the testing to prevent any apprehension.  The emotional state of a 
subject can affect his/her BMR by varying the levels of circulating epinephrine and 
norepinephrine levels.  Anxiety and tension in a subject has been shown to elevate 
BMR as an increase in epinephrine secretion results. To this purpose all subjects 
underwent an initial visit, when they were put under the calorimetry hood and 
allowed to rest for at least 5 minutes to experience the test day process. Subjects who 
felt at all apprehensive during this process were eliminated from the study.     
3. Restlessness or hypo/hyper ventilation may affect the volume of gases 
exchanged: Although intra-individual variation has been demonstrated to be 
insignificant (Shetty & Soares, 1988). It is essential that each test day is meticulously 
controlled, and that subjects stay relaxed during the testing period.  
4. Menstrual cycle: It has been found that the thermic effect of a test meal increases 
significantly after ovulation (Piers, 1994).  Although the change demonstrated was 
small, it is recommended that females subjects are tested after their menstruation and 
before ovulation, this is usually determined as between day 5 and 10 after 
commencement of menstruation.  This was not a necessary consideration during the 
acute studies, as only women 2 years post-menopause were recruited. However, in 
the chronic weight loss study, two subjects were pre-menopausal and were tested 
during day 5 and 10 of their cycles.  
5. Previous Dietary Intake:  In a review by Granata and Brandon (2002) it was 
demonstrated that the preceding dietary intake influences the amount of lipogenesis 
and the magnitude of thermogenesis after a high-carbohydrate meal. In addition, 
research demonstrates that overfeeding increases resting energy expenditure (REE) 
and the thermic effect of food (TEF). Therefore in all studies that included a fasted 
testing, the subjects were provided with a dinner pack of known energy and nutrient 
value 
6. Environmental temperature: Body temperature is very tightly controlled within 
the body. To this end, any changes in the environmental temperature will trigger 
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temperature control mechanisms so that the body is maintained at a constant 
temperature. For example, the metabolic rate will be elevated if the room 
temperature drops and the body’s heat conserving mechanisms, such as shivering are 
activated.  The metabolic testing room was therefore maintained at a comfortable 22-
23oC, and subjects were regularly asked if there were comfortable.                     
 
Indirect calorimetry necessitates the measurement of urinary non-protein nitrogen 
excretion, as it is the predominant (>90%) mechanism of nitrogen removal in normal 
subjects (Ferranini, 1988).  Urinary nitrogen excretion is the most feasible and 
practical method to use; the Kjeldahl method was utilised for this purpose.     
2.2.5.2 Measurement of nitrogen excretion 
The Kjeldahl method was employed to determine the nitrogen content of the urine 
samples. The Kjeldahl method used during these experiments has been adapted from 
Egan et al. (1981). In brief, the Kjeldahl method involves digesting the sample with 
an acid mixture until the carbon and hydrogen are oxidised and the protein nitrogen 
is converted into ammonium sulphate. The addition of a catalyst reduces the 
digestion time by raising the digestion temperature. The addition of hydrogen 
peroxide accelerates digestion and decreases foaming. When the solution is made 
alkaline the ammonium is converted to free ammonia.  The ammonia is distilled from 
the solution and the condensate collected in a boric acid solution.  This solution 
(which contains an indicator) is directly titrated with a standard acid. The percentage 
nitrogen can then be calculated in the sample (see equation below).  The CVintra% 
and CVinter% were 1.2 and 1.9, respectively.   
 
Figure 2:4 Equation to calculation nitrogen content of urine sample  
Measurement of blood lipids 
 
2.2.6 Blood collection  
Venous blood samples were taken from subjects lying in a supine position and rested 
for at least 30 minutes. Blood was drawn into specimen tubes (vacutainers) 
(sample titre mL – blank titre mL) x M HCL x 14.1 x 100 /  mg sample                   
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containing EDTA (plasma) and SST (sera), an additional tube was collected 
anaerobically by drawing blood into a vacutainer containing a gel separator. The SST 
vacutainer tubes were left to stand for 30 minutes at room temperature and then 
centrifuged at 3000 x g for 10 min, EDTA tubes were spun 5 minutes after 
collection. Serum and plasma was extracted and the samples stored at -80ºC for later 
analysis.  The anaerobically-collected tubes (for the determination of ionised 
calcium) were sent directly to an accredited laboratory and assayed within 12 hours.  
2.2.6.1 Measurement of blood lipids  
Serum triglycerides (TG) and total cholesterol were measured by enzymatic 
colorimetric kits (TRACE Scientific LTD, Melbourne, Australia). Serum HDL 
cholesterol was determined after precipitation of apo-B-containing lipoproteins with 
phosphotungstic acid and MgCl2 (diluted 1:2 with precipitant). HDL cholesterol 
contained in the supernatant was determined by enzymatic colorimetry (TRACE 
Scientific LTD, Melbourne, Australia). Samples were analysed in triplicate 
according to the manufacturer’s instructions. In brief, serum samples for the 
determination of triglycerides and total cholesterol were diluted 1:100 with the 
manufacturer’s reagent, and serum/plasma samples for the determination of HDL 
cholesterol were diluted 1:10 with the manufacturer’s reagent. The diluted samples 
and standards were mixed briefly (using microplate reader) then incubated at 37oC 
for 15 minutes. Samples were remixed and left to stand at room temperature for 7 
minutes. The absorbance of samples was determined at a wavelength of 490nm using 
a Bio-Rad 550 microplate reader and compared against the absorbance of the 
standards. Serum LDL cholesterol was determined by using a modified version of the 
Friedewald equation (Bairaktari et al.  2000).  The mean intra- and inter-assay 
coefficients of variance for total cholesterol, LDL- and HDL-cholesterol were less 
than 2%. 
 
LDL cholesterol = [total cholesterol]-[HDL cholesterol] – (0.46 x [TG]).   
 
The enzymatic determination of cholesterol is based on the following reactions: 
            Cholesterol esterase 
Cholesterol Esters      Cholesterol + Fatty acids 
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                                            Cholesterol oxidase 
Cholesterol + O2      Cholest-4-en-3-one + H202 
        
                                                                                                Peroxidase 
2H2O2 + hydroxybenzoic acid + 4-amioantipyrine  
       Quinoneimine Dye + 4H20 
The enzymatic determination of triglyceride is based on the following reactions 
    Lipase 
Triglyceride + H2O      Glycerol + Free Fatty acids 
 
           Glycerol kinase 
Glycerol + ATP     Glycerol-3-phosphate + ADP 
       Glycerol phosphate oxidase 
Glycerol-3-phosphate + O2   Dihydroxyacetone phosphate + 2H202  
       
 
 
H2O3+4-aminoantipyrine + 3,5–dichloro–2–hydroxybenzene sulphonate 
             Peroxidase             
      Quinoneimine Dye (red) + 2 H20 
 
2.2.6.2 Measurement of blood glucose 
2.2.6.2.1 Acute Studies  
Blood glucose was measured using the Accu-Chek Active glucose strips (Roche 
Diagnostic, Australia). Whole venous blood was applied to the strips and reacts with 
glucose dehydrogenase and NAD+ to produce a small electrical current which is 
directly proportional to the amount of glucose present in the blood sample.     
 
2.2.6.2.2 Chronic Study   
Serum glucose was measured according to manufacturers’ directions (Randox 
Laboratories Ltd.  Ardmore, Co.Antrim, UK). In brief, glucose is determined after 
enzymatic oxidation in the presence of glucose oxidase. The hydrogen peroxide 
produced, reacts catalysed by peroxidase, with phenol and 4-aminophenazone to 
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form a red-violet colour (using quinoneimine dye as indictor). The intensity of the 
colour is directly proportional to the glucose concentration and is measured at a 
wavelength of 505 nm.        
 
The enzymatic determination of glucose is based on the following reactions: 
Glucose + 02 + H20      gluconic acid  + H202 
2 H202 + 4-aminophenazone + phenol        quinoneimine + 4H20  
 
2.2.6.3 Measurement of insulin and insulin resistance 
Serum insulin was measured by enzyme-linked immunosorbent assay (ELISA) based 
on two monoclonal antibodies (Dako Diagnostic, UK) according to the 
manufacturer’s instructions. Briefly, calibrators (containing biosynthetic insulin in a 
protein matrix) as well as serum samples are incubated with an enzyme-labelled 
antibody for 1 hour in a microplate well coated with a specific anti-insulin antibody. 
Simultaneous incubation of the samples and antibody forms a complex, and 
subsequent washing in an organic buffered solution removes unbound enzyme-
labelled antibodies. The bound conjugate is detected by reaction with the substrate 
3,3’,5,5’-tetramethylbenzidine (TMB). The reaction is stopped by adding 1mol/L 
phosphoric acid to give a colorimetric endpoint that is read spectrophotometrically at 
a wavelength of 450nm.  Construction of a calibration curve allows for the 
determination of insulin concentration in the samples.  The mean intra- and inter-
assay coefficients of variance for insulin are less than 5%.  
 
The homeostasis model assessment (HOMA score) was used as a surrogate estimate 
of the state of insulin sensitivity by multiplying fasting insulin concentration (mIU/L) 
by fasting glucose concentration (mM) and dividing by 22.5 (Matthews et al.  1985).  
The HOMA score has been shown to be a reliable surrogate marker for in vivo 
insulin sensitivity in humans (Bonora et al.  2000).  Bonora et al. reported a strong 
positive correlation between euglycaemic, hyperinsulinaemic clamp-measured total 
glucose disposal (gold standard of insulin sensitivity) and HOMA-estimated insulin 
sensitivity (r = 0.82, P 0.0001) in 115 subjects with varying degrees of glucose 
tolerance and insulin sensitivity.  
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2.2.6.4 Measurement of glycerol  
Serum glycerol was measured using the colorimetric method (Randox Laboratories 
Ltd.  Ardmore, Co.Antrim, UK) according to manufacturer’s instructions.  In brief, 
the direct colorimetric procedure for the measurement of glycerol is described 
utilising a quinoneimine chromagen system in the presence of glycerol kinase, 
peroxidise and glycerol phosphate oxidase.  
The enzymatic determination of glycerol is based on the following reactions: 
  Glycerol kinase  
Glycerol + ATP   Glycerol-3-phosphate + ADP  
   
   Glycerol phosphate oxidase  
Glycerol-3-phosphate + 02   H202 + Dihydroxyacetone-phosphate  
2H202 + 3,5-dichloro-2-hydroxybenzene sulphonic acid + 4-aminophenazone  
Peroxidase  
  n-(4-antipyryl)-3-chloro-5-sulphonate-p-benzoquinoneimine  
  
The mean intra- and inter-assay coefficients of variance for glycerol are less than 
2%.  
 
2.2.6.5 Measurement of Non-Esterified Fatty Acids (NEFA)  
Serum NEFA was measured using an enzymatic method (Wako Pure Chemical 
Industries, Ltd. Osaka, Japan), according to manufacturer’s instructions.  In brief, 
this method relies upon the acylation of coenzyme A by the fatty acids in the 
presence of added acyl-CoA synthetase. The acyl-CoA thus produced is oxidised by 
added acyl-CoA oxidase with the generation of hydrogen peroxide.  Hydrogen 
peroxide, in the presence of peroxidase permits the oxidative condensation of 
30methyl-N-ethyl-N-(β-hydro-xyethyl)-aniline with 4-aminoantipyrine to form a 
purple coloured adduct which can be measured colorimetrically at a wavelength of 
550 nm. The mean intra- and inter-assay coefficients of variance for NEFA are less 
than 2%. 
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The following measurements were made at PathWest Laboratory, Perth WA. 
   
2.2.6.6 Measurement of Intact Parathyroid Hormone (iPTH) 
Plasma iPTH was measured using the Chemiluminescence Immunoassay method 
(Nichols Institute Diagnostics, San Clemente, USA), as per the manufacturer’s 
instructions.  In brief,  this method utilises two goat polyclonal antibodies to human 
iPTH.  One of the polyclonal antibodies is coupled to biotin, while the other 
polyclonal antibody is labelled with acridinium ester for detection. The iPTH is 
sandwiched between these antibodies.  After an initial incubation period with the 
acridinium labeled antibody, streptavidin coated magnetic particles and the capture 
antibody are added to the reaction mixture, a second incubation follows. Free 
labelled antibody is separated from the labeled antibody bound to the magnetic 
particles by aspiration of the reaction mixture and subsequent washing. The wells 
containing the washed magnetic particles are transported into the system 
luminometer, which automatically injects trigger 1 and trigger 2, initiating the 
chemiluminescence reaction.  The light is quantitated by the luminometer and 
expressed as relative light units. The amount of bound labelled antibody is directly 
proportional to the concentration of iPTH in the sample.  The mean intra- and inter-
assay coefficients of variance for iPTH are 4.2 % (concentration level range 7.58-
69.7 pmol/L) and 6.3 % (concentration level range 5.69-40.8 pmol/L), respectively.  
 
2.2.6.7 Measurement of Haemoglobin A1c  
Serum HbA1c was measured using the Ion Exchange High Performance Liquid 
Chromatography method (BioRad Variant Haemoglobin testing system, 270-2101, 
Munchen, Germany), as per manufacturer’s instructions.  In brief, glucose binds to 
HbA in a two stage process, the first stage is fast but reversible and the product is an 
aldimine or Schiff base.  The second stage is a slow, irreversible conversion of this 
product to the keroamine, HbA1c. Prepared haemolysate is injected onto the cation 
ion exchange analytical cartridge strongly retaining all haemoglobin fractions. A 
gradual increase in the ionic strength of a two buffer gradient system then displaces 
the strongly retaining haemoglobin fractions, which elute off at characteristic 
retention times. A dual-wavelength filter photometer monitors and records the 
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absorbance (415 and 690 nm) for each heamoglobin fraction.   The mean intra- and 
inter-assay coefficients of variance for HbA1c are within the range of 1.6-2.9 % 
(concentration levels 5.5-9.8 mmol/L).  
 
 2.2.6.8 Measurement of Triiodothyronine (3,5,3’-L-triiodothyronine, 
T3) – free T3 
Triiodothyronine is a hormone synthesised and secreted from the thyroid gland. T3 
and 4 are secreted into the circulation in response to thyroid stimulating hormone and 
play an important part in regulating metabolism. In the circulation, 99.7% of T3 is 
reversibly bound to transport proteins, primarily thyroxine-binding globulin (TBG) 
and to a lesser extent albumin and prealbumin.  The remaining T3 does not bind to 
transport proteins, but is free in the circulation.  This unbound fraction of the total T3 
concentration is free triiodothyronine (FT3).  Serum FT3 was measured using the 
ADVIA® Centaur™ System (Bayer Corporation, Diagnostics Division, Tarrytown, 
New York, USA), as per manufactures instructions. The ADVIA Centaur FT3 assay 
is a competitive immunoassay using direct chemiluminescent technology.  FT3 in the 
sample competes with a T3 analog, which is covalently coupled to paramagnetic 
particles in the Solid Phase for a limited amount of a combination of acridinium 
ester-labeled monoclonal mouse anti-T3 antibodies in the Lite Reagent. An inverse 
relationship exists between the amount of FT3 present in the patient sample and the 
amount of relative light units detected by the system. The mean intra- and inter-assay 
coefficients of variance for FT3 are less than 5%.  
 
2.2.6.9 Measurement of Paracetamol (Acetaminophen) 
Serum paracetamol was measured using the method as per manufacturer’s 
instructions (Cambridge Life Sciences plc, Cambridgeshire, UK). The principle of 
this assay is based on the use of an enzyme specific for the amide body of acylated 
aromatic amines.  It cleaves the paracetamol molecule, yielding p-aminophenol, 
which reacts specifically with o-cresol in ammoniacal copper solution to produce a 
blue colour.  The mean intra- and inter-assay coefficients of variance for Paracetamol 
are less than 1.4% .  
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2.2.6.10 Measurement of 25-Hydroxyvitamin D 
Serum 25-Hydroxyvitamin D was measured as per manufacturers instructions 
(DiaSorin Inc.  Minnesota, USA).   In brief, as calciferol enters the circulation it is 
metabolized to several forms, the major one being 25-hydroxycalciferol.  The first 
step in the metabolism of vitamin D, 25-hydroxylation, occurs mainly in the liver. 
Only a small amount of 25-OH-D is metabolized in the kidney to other 
dihydroxyvitamin D metabolites in man.  Since 25-OH-D is the predominant 
circulating form of vitamin D in the normal population, it is considered the most 
reliable index of vitamin D status.    This assay consists of a two-step procedure.  The 
first procedure involves a rapid extraction of 25-OH-D and other metabolites from 
serum with acetonitrile.  Following extraction, the treated sample is then assayed 
using radio-immuno-assay (RIA) method. The RIA method is based on an antibody, 
specific to 25-OH-D.  The sample, antibody and tracer are incubated for 90 minutes 
at 20-25
o
C. Following this phase separation is accomplished after a 20 minute 
incubation at 20-25
o
C with a second antibody precipitating complex.  A buffer is 
then added to this solution and centrifuged to reduce non-specific binding.  The mean 
intra- and inter-assay coefficients of variance for 25-Hydroxyvitamin D are less than 
5 %.   
2.2.6.11  Measurement of Ionised calcium  
Serum ionised calcium was measured using the calcium sensor method (Bayer 
Corporation, Diagnostics Division, Tarrytown, New York, USA). We used pH 
corrected ionised calcium results, as hydrogen ions compete with calcium for the 
calcium binding sites and hence a change in pH can have a direct effect on the 
calcium levels.  The calcium value adjusted to pH of 7.40 reflects the true ionised 
calcium concentration of blood normalized to pH 7.40.  Calcium is corrected 
according to the following equation.  
 
 
 
 
The calcium sensor used is a half-cell that combines with the external reference 
sensor to form a complete electrochemical cell capable of measuring calcium levels 
 
Adjusted Ca2+ = Ca2+ measured x 10 -0.178 (required pH- measured pH)  
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in a blood sample. The sensor contains a silver and silver chloride wire surrounded 
by an electrolyte solution that has a fixed concentration of calcium ions.  A 
membrane, consisting of an ionophore imbedded in a polyvinyl chloride membrane, 
separates the electrolyte solution from the sample. The ionophore is a compound that 
is highly selective for calcium ions over other ions.  When the sample comes in 
contact with the membrane of the measuring sensor, a membrane potential develops 
as calcium ions interact with the membrane. This membrane potential is compared to 
the constant potential of the external reference sensor.  The final measured potential 
is proportional to the calcium ion concentration in the sample.  The mean intra- and 
inter-assay coefficients of variance for ionised calcium are less than 2%.   
2.2.6.12  Measurement of Urine Samples 
Collection of urine was undertaken during metabolic test days, for the determination 
of nitrogen (protein oxidation) – see section 2.2.5.2. Twenty-four hour complete 
urine collections were made by each subject participating on the chronic weight loss 
study. Subjects were provided with a 4 litre container, which contained a weak 
hydrochloric acid solution to prevent the growth of bacteria. On the urine collection 
day, subjects were asked to empty their bladders on rising and note the time. The 
subjects then collected all urine for a total of 24 hours. On collection of the urine 
from the subjects, the volume was recorded, and 3 x 20 mL aliquots of urine 
decanted and frozen at -80
o
C.   
2.2.6.13  Measurement of Urinary Calcium  
Urine samples were first defrosted thoroughly; secondly a 2 ml sample was digested 
using 0.5 ml of concentrated nitric acid (for one hour in a 100oC water bath). This 
was allowed to cool and 1 ml of potassium chloride (500 mg/L potassium chloride, 
KCl) was added as a releasing agent, and diluted to 10 ml. The digestion process is 
carried out before reading the absorbance to free any bound calcium (such as calcium 
bound with protein). Two samples for each urine collection were prepared and 
analysis was done in duplicate. The method of Atomic Absorption Spectrometer 
(AAS) (Avanta Σ, GBC Scientific Equipment Pty Ltd.  Victoria, Australia) was used 
to determine the levels of calcium in each sample, as per the manufacturer’s 
recommended methodology.  Flame atomic absorption is a common technique for 
detecting metals in environmental samples. This technique is based on the fact that 
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ground state metals absorb light at specific wavelengths. Metal ions in a solution are 
converted to atomic state by means of a flame. Light of the appropriate wavelength is 
supplied and the amount of light absorbed is measured against a standard curve. The 
AAS was first standardised with 5 mg/L, 10 mg/L, 20 mg/L, 30 mg/L and 40 mg/L 
of potassium chloride and the absorbance of the urine samples read at 422.7 nm.    
 
During sample testing the following parameters were kept constant.  
Flame type: nitrous oxide / acetylene; Fuel flow: 4.94 l/min; Oxidant flow: 11.61 
l/min; Burner angle: 43.6
o
. 
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Chapter 3: The acute effect of  dairy and non-dairy 
calcium on diet induced thermogenesis, substrate 
utilisation & appetite  
3.1 Introduction  
Obesity along with its co-morbidities of dyslipidemia, insulin resistance and 
cardiovascular disease, is now a world-wide problem. The prevalence of 
overweight/obesity in Australia increases with age and is greatest in the 55-64 year 
age group (Thorburn, 2005). Overall, it is more common for Australians to have a 
weight problem, with 48% men and 30% of women being overweight and a further 
19% of men and 22% of women, obese (National Health and Medical Research 
Council, 1997).  Interestingly, 50% of the adult Australian population are consuming 
calcium at well below the Recommended Dietary Intake (RDI) (Australian Bureau of 
Statistics, 1998).  Vitamin D, a key regulator in calcium status, is also of concern. 
Recent Australian data states that 70% of the elderly and institutionalised Australian 
population have a frank or sub-optimal vitamin D status, while 23% of younger 
Australians seem to have a poor vitamin D status (Nowson & Margerison, 2002). 
The co-existence of poor calcium status and overweight/obesity presents a tantalizing 
paradigm for public health intervention. 
 
The regulation of calcium homeostasis is important to a large number of 
physiological processes, from blood clotting to muscle contraction to enzyme 
secretion. Over the years the role of calcium in osteoporosis and hypertension has 
been well-established. However, until recently calcium’s role in obesity and type-2 
diabetes were unheard of.  Zemel et al. (2000) work proposes that intracellular 
calcium holds the key to regulation of insulin sensitivity, lipid storage and synthesis. 
Interestingly Zemel’s tenet arose from clinical trials on hypertension, where it was 
observed that increasing the intake of calcium from ~400 mg/day to 1000 mg/day 
resulted in significant weight loss. Zemel speculated that the increased calcitrophic 
hormones, parathyroid hormone (PTH) and vitamin D3 secondary to a low calcium 
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intake, stimulated adipocyte calcium influx, which in turn stimulated fatty acid 
synthase activity and hence lipid storage (Zemel et al. 2000). If this is true, 
increasing calcium intake should lower calcitrophic hormones, reduce intracellular 
calcium and protect against fat gain.    
 
A number of epidemiological studies have supported Zemel’s original findings with 
a strong inverse correlation between calcium intake and adiposity (Parikh & 
Yanovski, 2003) in that persons with the lowest calcium intake tend to have the 
highest body weight.  Similarly data from the National Health and Nutrition 
Examination Survey III (NHANES III) also showed a strong inverse association for 
relative risk (RR) of obesity and calcium intakes (Zemel et al. 2000).  Similar 
relationships have also been demonstrated in the Australian population, based on an 
examination of the data from the National Nutrition Survey 1995. The results 
indicated that Australian men and women with higher calcium intakes, had lower 
body mass indices as well as waist circumferences, on controlling for various 
confounders (Soares et al. 2004). Retrospective analyses lend support to the thesis 
that calcium may influence the regulation of body weight.  Davies et al. re-evaluated 
the results from 5 clinical studies (one intervention and four observational studies) 
looking at dietary calcium and bone mineral content (2000).  Davies’ results showed 
a significant negative association between calcium intake and weight for all age 
groups; however it is important to point out that with these early studies weight / fat 
loss was not the major end point. More recently three clinical studies have 
documented that a high dairy calcium diet accelerated fat loss, particularly from the 
abdominal region. These results were obtained under energy deficit conditions 
(Zemel et al. 2004; 2005a; 2005b), as well as during weight maintenance (Zemel et 
al. 2005b).  Two studies by Thompson et al.  (2005) and Harvey-Berino et al.  
(2005); however, did not replicate these outcomes. Both studies concluded that a 
high-calcium diet did not augment weight loss above that obtained from calorie 
restriction alone. Clearly, the issue is far from settled. 
 
The influence of calcium on appetite is another factor that has been suggested as a 
mechanism for changes in body weight.  Most people who maintain a stable body 
weight spontaneously adapt their energy intake over a large range of energy 
expenditure through accurate mechanisms of control of food intake. Appetite 
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involves a complex sequence of interactions amongst the peripheral and central 
mechanisms.  There has been some suggestion that components in milk may reduce 
food intake (Schneeman et al. 2003; Anderson & Moore, 2004; Moran, 2004).  In 
our laboratory we have demonstrated a significant reduction in food consumption of 
human subjects following a high dairy versus a low dairy breakfast meal fed acutely. 
There was a trend for a less energy intake following the high dairy diet, this 
difference in energy intake was significantly different 24 hours post-testing (Ping-
Delfos et al. 2004). Findings by Barr et al. (2000)  have also hinted at a 
compensatory decrease in energy intake following a 3 serves of milk a day intake 
versus maintaining their usual intake. The milk group gained 0.6 kg more than the 
control group (P<0.01) but interestingly, the predicted weight gain due to an increase 
in energy intake of 200 to 250 kcal/day (836–1046 kJ) over a 12-week period should 
have been of least 2.5 kg.     
 
The present study examined the acute effects of increasing calcium intake on 
postprandial thermogenesis and substrate oxidation in overweight and obese subjects. 
It was based on the hypothesis that an increase in calcium intake would acutely 
stimulate fat oxidation and thermogenesis, and that calcium from dairy sources 
would be superior to elemental (non-dairy) calcium in these effects.  Furthermore, 
we wished to examine the effect of different sources of calcium on feelings of 
hungry/satiety and subsequent food intake.   
 
3.1.1 Methods 
3.1.1.1 Study design  
The study was a single blind, within-subject randomised comparison of the acute 
responses to three isocaloric mixed meals. The interval between trials ranged from 2 
to 3 weeks, and subjects were instructed to maintain their habitual intake and activity 
patterns throughout the study.   
3.1.1.2 Subjects  
Subjects were recruited by advertisement in the local media.  Subjects were initially 
screened by a telephone interview.  Inclusion criteria included: (i) absence of clinical 
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signs or symptoms of chronic disease; (ii) history of weight stability (± 2 kg for the 
preceding 12 months); (iii) not on medication affecting metabolic rate or body 
composition; (iv) resting diastolic blood pressure <90 mm Hg (checked at 
introductory appointment); and in the women (v) at least 2 years postmenopausal; 
(iv) not on hormone replacement therapy. Suitable recruits (from the initial telephone 
screening) were sent a map of Curtin University of Technology and were booked in 
for an introductory appointment. The purpose of this first visit was to meet with the 
chief investigator, to show the subjects the testing room and explain the test day 
protocol and most importantly familiarise the subjects with indirect calorimetry 
measurements. This familiarisation was an important part of the study as it is critical 
to prevent any apprehension from the subjects on the test day.  At this appointment 
subjects were also asked to complete a calcium food frequency questionnaire 
(Appendix A), they were also provided with an information sheet describing the 
study protocol (Appendix B) and asked to sign the written informed consent 
(Appendix B). The subjects were also provided with a checklist of instructions to 
follow before the experimental day (Appendix C).   
    
Eight subjects, 6 men and 2 postmenopausal women, aged between 47 and 66 years 
and body mass index (BMI) within the range 27.6 – 36.1 kg/m2 were recruited for the 
study (Table 3:1). The Human Research Ethics Committee of Curtin University of 
Technology (HR 245-2001) approved the protocol. All measurements were made in 
the clinical rooms of the Bentley Campus of Curtin University, Perth. 
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Table 3:1 Physical and metabolic characteristics of subjects.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Values are mean + SD  
3.1.1.3 Anthropometry and body composition measurements 
Standing height was measured using a stadiometer fixed to the wall and recorded to 
the nearest 0.1 cm. Body weight was measured after an overnight fast on each 
occasion, immediately after voiding, with subjects wearing underwear and a light 
surgical gown, on a digital balance and recorded to the nearest 100 g. Waist and hip 
circumferences were measured as described by Norton and Olds (2000) (refer to 
Chapter 2). Body composition was determined by Dual energy X-ray absorptometry 
(DEXA) (Lunar DPX-L, Madison, WI) at a certified commercial Bone Densitometry 
Centre (refer to Chapter 2).  
 
Age (yr.) 53.7 + 0.29 
Gender  Males n=6 
Females n=2 
Weight (kg) 92.4 + 0.87 
Body mass index (kg/m2) 32.5 + 0.12 
Fat mass (kg) 31.6 + 0.35 
Fat free mass (kg) 63.3 + 0.90 
Waist circumference (cm) 108.1 + 0.47 
Serum Vitamin D3 (nmol/L) 75.5 + 0.95 
Fasting TG (mM) 1.7 + 0.003 
Fasting TC (mM) 5.6 + 0.003 
Fasting LDL (mM) 3.4 + 0.0075 
Fasting HDL (mM) 0.7 + 0.00073  
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3.1.1.4 Measurement protocol 
Subjects were requested to abstain from any strenuous exercise for 36 h prior to the 
measurement.  
3.1.1.4.1 Pre-experimental day dinner meal  
A frozen dinner meal was provided to each subject to be consumed the night before 
the test day.  The meal chosen was Kan Tong Chicken Chow Mien, this meal was 
chosen for its easy of preparation and low calcium content (<50 mg).  Each meal 
weighs 340g, and its composition per 100 g is as follows:  
 
Energy 380 kJ 
Protein 5.1 g 
Fat 0.4 g 
Carbohydrate 15.2 g 
Sugars 0.8 g 
Calcium < 50 mg  
Sodium 280 mg  
Potassium 95 mg 
 
To further control calcium intake the night before the test day, each subject was 
provided with a 2 L bottle of deionised distilled water, for ad libitum consumption.  
 
Subjects arrived at the laboratory after a 12 h overnight fast, and emptied their 
bladder (the time was recorded), the subjects were then weighed. They lay supine for 
a mandatory 30-min rest period, while the Deltatrac II metabolic monitor (Datex, 
Finland) was calibrated. At the end of this rest period, the canopy was placed over 
the head of the subject and they were asked to remain awake and motionless, as far 
as possible, for a 30 min resting metabolic rate (RMR) measurement.  This protocol 
yields an RMR not very different from a basal metabolic rate measurement obtained 
immediately on waking, after an overnight stay in the laboratory (Soares et al. 1989).  
 
After the RMR measurement, the plastic canopy was removed and a fasting blood 
sample (15 ml) was collected. Following the blood collection subjects made a fasting 
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collection of urine. They were given a breakfast meal, which they consumed within 
10 minutes.  
3.1.1.4.2 Test breakfast meal  
The composition of the test breakfasts are provided in Table 2:2. The meals 
contained the following foods to meet the percentage macronutrients and calcium 
goals (Table 2:2): white bread (Goodman Fielder; Malaga, West Australia), butter 
(Bowland Dairies Pty Ltd; Rowville, Victoria, Australia), Adelphi ham and tomato 
(purchased from Coles Supermarket, Karawara, West Australia), muesli bar (Uncle 
Toby’s; Wahgunyah, Victoria, Australia). The LD meal was supplemented by a low 
calcium, low vitamin D UHT milk and the HD meal was supplemented with a high 
calcium, high vitamin D milk (all milks were low in fat (1%) and provided by 
Murray Goulburn Co-Operative Co. Ltd; Brunswick, Victoria, Australia). The HC 
meal was supplemented with orange juice (Berri Ltd; Carlton, Victoria, Australia), 
and consumed with 2 tablets of Citracal (Mission Pharmacal Australia Pty. Ltd.  
Sydney, NSW, Australia). The solid component of all meals were of a similar weight 
(~400 g) and fluids consumed were of identical volumes (200 ml). The macronutrient 
content of the breakfast meals was determined using Foodworks analysis package 3.0 
(Xyris software, Highgate Hill, Australia), the database uses data from AusNut, 
1995, along with the manufacturer’s product information. All subjects completed a 
palatability questionnaire that enquired about amount, taste, and overall acceptability 
of each meal. Each answer was scored on a 15 cm visual analogue scale anchored by 
the most negative to the most positive response for each question (Appendix D).  
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Table 3:2  Nutrient Composition of Breakfast Meals  
 
Data are mean ± SEM. * Vitamin D content was calculated using the NUTTAB database for one 
sample of each of the three test meals (Food Standards Australia & New Zealand, 2006) ** Volume 
was calculated by the analysis of one meal as a sample of each of the three test meals.  GL – 
glycaemic index, GL – glycaemic load.     
 Low dairy 
calcium (LD) 
High dairy calcium 
(HD) 
High non-dairy 
calcium (HC) 
Energy content (kJ) 2391.0 + 0.028 2372.8 + 0.46 2386.9 + 0.29 
Protein (g) 
  (% of total energy) 
20.7 + 0.004 
(14.7 + 0.002) 
21.1 + 0.004 
(15.1 + 0.001) 
20.7 + 0.002 
(14.7 + 0.001) 
Total fat (g) 
  (% of total energy) 
22.0 + 0.003 
(34.0 + 0.004) 
22.1 + 0.001 
(34.5 + 0.005) 
21.6 + 0.009 
(33.4 + 0.013) 
Carbohydrate (g) 
  (% of total energy) 
69.9 + 0.00 
(46.8 + 0.005) 
68.3 + 0.03 
(46.0 + 0.01) 
70.7 + 0.016 
(47.4 + 0.006)  
Fibre (g) 4.9 + 0.00 4.7 + 0.005 4.9 + 0.002 
Calcium (mg) 175.8 + 0.04 531.7 + 0.05 575 + 0.00 
Vitamin D (μg)* 1.7  4.8 1.9 
Volume (mL)**  365 362 350 
Weight (g) 401.1 + 0.05 408.7 + 0.04 408.1 + 0.032 
GI/GL 67/47 62/44 69/49 
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Figure 3:1 Example of high dairy/calcium breakfast meal  
 
The palatability questionnaire was completed at this time. Twenty minutes into each 
postprandial hour, subjects returned to the supine position and rested for 10 min. The 
canopy was then placed over their head and measurements made for the last 30 min 
of the hour. The first 5 min was not included in subsequent data analysis. In between 
measurements subjects were allowed to sit up in bed and listen to music, or read.  
Some elected to sit at a table close to the bed, where they did craft work or read a 
book. An intermittent measurement protocol provides accurate postprandial data 
relative to that obtained by continuous minute-to-minute measurement over the 
postprandial period (Piers et al. 1992). De-ionised water was allowed ad libitum over 
the first postprandial visit, and the amount consumed was noted. These amounts were 
kept constant for subsequent visits. All subjects made two separate urine collections, 
hours 0-3 and 3-6 after the meal. The weight and duration of all collections were 
noted, urines were acidified and an aliquot was frozen at –80oC. Total urinary 
nitrogen excretion was estimated by the Kjeldahl technique.  
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Figure 3:2 Overview of Study Protocol  
   
         
 
3.1.1.4.3 Resting metabolic rate 
Resting metabolic rate (RMR) was measured by indirect calorimetry using a 
Deltatrac II metabolic monitor (Datex Ohmeda, Finland); an open-circuit ventilated 
canopy measurement system. The measurement was conducted under standardised 
conditions, as per the protocol of (Piers et al. 2002) with subjects lying (a) at 
complete physical rest; (b) in a thermally neutral environment; (c) 12-14 hours after 
their last meal and a minimum of 8 hours of sleep; (d) awake and emotionally 
undisturbed; and (e) without disease and fever. The within-subject coefficient of 
variation (CV) in RMR was 3.3% in this study.  The Deltatrac II was calibrated on 
the morning of each experimental day. Performance of the instrument was also 
checked at regular intervals during the study period by monitoring the ratio of carbon 
dioxide produced to oxygen consumed, during a 30 min ethanol burn. The mean 
(SD) ratio for 20 ethanol burns was 0.663 (0.008) with a CV of 1.2 %.  
 
  Æ Test meal
        
 -1        0       1       2       3      4      5       6      hr
DIT measurement, followed by blood sample, blood 
pressure and VAS questionnaire  
Day 
before  
LC meal provided followed 
by an o’night fast  
 
Urine collected, ht, wt & waist measured, 30 min rest, 
followed by baseline RMR & blood sample  
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Figure 3:3 Indirect Calorimetry method  
 
 
3.1.1.4.4 Diet induced thermogenesis and substrate oxidation rates  
Diet induced thermogenesis (DIT) was measured as described previously (Piers et al. 
1992), and expressed in absolute values (kJ/6h) and as a percentage of the energy in 
the breakfast meal. Whole-body substrate oxidation rates were calculated at rest 
(fasting), and for every hour up to 6h postprandial, using measures of oxygen 
consumption, carbon dioxide production and urinary nitrogen excretion in that 
postprandial phase. The equations of Ferranini (1988) were used to calculate energy 
expenditure and substrate oxidation rates.  
3.1.1.4.5 Blood pressure measurement  
The blood pressure measurement was taken during the last 5 minutes of RMR 
measurement, to ensure that subjects were relaxed during measurements. The blood 
pressure machine used was the Datex-Engstrom Cardiocap™ II. The subjects were 
lying in a supine position, as for the measurement of energy expenditure, with the 
arm cuff already attached to the arm. Three blood pressure measurements were 
 Chapter 3: The acute effect of dairy & non-dairy calcium on diet induced thermogenesis, substrate oxidation & 
appetite  
130
taken, with a minute rest in between and the mean of the three measurements 
recorded for each subject. 
3.1.1.4.6 Temperature  
Core body temperature was measured, at the tympanic membrane, through the ear 
canal in order to monitor change in temperature occurring as food is digested during 
the test day. This procedure was undertaken immediately after each blood draw, once 
the subject was in the seated position.  
3.1.1.4.7 Blood assays  
Venous blood samples were drawn at baseline and at the end of each 30 min RMR 
measurement. Blood for determination of insulin, total cholesterol (TC), low density 
lipoprotein (LDL) cholesterol (by calculation), high density lipoprotein (HDL) 
cholesterol and triaclyglycerol (TG), non-esterified free fatty acids (NEFA) and 
glycerol was left to stand for 30 minutes at room temperature and then centrifuged at 
3000 x g for 10 min. Serum was extracted and the samples stored at -80ºC until later 
analysis. A finger prick blood sample was also taken and blood glucose was 
measured using Accu-Chek Active glucose strips (Roche Diagnostic, Australia). 
Serum insulin was measured by enzyme-linked immunosorbent assay (ELISA) based 
on two monoclonal antibodies (Dako Diagnostic, UK) according to manufacturer’s 
instructions.  Serum TG and TC were measured by enzymatic colorimetric kits 
(TRACE Scientific Ltd, Melbourne, Australia). Serum HDL cholesterol was 
determined after prior precipitation of apo B-containing lipoproteins with 
phosphotungstic acid and MgCl2 by enzymatic colorimetry (TRACE Scientific Ltd, 
Melbourne, Australia). Serum LDL cholesterol was determined by using a modified 
version on the Friedewald equation: LDL cholesterol = [total cholesterol] – [HDL 
cholesterol] – (0.46 x [TG]) (Bairaktari et al. 2000).  NEFA and Glycerol were 
determined by an enzymatic colorimetric method (WAKO NEFA C Kit, Novachem 
and RANDOX Ltd, United Kingdom, respectively). Individual CVintra% were <2.1% 
(glucose), CVintra% and CVinter%, <5% (insulin), <2% (TC), <2% (HDL), <2% (TG) 
and <5% for both NEFA and glycerol.     
 
In addition, an anaerobically collected serum sample was taken from each subject, 
this was sent to an accredited laboratory for the determination of ionised calcium.  
 Chapter 3: The acute effect of dairy & non-dairy calcium on diet induced thermogenesis, substrate oxidation & 
appetite  
131
Also an aliquot of plasma was kept and sent to the same accredited laboratory for the 
determination of intact parathyroid hormone.    
3.1.1.4.8 Appetite, satiety and sensory ratings    
To determine the subject’s subjective feelings of hunger, appetite and satiety the 
Visual Analogue Scale (VAS) was utilised.  The VAS questionnaire is a 10 cm scale 
anchored by the most negative to the most positive response for each question.  The 
questions asked were: 1. How hungry do you feel?, 2. How full do you feel?, 3. How 
strong is your desire to eat?, 4. How much do you think you could eat now? and 5. 
Your preoccupation with thoughts of food? (Appendix E) (Stubbs et al. 2000).  The 
subjects make a vertical mark or cross on the scale to determine their response.  The 
VAS has the advantage of being easy, quick to use and very simple to interpret.  The 
questionnaire shows good reproducibility under controlled conditions, provided they 
are used in a with-in subject design (as was the case in this study).  The VAS 
questionnaire was administered to each subject following the temperature 
measurement.  
3.1.1.4.9 Energy consumption after experimental period  
Following the 6 hour testing period all subjects were offered a buffet meal before 
they returned home.  The subjects were encouraged to eat the buffet ad libitum, an 
assistant investigator sat with each subject to chat and assist in creating a relaxed 
atmosphere. Once the subjects had finished eating they were provided with a food 
recording booklet (Appendix F), and provided with instructions on how to complete 
an accurate record of their intake for the following 24 hours. The booklet also 
includes photographs of standard portion serves, to assist with the accurate 
completion of the food diary.  
 
Following consumption of the buffet and once the subject had left the test dining-hall 
all foods provided were re-weighed and actual food consumption was recorded.  The 
foods provided to the subjects is demonstrated in table 3:3.        
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Table 3:3 List of Foods Provided to the Subjects and consumed ad libitum   
Item  Brand name Amount  
Soup  Heinz Very Special Cream 
of Pumpkin Soup (98% fat 
free)  
500 g 
French stick – bread Coles brand 150 g 
Yoghurt  Yoplait – Pineapple & 
Mango (99% fat free) 
2 x 200 g tub 
Savoury biscuits  Arnott’s Vita Weat crackers 
(original)  
6 crackers 
Cheese  Coon Tasty Dairy  Farmers 3 slices – cut in half 
Carrot sticks  80 g  
Almonds Sunbeam  100 g 
Turkish apricots SunBeam sun dried 150 g 
Canned fruits  Goulbourn Valley Two fruits 
in light juice (pears & 
peaches) 
2 x 140 g tub  
Apple bars  Farmland oven baked bar 
(97% fat free) 
2 bars 
Milk chocolate Cadbury dairy milk 
chocolate 
6 small bars (~15.8 g without 
wrapper) 
Orange juice Just Juice 99.9% orange 
juice 
900 ml 
Milk  Brownes Hi-Lo Calcium rich 150 ml 
Tea  Lipton’s teabags * 
Coffee Nescafe – Blend 43 * 
Sugar Farmland white sugar 100 g  
Tea and coffee were served according to subject request (coffee powder was also weighed) 
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Figure 3:4 Layout of buffet meal provided to each subject post-testing  
 
3.1.1.4.10 Calcium bioavailability  
The bioavailability of the three test meals was determined using three standard 
methods; ionised calcium (pH corrected) and intact parathyroid hormone (both 
measured by a accredited laboratory in Perth). As the third method, urinary excretion 
of calcium was measured using the GBC Flame Atomic absorption 
Spectrophotometer (Avanta Σ, GBC Scientific Equipment Pty Ltd.  Victoria, 
Australia) – refer to Chapter 2 for details of these methods.   
3.1.1.4.11 Gastric emptying  
When comparing the effect of different dietary intakes on energy metabolism and 
substrate utilisation it is essential to determine that the rate of gastric emptying is not 
a confounding factor. Varying rates of gastric emptying will obviously influence the 
rate of nutrient absorption and therefore energy expenditure resulting in differences 
in the diets due to intra-subject variations and not the direct affect of the nutrient 
intervention.  The rate of gastric emptying influences physiological variables 
including glycaemia and insulin responses (Mourot et al. 1988), along with 
subjective feelings of hunger and satiety (Robinson et al. 1988).  The paracetamol 
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marker method of gastric emptying is a simple, non-invasive technique, well 
accepted by subjects (Medhus et al. 1998; Willems et al. 2001).  Studies have also 
examined the paracetamol marker method against the gold standard of gastric 
emptying, the scintigraphic technique, and concluded that the paracetamol method 
offers an accurate approximation of gastric emptying (Naslund et al. 2000; Willems 
et al. 2001).  In a sub-set of subjects 1000 mg of Paracetamol™ (Glaxo Smith Kline, 
Erminton, NSW, Australia), this equated to 2 tablets, was provided and consumed 
with the test breakfast meal.  A blood sample was taken every hour and the sample 
sent to an accredited laboratory in Perth for the determination of levels of 
paracetamol.        
3.1.1.4.12 Glycaemic Index / Load of test meals     
To ensure that interpretation of the results were not confounded by the glycaemic 
index (GI) or load (GL) of the meals, these values were determined using data from 
the International Tables of Glycaemic Index (Foster-Powell & Miller, 1995; Foster-
Powell et al. 2002).  Glycaemic Load was further calculated using the equation 
below (Foster-Powell & Miller, 1995; Foster-Powell et al. 2002).  
  
GL = GI x carbohydrate content of food 
 
3.1.1.5 Statistical analysis 
All data are presented as mean + standard error of the mean (SEM), unless otherwise 
stated. Change between fasting and fed states, was calculated by subtracting the 
fasting value x duration of measurement, from the total postprandial value over 6h. 
Since the intervals of measurement in the postprandial period were equal, this 
summary statistic was analogous to determining the incremental area under the curve 
(Mathews et al. 1990). Total postprandial fat and carbohydrate oxidation were also 
adjusted for their respective fasting values using the method of Ravussin & Bogardus 
(1989). A repeated measures ANOVA was used to determine statistical significance, 
which was set at the 5% level. Post-hoc test used the LSD procedure. Pearson’s 
correlation coefficients for all anthropometric, body composition and metabolic 
variables were separately calculated for each meal. Data were analysed using the 
SPSS for Windows (Version 11, SPSS Inc. USA) statistical software package.  
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3.1.2 Results 
The physical characteristics of the subjects are shown in Table 3:1.  
3.1.2.1 Effect of breakfast meals 
3.1.2.1.1 Energy expenditure & substrate oxidation 
There was no significant difference in body weight or RMR between the three trials. 
However, basal FOR (fat oxidation rate) was significantly lower following the high 
calcium meals, and COR (carbohydrate oxidation rate) significantly higher following 
the HC meal, despite randomisation of the test meals (Table 3:4). DIT, in absolute 
terms (kJ/6h) or as percentage of energy in meal (%), was not different between test 
meals (Table 3:4). There was a significant rise in RQ following all meals, but the 
change in RQ was significantly (P=0.029) lower by 12.7% and 7.8% following the 
HC and HD meals, respectively (Table 3:5).  Fat oxidation was significantly 
suppressed after each meal, but the suppression was significantly less by 38% and 
44% following the HC and HD meals respectively. Reciprocally, the increase in 
carbohydrate oxidation (ΔCOR) was significantly (P=0.027) lower by 60% (HC) and 
55.4% (HD) compared to the LD meal (Table 3:5). Sum of postprandial FOR 
adjusted for fasting values, was also significantly different between meals (P = 
0.039), with the rank order LD< HC<HD (Table 3:5). The sum of postprandial COR 
adjusted for fasting values showed a trend to be lowest following HD (P=0.06, Table 
3:5). 
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Table 3:4  Fasting measurements prior to the three test meals.   
 
Values are mean ± SEM, n = 8. Values with unlike superscripts in the same row were significantly different on a post hoc LSD procedure (P<0.05).  
 
  
Low dairy calcium (LD) 
 
High dairy  
calcium (HD) 
 
High non-dairy calcium 
(HC) 
 
Significance by ANOVA for 
repeated measures 
RMR (kJ/ hr) 298.5 + 23.1 296.1 + 22.4 292.9 + 24.1 P=0.31 
RQ  0.80 + 0.02 a 0.85 + 0.02 b 0.89 + 0.02 b P=0.009 
Protein oxidation (g/hr) 3.0 + 0.4 3.8 + 0.7 3.33 + 0.2 P=0.26 
Fat oxidation (g/hr) 4.1 + 0.5 a 2.9 + 0.6 b 1.9 + 0.7 b P=0.003 
Carbohydrate oxidation 
(g/hr) 
5.3 + 1.2 a 7.4 + 1.1 10.2 + 1.6 b P=0.026 
Serum glucose (mmol/L 5.25 + 0.2 5.13 + 0.14 5.09 + 0.98 P=0.22 
Serum insulin (uIU/ml) 11.83 + 4.20 10.63 + 4.29 13.11 + 4.84 P=0.31 
Serum NEFA (mmol/L) 0.65 + 0.076 0.615 + 0.092 0.627 + 0.076 P=0.54 
Serum glycerol (μmol/L) 77.86 + 5.45 76.39 + 7.99 73.73 + 5.84 P=0.27 
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Table 3:5 The influence of the source of calcium on postprandial thermogenesis and substrate oxidation.   
Values are mean ± SEM, n = 8.  †Calculated as sum of postprandial values over 6 hr–(fasting value per hr x 6). ‡Calculated as sum of postprandial values over 6h adjusted for 
fasting baseline. Values with unlike superscripts in the same row were significantly different on a post hoc LSD procedure (P<0.05).  
 
 Low dairy calcium 
(LD) 
High dairy calcium 
(HD) 
High non-dairy 
calcium (HC) 
Significance by ANOVA 
for repeated measures 
Thermogenesis (kJ/6h)†  155.3 + 26.3 165.7 + 19.5 170.8 + 32.4 P=0.59 
DIT (%) 6.5 + 1.1 7.0 + 0.8 7.2 + 1.4 P=0.58 
Change in RQ† 0.32 + 0.09 a -0.024 + 0.11 b -0.039+ 0.08 P=0.029 
Change in protein oxidation (g/6hr)† -11.5 + 2.4 -16.7 + 4.4 -13.7 + 0.7 P=0.31 
Change in carbohydrate oxidation (g/6hr) † 34.1 + 7.6 a 15.2 + 7.1 b 13.6 + 7.5 b P=0.032 
Adjusted sum of carbohydrate oxidation (g/6hr)‡ 68.0 + 5.1 59.8 + 7.5 72.5 + 4.8 P=0.061 
Change in fat oxidation (g/6hr)† -6.5 + 2.2 a 3.3 + 2.5 b 2.9 + 2.3 b P=0.005 
Adjusted sum of fat oxidation  (g/6hr) ‡ 14.1 + 1.8 a 20.9 + 2.4 b 18.2 + 1.7 P=0.039 
Change in glucose (mmol/L) 2.04 + 1.25 1.73 + 1.02 1.65 + 0.50 P=0.76 
Change in insulin (uIU/ml) † 181.93 + 50.18 193.09 + 40.16 188.18 + 31.90 P=0.73 
Change in NEFA (mmol/L) † -1.50 + 0.26 a -0.94 + 0.27 b -1.22 + 0.32 P=0.035 
Change in glycerol (μmol/L) † -48.29 + 27.0 2.31 + 26.78 0.99 + 25.62 P=0.31 
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3.1.2.1.2 Substrates & hormones 
There were no significant differences between the three meals for basal or 
postprandial glucose or insulin concentrations (Table 3:5). Following all meals 
postprandial NEFA levels were suppressed, with the HD meal significantly less 
suppressed over the 6h postprandial period relative to the LD (LD –1.50 + 0.26, HC 
–1.22 + 0.32 and HD –0.94 + 0.27 mmol/L, P=0.035). Serum glycerol was less 
suppressed after the HD meal by almost 70% but results did not attain statistical 
significance (LD -48.30 + 27.0, HC 1.0 + 25.62 and HD 2.3 + 26.78 µmol/L, 
P=0.31). Pearson’s correlations did not detect any significant relationships between 
variables. 
 
3.1.2.1.3 Blood Pressure  
3.1.2.1.3.1 Systolic Blood Pressure  
Blood pressure was measured five minutes at the end of each indirect calorimetry 
measurement to ensure that the subjects were relaxed during the testing period.  
There was no significant difference in the change in systolic blood pressure from 
baseline over the 6 hours of testing between each of the breakfast meals (RM-
AVOVA P=0.58, LD -2.9 + 11.1, HD -13.3 + 12.0, HC -4.3 + 13.0 mmHg).   
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Figure 3:5 Systolic blood pressure, measured each hour following breakfast 
meals low in dairy & calcium ({), high in dairy and calcium (U) and no dairy 
but high in calcium (z).   
Values are means + SEM shown by vertical bars.    
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3.1.2.1.3.2 Diastolic Blood Pressure  
The measurement of diastolic blood pressure also remainder consistent between the 
three breakfast meals, with no differences in the change from baseline (RM-
ANOVA, P=0.45, LD -2.1 + 4.3, HD -13.3 + 7.7, HC -11.3 + 8.4 mmHg).  
Figure 3:6 Diastolic blood pressure, measured each hour following breakfast 
meals low in dairy & calcium ({), high in dairy and calcium (U) and no dairy 
but high in calcium (z).   
Values are means + SEM shown by vertical bars.     
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3.1.2.1.4 Temperature  
Core body temperature was measured at the tympanic membrane, in order to monitor 
the change in temperature occurring over time following the consumption of a test 
breakfast test meal. There was no significantly different between the breakfast meals 
(LD 1.52 + 0.52, HD 1.11 + 0.45, HC 0.94 + 0.46 oC, RM-ANOVA P=0.44).     
 
 
Figure 3:7 Change in temperature measured each hour following breakfast 
meals low in dairy & calcium ({), high in dairy and calcium (U) and no dairy 
but high in calcium (z).   
Values are means + SEM shown by vertical bars.      
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3.1.2.1.5 Sensory evaluation of the test meals 
Sensory evaluation of the test meals showed no significant difference in the scores 
for ‘amount’ (LD 9.0 + 1.0 cm, HD 7.0 + 0.8 cm, HC 7.3 + 1.1 cm, RM-ANOVA, 
P=0.19), ‘taste’ (LD 12.8 + 0.9 cm, HD 11.8 + 1.2 cm, HC 12.7 + 0.9, RM-ANOVA, 
P=0.35) and ‘overall acceptability’ of each meal (LD 12.9 + 0.9 cm, HD 13.2 + 0.4 
cm, HC 14.1 + 0.2 cm, RM-ANOVA, P=0.22).  
3.1.2.1.6 Hunger/fullness ratings  
Subjects were asked to fill in visual analogue scale questionnaires at baseline and 
after each hour following the consumption of the breakfast meal. The purpose of 
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these questionnaires is to determine the subject’s subjective feelings of hunger and 
satiety.  
 
3.1.2.1.6.1 Question 1 – How hungry do you feel? 
Question 1 asked, How hungry do you feel? The y-axis indicates 0, not hungry at all 
to 10, as hungry as I’ve ever felt.  Analysis by repeated-measures ANOVA 
demonstrates that there was no significant difference between the three diets 
consumed on the subjects feelings of hunger/satiety as a change from baseline 
(P=0.17, LD -3.6 + 5.6. HD -11.8 + 5.3. HC -5.6 + 5.2 cm).  Similarly there was no 
significant difference between the diets consumed and subjective feelings of hunger 
or satiety at time point 0 (before the diet was consumed), hour 3 or hour 6 (P=0.22, 
P=0.06 and P=0.57, respectively).   
 
Figure 3:8 Responses to Question 1 – How hungry do you feel? following 
breakfast meals low in dairy & calcium ({), high in dairy and calcium (U) and 
no dairy but high in calcium (z).   
Bars represent SEM. 0= not hungry at all, 10=as hungry as I’ve ever felt.   
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3.1.2.1.6.2 Question 2 -  How full do you feel? 
Question 2 asked, How full do you feel? The y-axis indicates 0, not at all full to 10, 
as full as I’ve ever felt.  Analysis by repeated-measures ANOVA demonstrates that 
there was no significant difference between the three diets consumed on the subjects 
feelings of hunger/satiety as a change from baseline (P=0.53, LD 3.9 + 3.7, HD 6.3 + 
5.9, HC 3.8 + 4.6 cm).  
 
Figure 3:9 Responses to Question 2 – How full do you feel? following breakfast 
meals low in dairy & calcium ({), high in dairy and calcium (U) and no dairy 
but high in calcium (z).  
Bars represent SEM. 0= not hungry at all, 10=as hungry as I’ve ever felt.   
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3.1.2.1.6.3 Question 3 – How strong is your desire to eat? 
Question 3 asked, How strong is your desire to eat? With this question the response 
options were weight from 0, very strong desire to eat to 10, very weak desire to eat. 
It is important to have a question within this type of design, to ensure subjects are 
reading the questions before answering. Analysis by repeated-measures ANOVA 
demonstrates that there was no significant difference between the three diets 
consumed on the subjects feelings of hunger/satiety as a change from baseline 
(P=0.37, LD 11.2 + 5.1, HD 14.4 + 5.1, HC 9.8 + 5.9 cm).  At the end of the test day 
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there was no significantly greater desire to eat by the subjects after consuming any of 
the diets (RM-ANOVA, P=0.25, LD 3.3 + 0.9, HD 2.8 + 0.9, 2.2 + 0.6 cm).  
 
Figure 3:10 Responses to Question 3 – How strong is your desire to eat? 
following breakfast meals low in dairy & calcium ({), high in dairy and calcium 
(U) and no dairy but high in calcium (z).   
Bars represent SEM. 0= very strong, 10=very weak.   
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3.1.2.1.6.4 Question 4 – How much do you think you could eat now? 
Question 4 addressed the question, How much do you think you could eat now?  
With this question the response options were weighted from 0, nothing at all to 10, a 
large amount. Analysis by repeated-measures ANOVA demonstrates that there was 
no significant difference between the three diets consumed on the subjects feelings of 
hunger/satiety as a change from baseline (P=0.38, LD -11.0 + 3.4, HD -12.6 + 3.4, 
HC -8.1 + 3.6 cm).  At the end of the test day there was no significantly greater 
desire to eat by the subjects after consuming any of the diets (RM-ANOVA, P=0.14, 
LD 7.2 + 0.5, HD 7.0 + 0.6, 6.0 + 0.8 cm).  
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Figure 3:11 Responses to Question 4 – How much do you think you could eat 
now? following breakfast meals low in dairy & calcium ({), high in dairy and 
calcium (U) and no dairy but high in calcium (z).  
Bars represent SEM. 0= Nothing at all, 10=A large amount.   
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3.1.2.1.6.5 Question 5 – Preoccupation with thoughts of food  
Question 5 addressed the question, Your preoccupation with thoughts of food?  With 
this question the response options were weighted from 0, No thoughts of food to 10, 
very difficult to concentrate on other things. Analysis by repeated-measures ANOVA 
demonstrates that there was no significant difference between the three diets 
consumed on the subjects subjective response to this question, as a change from 
baseline (P=0.66, LD -1.3 + 3.3, HD –3.3 + 5.0, HC -0.04 + 5.1 cm).  At time point 3 
(3 hours post-prandially) there is a distinct separation between the diets and the 
subjects when fed the high calcium (HC) diet reported that they found it harder to 
concentration on this diet (RM-ANOVA, P=0.02, LD 2.5 + 0.4, HD 2.7 + 0.4, HC 
4.4 + 0.7 cm). However, by the end of the test day this difference had dissipated and 
the subjects reported no difference in there preoccupation with food between the 3 
diets (RM-ANOVA, P=0.54, LD 5.4 + 0.8, HD 5.6 + 0.7, HC 5.5 + 0.8 cm).     
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Figure 3:12 Responses to Question 5 – Preoccupation with thoughts of food? 
following breakfast meals low in dairy & calcium ({), high in dairy and calcium 
(U) and no dairy but high in calcium (z).   
Bars represent SEM. 0= No thoughts of food, 10=Very difficult to concentrate on other things.   
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3.1.2.1.7 Food consumption after test period  
3.1.2.1.7.1 At buffet meal  
The buffet meal provided was an ad libitum meal; however, the actual amount of 
food consumed was measured once the subject had left the premises. There was no 
significant difference between either of the test meals on total energy (Table 3:6) 
protein, fat or carbohydrate consumed (Table 3:6).  
Table 3:6 Nutrient intake following the consumption of a buffet meal (n=8)  
Meal  Energy (kJ) Protein (g) Fat (g) Carbohydrate 
(g) 
LD 3625.3 + 512.6 26.3 + 3.4 30.0 + 4.5 116.9 +18.8 
HD 4251.2 + 504.4 30.2 + 2.6  31.2 + 2.3 147.8 + 21.9   
HC 3564.6 + 236.2 26.1 + 1.7 25.7 + 2.0  124.0 + 12.0  
RM-ANOVA 
(P value) 
0.10 0.96 0.14 0.11 
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3.1.2.1.7.2 Food intake at the end of the test day  
Subjects were provided with detailed instructions to complete a food record diary. 
All foods and drinks consumed had to be detailed in the diary and this was confirmed 
with a telephone conversation by the chief investigator to ensure the completeness of 
the diary.  The time periods examined were up to the end of the test day and then 
total consumption 24 hours following the buffet meal. There were no significant 
differences between the three test meals on total energy intake, protein and 
carbohydrate intake; however, a trend for a reduced consumption of fat in the HC 
versus the LD diet was observed.    
 
Table 3:7 Nutrient intake of the buffet meal and spontaneous food intake 
recorded at home, up until midnight (n=8) 
Meal  Energy (kJ) Protein (g) Fat (g) Carbohydrate 
(g) 
LD 7706.0 + 1245.2 75.7 + 15.2 74.3 + 14.8 * 197.8 + 34.7 
HD 7934.7 + 1473.7 82.8 + 23.5 60.6 + 14.4 221.2 + 35.4   
HC 6810.6 + 865.2 64.2 + 7.5 50.8 + 8.0 * 194.2 + 25.3  
RM-ANOVA 
(P value) 
0.31 0.33 0.051 0.39 
 
3.1.2.1.7.2.1 Time lag between the end of the buffet meal and next meal intake  
Subjects were asked to record the time at which they consumed their next meal on 
returning home from the study (post-buffet meal). The time at which they had 
finished eating had also been recorded by the chief researcher and hence the time lag 
for each meal was calculated.  We observed a significant difference between the 
three breakfast meals, in the order of HD>HC>LD (RM-ANOVA, P=0.03, LD 170.9 
+ 30.4, HD 238.0 + 14.5, HC 212.8 + 11.7 minutes).  These differences were not 
significant by a LSD post-hoc test.     
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3.1.2.1.7.3 Food intake 24 hours post-buffet  
Total food intake recorded for a 24 hour period following the consumption of the 
buffet meal was not significantly different for total energy consumed, protein, fat or 
carbohydrate intake.  
 
Table 3:8 Nutrient intake 24 hours after the buffet meal (n=8) 
Meal  Energy (kJ) Protein (g) Fat (g) Carbohydrate 
(g) 
LD 11119.2 + 1554.8 112.3 + 18.0 101.6 + 18.1 298.4 +39.7 
HD 11976.2 + 1357.1 125.1 + 22.6  99.0 + 11.2 327.2 + 41.1   
HC 12001.1 + 1140.5 118.6 + 11.5 99.5 + 12.6  331.1 + 37.8  
RM-ANOVA 
(P value) 
0.39 0.55 0.89 0.31 
 
 
3.1.2.1.8 Bioavailability of calcium  
Three standard approaches were used to determine the bioavailability of calcium 
from the breakfast meals; serum ionised calcium, pH corrected (iCa), intact 
parathyroid hormone (iPTH) and urinary calcium excretion of calcium, expressed as 
mg calcium per g of nitrogen excreted (UC). All results were expressed as a percent 
change from baseline.  
3.1.2.1.8.1 Ionised calcium  
There was no significant difference between the three breakfast meals consumed and 
the percent change from baseline for pH corrected ionised calcium (LD 11.71 + 3.31, 
HD 8.66 + 9.40, HC 11.64 + 9.64 %, RM-ANOVA, P=0.99).   
 
3.1.2.1.8.2 Intact Parathyroid Hormone   
There was a trend for the suppression of iPTH (expressed as percent change from 
baseline) following the consumption of the HC versus the LD breakfast meal; 
however, this did not reach significance (LD 10.40 + 41.28, HD -28.50 + 19.64, HC -
107.00 + 43.32, RM-ANOVA, P=0.08).   
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3.1.2.1.8.3 Urinary calcium  
There was a trend for a greater urinary calcium excretion (expressed as percent 
change from baseline) following the consumption of the HC versus the LD breakfast 
meal; however, this did not reach significance (LD 93.51 + 47.75, HD 278.12 + 
148.76, HC 303.49 + 90.65, RM-ANOVA, P=0.08).   
 
3.1.2.1.9 Gastric emptying  
There was no significant difference in delta postprandial paracetamol concentration 
(LD 31.4 + 2.7, HD 30.5 + 1.9, HC 31.2 + 2.3 mg/L, P=0.60), time taken to reach 
maximum concentration (LD 105 + 18.8, HD 105 + 22.0, HC 75 + 9.8 minutes, 
P=0.23) nor the maximum paracetamol concentration (LD 14.3 + 0.9, HD 13.6 + 0.8, 
HC 14.8 + 0.9 mg/L, P=0.36) reached between any of the test meals. 
 
Figure 3:13 Gastric emptying following the breakfast meals responses in eight 
subjects, following breakfast meals low in dairy & calcium ({), high in dairy 
and calcium (U) and no dairy but high in calcium (z).  
Bars represent SEM.   
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3.1.2.1.10 Glycaemic Index/Load  
There was no significant difference between each of the test meals for GI (LD 67, 
HD 62, HC 69) or GL (LD 47, HD 44, HC 49).   
 
3.1.3 Discussion  
The regulation of fat balance is critical to energy balance and the equilibrium of fat 
stores in the body (Flatt, 1995). Fat balance is determined by the body’s ability to 
match fat oxidation to fat intake. Any dietary factor that can stimulate fat oxidation 
over a prolonged period would hence reduce fat stores, provided there was no 
compensatory increase in fat intake. We pursued the idea that calcium and other 
ingredients in dairy, may help alter body composition if they could either, stimulate 
whole body fat oxidation, increase postprandial energy expenditure or accelerate 
mobilization of fat stores (lipolysis). For this purpose the control test meal was low 
in dairy (and calcium) and vitamin D (LD).  The second meal (HD) was high in dairy 
and hence calcium with additional vitamin D. Vitamin D was added to enhance the 
absorption of calcium (Holick, 2004) and to mimic the US practice of fortifying all 
dairy products with vitamin D (Newmark et al. 2004).  The third experimental meal 
(HC) was a high calcium meal using calcium citrate (pharmacological). There is 
evidence to indicate that calcium is better absorbed as calcium citrate in both fasting 
and mixed meal situations (Sakhaee et al. 1999). In addition this meal was served 
with orange juice to maximise the absorption of the calcium citrate tablets 
(Mehansho et al. 1989; Heaney et al. 2005).  
 
There were no differences in the taste preference and overall acceptability of each 
meal as determined by sensory assessment questionnaires. Palatability of a test meal 
is known to affect insulin responses and ultimately substrate utilization (Sawaya et 
al. 2001). The amount and volume of each meal was also similar (Table 3:2).  It was 
also important to determine that our results were not affected by differencing rates of 
gastric emptying; to this end the paracetamol absorption test was used. We 
demonstrated no difference between either of the breakfast test meals for post-
prandial paracetamol concentration, time taken to reach maximum concentration nor 
maximum paracetamol concentration reached. Hence, we can confidently conclude 
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that neither palatability nor gastric emptying of the test meals confounded the 
outcomes.  
 
We observed that subjects acutely fed a high dairy or high calcium meal exhibited a 
lesser suppression of FOR over a 6 hr postprandial period, when compared to a low 
dairy calcium meal. These findings have been confirmed by our group using a 
sequential meal design (Soares et al. 2004). Our results also compare favourably 
with evidence from the literature. In a cross-sectional study, Melanson et al. (2003) 
showed a positive correlation (r=0.38, P=0.03) between acute calcium intake and fat 
oxidation using whole-body room calorimetry. Moreover, in a prospective study of 
energy restriction, these authors showed a greater 24 hour fat oxidation following 
high calcium intakes (Melanson et al. 2005). One long-term study has also 
demonstrated a greater fat oxidation rate in subjects who followed a high calcium 
diet for a year (Gunther et al. 2005). In contrast, Jacobsen et al. (2005) manipulated 
calcium and protein intakes over 2 week periods and did not find any change in 24h 
energy expenditure nor fat oxidation between diets.  
In this study circulating levels of NEFA were less suppressed following both high 
calcium meals, which paralleled the changes in fat oxidation. The similar glycaemic 
and insulinemic responses following all three meals (Table 3:5)  would suggest that 
the relatively elevated NEFA levels did not result from a reduced insulin action.  
Frayn (1998) and Coppack et al. (1994) have argued that following a mixed meal, 
chylomicron triglyceride is preferentially acted upon by adipose tissue lipoprotein 
lipase. While re-esterification into TG does occur, much of this NEFA fails to be 
‘trapped’ within adipose tissue and finds itself back in circulation.  
 
A role for the sympathetic nervous system (SNS) in postprandial events cannot be 
discounted. SNS activity contributes to meal induced thermogenesis, and is a potent 
stimulator of adipose tissue lipolysis (Coppack et al. 1994). Although not statistically 
significant, the postprandial changes in serum glycerol were similar between the two 
high calcium meals, and around 70% higher relative to the low calcium meal. 
Evidence of a significantly higher glycerol level following high calcium intakes, has 
also been obtained under hypocaloric conditions (Zemel et al. 2005a; Zemel et al. 
2005b), as well as during weight maintenance (Zemel et al. 2005a; Zemel et al. 
2005b). While we acknowledge that measurements of circulating glycerol are not the 
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best quantitative index of adipose tissue lipolysis, the consistency of effects across 
studies merits further investigation. We anticipated a higher DIT between meals, but 
could not demonstrate such an effect. Hence higher intakes of calcium acutely 
modulate the type of fuel being utilized in the postprandial state, without a change in 
energy production. The calcium content of the meals tested here (530-575 mg), 
would in all probability exceed what is habitually consumed at individuals meals. 
Whether this would result in an attenuation of the effect on fat oxidation remains a 
possibility, but requires dose response studies for confirmation. Secondly, an 
increased frequency of calcium consumption would increase net amount absorbed for 
the day. Hence both factors are important when extrapolating results from acute meal 
based studies to dietary prescription for body weight regulation. 
 
With a greater increase in fat oxidation demonstrated with the high calcium diets it 
would be expected that an increase in energy expenditure would be demonstrated. 
Although there was a greater increase in energy expenditure and diet induced 
thermogenesis with both high calcium containing diets, these did not reach 
significance.  This is likely due to the reciprocal decrease in carbohydrate oxidation 
as the fat oxidation increased (was less suppressed).  It must be noted that other acute 
studies examining the role of dairy/calcium in energy expenditure although have 
demonstrated a greater fat oxidation have failed to show the enhanced energy 
expenditure (Melanson et al. 2003; Jacobsen et al. 2005; Melanson et al. 2005).   We 
also endeavoured to capture the change in thermogenesis through the measurement 
of auditory temperature to demonstrate a change in temperature induced by the diet; 
however no significant differences were observed between the three diets provided.    
 
It has been suggested that dairy foods have a satiating effect due to their effect on the 
hormone, cholecystokinin (CCK).  An increase in CCK has been associated with a 
meal-induced satiety (Schneeman et al. 2003).  We were unable to measure CCK, 
but used VAS questionnaires to determine the subject’s feelings of hunger and 
satiety before, during and following the testing period.  The VAS questionnaire is a 
very simple and easy method to use to determine subjects feelings of hunger and 
satiety, and has been validated for use especially in a with-in study design, such as 
this study (Flint et al. 2000).  We were unable to demonstrate any differences in 
feelings of hunger or fullness between the 3 test meals provided.  Of all 5 of the 
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questions asked to determine the subject’s subjective feelings of satiety, the results 
were consistent across all 3 diets. In other research from our laboratory, we similarly 
did not find any difference between subjects subjective feelings of satiety following a 
high versus a low dairy breakfast, followed by a low calcium meal provided at 
lunchtime (Ping-Delfos et al. 2004).  One recently published study by Tsuchiya et al. 
(2006) has demonstrated a greater fullness and reduced hunger following the 
consumption of a yoghurt and a liquid yoghurt drink compared to a fruit drink and 
dairy beverage; however, it seems more likely that the greater satiety following these 
meals could have been due to the thicker consistency of the yoghurt test meals 
(Mattes & Rothacker, 2001) and a significantly higher protein content of the yoghurt 
based meals could have contributed to the effect (Hu, 2005; Orr & Davy, 2005). In 
this study the protein content as well as the viscosity of the breakfast meals were 
consistent across the 3 test meals.    
 
We also calculated the subject’s food intake following the end of the test period and 
24 hour post-testing.  We were unable to demonstrate any significant differences 
between either of the test breakfast meals. The food consumed after the buffet meal 
and up until midnight, demonstrated a trend for a greater fat intake on the LD diet 
versus the HC meal (P=0.051); however, no differences emerged for total energy 
intake nor intake 24 hours post-testing.  In our laboratory we have demonstrated a 
significant reduction in food consumption of human subjects following a high dairy, 
(high vitamin D) breakfast meal versus a low dairy, (low vitamin D meal), the 
differences in consumption only reached significance once the food intake had been 
observed for 24 hours, with less food consumed following the high dairy meal (7143 
+ 431 kJ vs. 8484 + 699, P<0.02) (Ping-Delfos et al. 2004).  The difference between 
these results and the present study may be due to the slightly difference in study 
design, with Ping-Delfos et al. study the subjects were given a high versus a low 
dairy breakfast meal, followed by a low calcium lunch time meal. This present study 
was only interested in the responses following the acute intake of a breakfast meal.  
Interestingly, although Tsuchiya et al. (2006)  study demonstrated a significantly 
greater satiety with the yoghurt meals, the subjects did not reduce their energy 
consumption at the next meal.  It has been argued by some that there is a lack of 
consistency between appetite rating scales and the following energy intake, in both 
normal weight (Mattes, 1990) and overweight subjects (Doucet et al. 2003).    
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If dairy / calcium is to be beneficial in the long-term management of weight control, 
a reduction in the time taken to eat the next meal or snack maybe important. We 
measured time to consumption of the next meal following the consumption of the 
buffet meal and demonstrated a trend (P=0.07) for a longer time lag before the next 
meal is consumed between the HD and LD meals (~ 60 minutes). This is very similar 
to our other findings (Ping-Delfos et al. 2004) with a greater time lag of 77 minutes 
between the high and low dairy breakfast meal.    
 
In any study involving the manipulation of a nutrient it is important to be reassured 
that the results are not biased by poor absorbance of that nutrient. We examined 3 
markers of calcium bioavailability; serum ionised calcium, intact parathyroid 
hormone suppression and urinary calcium excretion. It has been suggested by some 
authors that serum ionised calcium is not a good measure of calcium bioavailability 
as this nutrient is tightly regulated with the body and small changes over time will 
not elicit a good understand of the absorption of calcium (Heaney, 2001). However, 
our data for parathyroid hormone suppression and urinary calcium excretion, 
although not significant, showed a trend for a rank order of bioavailability across 
these two methods with LD<HD<HC. The observations that FOR following HD 
were similar to HC, despite poorer bioavailability of calcium, may indicate the 
presence of other bioactive components in dairy that influence fat oxidation (Zemel, 
2002; Parikh & Yanovski, 2003; Zemel, 2003).   
 
3.1.3.1 Conclusion  
To the best of our knowledge, this is the first prospective study that shows a greater 
postprandial fat oxidation rate following high calcium meals, both dairy and non-
dairy. The lesser postprandial suppression of NEFA would drive the increase in the 
fat oxidation, and the trend for a greater lipolysis would serve to maintain the 
relatively higher NEFA levels following such meals.  Calcium rich meals did not 
alter subjective feelings of hunger or satiety, nor immediate food intake (buffet) 
following such meals. However, the inter-meal interval was prolonged relative to a 
low calcium diet, with some indication of a decrease in fat intake. Overall, 24 hour 
food intake was similar across meals.  Such data provide a mechanistic framework 
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for understanding how the intake of calcium rich foods may influence human energy 
balance. Confirmation of these putative effects through well designed dietary 
interventions are required to confirm calcium’s role in the regulation of body 
composition.   
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Chapter 4: The Potential Role of  Dietary Calcium in 
Obesity – a randomised controlled trial  
4.1  Introduction  
In our acute study we have demonstrated a greater postprandial fat oxidation rate 
following the consumption of a single high calcium, high vitamin D, from both dairy 
and non-dairy meals.  To date there are limited prospective randomised clinical 
studies designed to elucidate the effect of calcium and dairy on weight loss and body 
composition changes in humans. Importantly the studies that do exist are not 
consistent in their findings, making the outcomes of this PhD research particularly 
pertinent.    
 
To date, there have only been six randomised clinical trials designed to specifically 
relate calcium from dairy sources to weight loss.  These studies had been discussed 
thoroughly in chapter 1 (Literature Review) and a review table has been added at the 
end of this chapter for reference.  In brief, 3 studies have found a positive role of 
dairy calcium in aiding weight loss (Zemel et al. 2004b; 2005a; 2005b).  However, 
two studies that had similar study designs to Zemels group failed to find significant 
body composition differences between treatment groups (Harvey-Berino et al. 2005; 
Thompson et al. 2005). A lack of significant difference between treatment groups 
was also concluded from Bowen et al. (2005); however, this study manipulated the 
protein content as well as calcium and was therefore not included in the tables.  
 
Clearly, there are several important issues that needed to be resolved.  Firstly, the 
question arose whether calcium did in fact have a weight reducing effect per se, and 
secondly, whether other components in dairy (particularly protein) would have an 
added benefit. All previous studies had employed a double or multi-stranded parallel 
design, which in essence necessitated a between-subject comparison. The key facets 
that determine the success of such a design, is how well the subjects are matched at 
the start, the relative compliance to dietary prescription and the absence of unforseen 
  
 
 
Chapter 4: The Potential Role of Dietary Calcium in Obesity – a randomised crossover trial 
 
156
confounders arising during the study.  It was therefore important to proceed with a 
weight loss study that asked a simple question, using a good design with proper 
attention to study execution.   
4.1.1 Study design 
We employed a single-blind, randomised crossover design comparing the effects of a 
high calcium diet (milk mineral powder) ~1200-1300 mg/d against a low calcium 
(~550-700 mg/d) hypocaloric mixed meal diet. The study involved 2 x 12 weeks of 
weight loss with a 12-week wash-out period (timed to coincide with the Christmas 
season (Figure 4:1). Postprandial measurements were made in the 10th week of each 
diet period using a low calcium, high fat test meal (refer to chapter 5).  
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Figure 4:1 Study design  
(HC = high calcium (dark shading), LC = low calcium (light shading) 
 
 
Period 1  
Aug-Dec 
2004  
Subjects recruited n=40 
Randomised to high-calcium 
(yellow) or low calcium 
(green) diet  
Assessed for eligibility  
(phone interview and food 
intake questionnaire)  
6 subjects 
withdrew: 3 job 
changes, 2 health 
reasons, 1 unable 
to comply with 
dietary protocol  
n=20 
 
One subject withdrew 
from the study before 
the start  
n=19 
 
n=14 
 
n=19 
n=13 
 
 
Period 2   
Jan-May 
2005  
4 subjects 
withdrew: 2 
unable to comply 
with dietary 
protocol, 2 job 
commitments  
n=16 
n=14 
n=19 
n=29 
Completed 
study  
n=25 
Subjects rejected due to: high 
calcium intake, unable to consume 
dairy products, unable to adhere to 
dietary protocol  
4 subjects rejected as non-
adherers:  had not adhered to 
dietary protocol   
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4.1.2 Subjects 
Subjects were recruited from the local media (ABC radio and Curtin University FM) 
and all subjects resided in Perth, WA. Subjects were screened initially through a 
telephone interview, which included a brief overview of the study, questions about 
previous weight loss, expectations on the study and a subjective assessment of 
subject suitability. A nutritional questionnaire was also undertaken, which was 
adapted by Professor Caryl Nowson (personal communication) using data from 
Angus & Eisman (1988; 1989).  The questionnaire asks simple frequency (weekly or 
daily) consumption of some common calcium containing foods.  Following this 
telephone screening, suitable subjects were sent a letter detailing the study protocol 
and time requirements during the study, along with a consent form (Appendix G).  
Once the signed consent form had been received by the researcher, subjects were 
asked to attend a medical screening appointment at the Health Centre, Curtin 
University.  Ninety-seven subjects responded to our call, and 40 subjects were 
selected based on the following inclusion criteria; i) absence of clinical signs or 
symptoms of chronic disease; ii) history of weigh stability (+ 2 kg for the preceding 
12 months); iii)  not on medication affecting metabolic rate, body composition or 
calcium metabolism; iv) measured BMI > 28 kg/m2  v) able to consume dairy 
products vi) current calcium consumption < 800 mg/day (due to paucity of suitable 
subjects a few subjects did not meet this criteria) vii) vitamin D status >50 nmol/L 
indicating vitamin D replete (4 subjects did not meet this criteria) . Subjects were 
assessed for medical suitability to participate in a weight loss study and a blood 
sample was taken to determine baseline thyroid function.            
 
From an initial cohort of 40 subjects, 29 completed both arms of the study (reasons 
for drop-out included time commitment, commencement of a new job, diagnosed 
with breast cancer, and difficulty following the prescribed diet). Of the 29 subjects, a 
further 4 subjects were omitted from the analysis as they were deemed; non-adherers  
with the intervention (see comments below).  
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4.1.3 Standardised diets 
The aim of the intervention was to increase the intake of dairy calcium while on a 
hypocaloric diet. The intake of calcium on the low calcium diet was ~500-600 mg/d, 
whilst the high calcium diet was 1200-1300 mg/d.  Each subject had an 
individualised diet based on their measured resting metabolic rate (RMR) x 1.5 
(activity factor).  This was calculated at the start of each arm of the study. Dietary 
energy was then prescribed at 70% of that value with protein, fat (including saturated 
to unsaturated fat) and carbohydrate held constant and composed of 20, 25 and 55% 
of the diet, respectively (Table 4:1). The subjects were provided with dietary 
modules (5 options for breakfast, 5 options for lunch and 8 options for dinner) each 
breakfast, lunch and dinner module was matched for energy, protein, fat, 
carbohydrate, calcium and fibre content. The diets were based on typical eating 
patterns of Australians, as well as the Australian Dietary Guidelines (Nutbeam et al. 
1993) (Table 4:1). Ongoing dietary instruction and support was provided by the 
principle researcher. The majority of food amounts were provided in standard metric 
cup sizes, to aid compliance. Calibrated digital scales were used to measure all other 
items of food.  The subjects ingested their own food for the duration of the study. 
However, intervention foods were provided as 100 g UHT milk cartons (Murray 
Goulburn Co-Operative Co. Ltd; Brunswick, Victoria, Australia) and 1 litre 
containers of frozen yoghurt (daily consumption of 2 x 50 g portions); either mixed 
with Polyjoule for the low calcium diet or with NatraCal for the high calcium milk 
powder [NatraCal™ is a natural milk powder manufactured from skim milk and 
natural milk calcium extracted from fresh whey].  The intervention foods (milk and 
yoghurt) were matched in energy, protein, fat, carbohydrate content.  
 
Since bioavailability of calcium decreases exponentially with increasing calcium 
intake (Heaney et al. 1990), all subjects were instructed to consume their dairy 
products in 3 equally divided doses over the day.  The subjects completed daily 
dietary sheets, whereby they noted the module number they had chosen at each meal 
time and marked a box with M (milk) or Y (yoghurt) to confirm they had consumed 
the 3 dairy serves allocated and additional space was provided for the purpose of 
note taking with regards to deviation from the prescribed diet (Appendix H). The 
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food recording sheets were discussed with the chief researcher at each fortnightly 
visit. In addition, each subject was contacted by phone in the week between their 
appointment and asked general compliance questions, given a reminder about the 
next visit and any specific protocol instructions for the coming week (for example, 
fasting or physical activity diary to be completed). In this manner each subject 
received weekly contact with the principle researcher and dietitian.  During week 6 
of the study subjects were asked to complete a 3-day dietary intake record using 
household measures and/or scales.    
 
Table 4:1 Comparison of the Study Diets in Part 1 & 2 to the Australian Dietary 
Goals.   
Macronutrient       Study Diet 
 Part 1           Part 2 
Australian 
Dietary Goals 
Carbohydrate (% 
of total kJ) 
55 + 0.75 55 + 0.98 > 50 
Protein (% of total 
kJ) 
20 + 0.41 20 + 0.46 15 – 20  
Fat (% of total kJ) 25 + 0.73 25 + 0.73 15 – 30 
Fibre (g) 29 + 1.11 29 + 0.93 30  
Values provided as means (+ SD).   
 
4.1.4 Physical Activity assessment   
Subjects were asked to maintain a complete 3-day physical activity diary, including 2 
week days and 1 weekend day, before commencement of the study. This physical 
activity diary was then repeated for 3-days during week 4 and 8.  The diary consisted 
of one-hour blocks from 07.00 hours until 23.00 hours. It was assumed that subjects 
slept between 23.00 and 07.00 hours; however, they were asked to indicate the 
number of minutes of sleep versus general activity. The activity diary listed a number 
of activities e.g. walking, sport & leisure, housework, gardening and office activities. 
Subjects were asked to indicate the number of minutes spent in each activity over 
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each hour (Appendix I).  MET (Metabolic Equivalent) values for each activity were 
assessed from the American College of Sports Medicine manual (Bouchard et al. 
1983; American College of Sports Medicine, 2001). A MET score is equivalent to 
3.5ml O2.kg-1.min-1.  For the purpose of comparing baseline activity with activity 
during the intervention, each subject’s data was calculated as an absolute MET hour 
score. Mean MET hour scores were calculated for the 3-day records at baseline and 
compared to mean values for each 3-day recording period for week 4 and 8 
combined (= 6 days).        
 
4.1.5 Anthropometry and Body Composition 
Standing height was measured using a wall-fixed stadiometer and recorded to the 
nearest 1 mm. Body weight was measured immediately after voiding and after an 
overnight fast (baseline and then at fortnightly meetings with the chief researcher). 
Subjects wore underwear only and changed into a light surgical gown. The 
measurement was taken on a digital scale recorded to the nearest 100 g. Waist and 
hip circumferences were measured as described by Norton and Olds (2000). Body 
composition was determined by Dual energy X-ray absorptometry (DEXA) (Hologic 
QDR-4500A) at a certified commercial Bone Densitometry Centre.  Daily scanning 
of the anthropometric spine phantom were conducted (using the Hologic protocol).  
In addition a daily reading is checked using Shewart Multi-rule Charts and Cusum 
plots (Lu et al. 1996). In addition a weekly step phantom is analysed to enable 
standard body composition measurements to be compared. An abdominal region of 
interest (ROI) was delineated as previously described by Ley et al. (1992). In brief, 
the area is bound by the upper part of the body of T12 and the iliac crest and its sides 
lateral to any trunk soft tissue.   
 
4.1.6 Blood Pressure measurements  
Systolic and diastolic blood pressure were measured at baseline, week 6 and at the 
end of each diet period under standardised conditions (after an overnight fast, in a 
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post-absorptive state and having rested in a supine position for at least 1 hour). The 
Omron blood pressure machine (Model T8, Omron Corporation, Japan) was used for 
all measurements. This blood pressure machine has previously been cross-validated 
by the Bland-Altman approach in a group of 25 subjects, and showed intra-class 
correlation coefficients of 0.94, 0.89 and 0.981 and no difference between machines 
for SBP, DBP or HR respectively. Intra-individual variations in BP had a coefficient 
of variation of <1.5% (Sivakumar & Soares, 2006). 
 
4.1.7 Measurement of biochemical indicators  
Fasting venous blood samples were drawn at baseline and at the end of each dietary 
period (week 12). Blood samples were used for the determination of insulin, glucose, 
total cholesterol (TC), high density lipoprotein (HDL) cholesterol, low density 
lipoprotein (LDL) cholesterol (by calculation), and triaclyglycerol (TG), as 
determined by the chief researcher (for details of methodology refer to chapter 2). 
Blood samples were collected in plasma and serum tubes, the former allowed to 
stand on ice for 30 minutes and the latter at room temperature, all tubes were then 
centrifuged at 3000xg for 10 minutes. Serum and plasma were extracted and the 
samples stored at -80ºC for later analysis.  Additional samples were collected for the 
determination of 25, dihydroxy-vitamin D, ionised calcium, intact parathyroid 
hormone and free 3,5,3’ triiodothyronine, these were sent to a certified laboratory in 
Perth (refer to methods section, chapter 2 for details of assay methods). 
 
4.1.8 Measurement of urinary nitrogen excretion 
On twenty-four complete urine collections was undertaken by each subject at the 
start intervention and during week 6 (refer to section 2.2.5.2 for details of 
methodology).     
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4.1.9 Dietary Assessment Questionnaire  
At the end of each dietary intervention period (12 weeks), subjects were given a 
questionnaire to determine their assessment of the diet quality.  For each question 
they were asked to make a mark (l or X) on a 150 mm line which extended between 
two extreme ranges. The length of the mark was then measured with a ruler. The 
questions were: 1. How would you rate the diet provided? 2. How would you rate the 
taste of the milk provided by the researcher? 3. How would you rate the taste of the 
yoghurt provided by the researcher?    
 
4.1.10 Postprandial measurements (week 10) 
During week 10 of the study postprandial measurements were taken over a 5 hour 
period following the consumption of a low calcium, high fat test meal, to determine 
differences in substrate oxidation rates following the high calcium versus the low 
calcium dietary intervention (refer to chapter 5 for details of this study).     
 
4.1.11 Power calculations 
The power calculations were based on a cross-over design. Conservatively a 2kg 
difference in body fat loss was expected between the two diets. For a 100 kg person, 
the precision of body fat estimates from DEXA, is at worst 3 kg.  For an α error of 
5%, 24 subjects are required to give a power of 80%.  This sample size is sufficient 
to uncover differences in biochemical parameters as well. However, a total of 40 
subjects were recruited for the intervention study, to allow for a 20% drop out, plus a 
safety margin to allow for other confounders. 
 
4.1.12 Statistical analysis  
Data were analysed using the STATA Statistical Software (Release 8.0, College 
Station, TX, USA) package. All results are presented as mean values and standard 
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errors of the mean (SEM), unless otherwise stated and all data was assessed for 
normality. All variables not conforming to normality were log transformed.  The 
outcome variables of interest were body weight, fat mass, lean mass (total and 
abdominal region of interest), waist and hip measurements. The change in a variable 
of interest associated with a particular diet and the difference between the changes in 
a variable of interest between the two diet periods, in the same subject, were obtained 
as follows.   
 
Change in variable = measure after diet – measure before diet 
and 
Difference in change = change on the high calcium diet – change on the low calcium 
diet 
 
The difference between the changes in the variables of interest, or the differences in 
variables at the end of each diet period, were analysed using ANOVA for the 2 x 2 
crossover study design. This is similar to repeated measures, except that the 
treatment factor (effects of the two diets in question) was assigned across the time 
periods.  Each subject received both treatments in a particular sequence (sequence in 
which the diets were administered: HC diet then LC diet = 1, LC diet then HC diet = 
2). Within each subject, a period effect was also assessed.  A significant sequence 
effect, was ignored, as recommended by (Senn, 1994), when assessing 
TREATMENT effects using an ANOVA for a 2 x 2 cross-over study.   
 
A paired t-test was used to compare paired data within individuals. Regression 
analysis with robust variance estimates was used to test for any treatment, sequence 
and period effects, after adjusting for confounding factors (STATA Reference 
Manual: Version 8.0, 2003; STATA Corporation).    
 
As measurements regarding weight often result in large variability, correlations were 
run between weight loss and a number of relevant confounders (Appendix J). 
Variables of interest where then used as confounders with a regression model with 
robust clusters.  
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To determine changes over time a repeated measures ANOVA was used to determine 
statistical significance, which was set at the 5% level. Post-hoc test used the LSD 
procedure (unless otherwise stated). Data analysed this way used the SPSS for 
Windows (Version 11, SPSS Inc.  USA) statistical software package. 
 
4.1.13 Ethics  
The Human Research Ethics Committee of Curtin University of Technology (HR 
245-2001) approved the protocol and conformed to the Helsinki Declaration. All 
measurements were made in the clinical rooms of the Bentley Campus of Curtin 
University, Perth. 
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4.2 Results 
4.2.1 Subject Characteristics  
Table 4:2 Clinical characteristics of subjects at baseline 
 Part 1.  Part 2.  
+ SD HC 
n=14 
(♂2) 
LC 
n=19 
(♂4) 
Independent 
t-test  
(P value) 
LC  
n=13 
(♂2) 
HC 
n=16 
(♂4) 
Independent 
t-test (P 
value)  
Age (yr) 53.3 + 
5.3 
54.1 + 
4.8 
0.67 53.3 + 
5.5 
54.1 + 
4.4 
0.67 
Weight (kg) 88.26 + 
15.85 
90.37 + 
13.24 
0.69 83.72 + 
16.07 
83.54 + 
11.24 
0.97 
Height (m) 1.65 + 
0.08 
1.65 + 
0.10 
0.82 1.64 + 
0.09 
1.67 + 
0.09 
0.52 
BMI (kg/m2) 32.42 + 
3.54 
33.21 + 
5.38 
0.61 30.77 + 
3.72 
30.14 + 
3.89 
0.66 
% total body 
fat 
39.65 + 
6.44 
38.14 + 
7.01 
0.53 37.22 + 
6.73 
35.19 + 
6.93 
0.43 
FFM 52.38 + 
12.60 
54.55 + 
10.17 
0.59 52.10 + 
12.70 
53.52 + 
9.23 
0.73 
TC  (mM) 5.75 + 
1.01  
5.79 + 
0.99 
0.78 5.65 + 
0.85 
5.82 + 
1.11 
0.65 
Ca intake 
(mg) 
(baseline)* 
558.2 + 
203.70 
609.7 + 
213.55 
0.49 NA NA NA 
Baseline 
energy 
intake (kJ) 
9185 + 
123 
8923 + 
143 
0.75 8247 + 
89 
8483 + 
98 
0.67 
HC – high calcium, LC – low calcium, NA – not applicable. Values are means + standard deviations). 
Abbreviations: BMI - body mass index,  Ca - calcium. TC – total cholesterol, Gluc. – Glucose.  
* Ca intake was assessed from the mean value obtained from a 3-day food diary (Appendix F).    
 
Table 4:2 outlines the clinical characteristics of the subjects comparing the 
completers in part 1 (n=33), between dietary treatments and the completers on part 2 
(n=29) of the study, measured at baseline or during the screening process.  There 
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were no significant group differences in age, weight, height, body mass index (BMI), 
total body fat (measured by DEXA), nor baseline calcium intake, as measured by a 
validated nutritional questionnaire.     
 
4.2.2 Dietary Assessment Questionnaire 
The subjects did not rate the diets differently when following the high calcium versus 
the low calcium diet, which indicates that they were well-blinded to the diets 
provided. Question 1. overall rating of the diet provided (HC 85 + 13, LC 83 + 12, 
ANOVA, P=0.75). Question 2. How would you rate the taste of the milk provided 
(HC 75 + 8, LC 63 + 9, ANOVA, P=0.64) and Question 3. How would your rate the 
taste of the yoghurt (HC 89 + 10, LC 85 + 9, ANOVA, P=0.78).  
 
4.2.3 Monitoring compliance on the diets 
4.2.3.1 Objective methods of compliance 
   4.2.3.1.1  Dietary Intake  
As previously mentioned subjects were prescribed an individualised diet, based on 
their measured RMR and an activity factor of 1.5. Energy intake was then prescribed 
at 70% of this value to achieve weight loss.  This prescribed value was compared 
with mean values from 3-day food diaries, completed during week 6 of the study. 
There were no significant differences between treatment groups or period effects, for 
recorded versus actual (prescribed) dietary intake, indicating good compliance across 
both groups (Table 4:3).  There were no significant differences between groups for 
calcium intake prescribed versus actual calcium intake consumed (as measured by a 
3-day food diary) (Table 4:4), indicating good compliance across the groups.    
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Table 4:3 Comparison of energy intake between the dietary treatments and 
periods 1 & 2  
Treatment Recorded 
(kJ) 
Diet 
provided 
(kJ) 
Difference 
(kJ) 
Paired t-test  
(P value) 
High calcium  5962.7 + 176.3 6003.3 + 167.4 40.6 + 66.5  0.55 
Low calcium  5965.3 + 208.8  6158.9 + 207.2 193.6 + 103.8 0.07 
Period effect     
Part 1 6080.6 + 184.8 6251.1 + 189.8 170.5 + 105.9 0.12 
Part 2 5847.4 + 190.1 5911.1 + 181.8 63.72 + 65.1 0.34 
Values are means + SEM,  n=25   
 
Table 4:4 Comparison of calcium intake between the dietary treatments and 
periods 1 & 2 
Treatment Recorded 
(kJ) 
Diet 
provided 
(kJ) 
Difference 
(kJ) 
Paired t-test  
(P value) 
High calcium  1340.7 + 17.3 1341.0 + 14.6 1.7 + 2.7 0.96 
Low calcium  640.4 + 14.6 634.8 + 12.1 5.6 + 2.5 0.57 
     
Part 1 
HC 
LC 
 
1367.1 + 21.6 
659.5 + 16.1 
 
1359.4 + 18.8 
651.4 + 12.6 
 
-7.7 + 2.8 
-8.4 + 3.5 
 
0.47 
0.58 
Part 2 
HC 
LC 
 
1317.6 + 11.1  
612.6 + 10.3 
 
1324.9 + 9.0 
610.6 + 9.8 
 
7.3 + 2.2 
-2.0 + 0.5 
 
0.29 
0.86  
Values are mean + SEM, n=25 
 
   4.2.3.1.2 Physical activity  
Each subject completed 3-days x 24-hour activity charts prior to commencing the 
study. These 3-day activity charts were repeated at week 4 and 8 (mean value 
compared with baseline) to ensure subjects did not increase or decrease their activity 
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during the intervention.  There were no significant between-group differences nor 
period effects for subjects reported activity (MET hours) at baseline versus mean 
values for week 4 & 8.  
 
Table 4:5 Comparison of energy expended before the intervention versus during 
the intervention (between the treatments and periods).    
Treatment Baseline 
(MET hours) 
Mean week 4 
& 8 (2 x 3 
days of 
recording) 
Difference Paired t-test 
P value 
High calcium  84.30 + 2.40 86.48 + 1.72 -2.18 + 1.72 0.22 
Low calcium  88.14 + 1.75 86.97 + 1.89 1.17 + 1.61 0.47 
Period effect     
Part 1 88.28 + 2.42 88.25 + 1.96 0.036 + 2.02 0.99 
Part 2 84.16 + 1.71 85.20 + 1.59 -1.04 + 1.30 0.43 
Measured as MET hours. Values are mean + SEM, n=25 
  4.2.3.1.3 Weight loss 
Body weight was monitored at baseline and on each visit by the chief researcher. 
Results in Figure 4:2, 4:3 and 4:4 indicate a significant drop in weight on every visit 
between 0-12 weeks, as determined by repeated measured ANOVA with a 
Bonferroni adjustment for multiple comparisons (P=0.0005). This was consistent on 
each diet and during each period on the RCT.  
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Figure 4:2 Change in weight (kg) between dietary groups during period 1    
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Figure 4:3  Change in weight (kg) between dietary groups during period 2 
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Figure 4:4  Change in weight (kg) between dietary groups, all subjects 
combined.  
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   4.2.3.1.4 Nitrogen excretion versus protein intake 
To determine dietary compliance amongst our cohort, we correlated urinary nitrogen 
excretion versus dietary protein intake (expressed as nitrogen). This method has been 
used widely as a marker of dietary compliance (Bingham, 2003).  
 
Within each dietary treatment urinary nitrogen excretion correlated positively with 
dietary nitrogen intake (Table 4:6). Similarly, significant positive correlations were 
demonstrated for each dietary treatment during period 1 of the study; however, no 
correlations were observed during period 2.  
 
Table 4:6  Urinary nitrogen excretion (g) correlated against dietary protein 
(expressed as nitrogen) intake from the diet  
 g nitrogen in 
urine 
g nitrogen 
from diet 
Correlation  
( R ) 
P value 
High calcium 
(n=25) 
10.38 + 0.47 11.94 + 0.53 0.55 0.004 
Low calcium 
(n=25) 
9.83 + 0.48 11.18 + 0.44  0.44 0.03 
Period 1.  
High calcium 
(n=12)  
11.31 + 0.82 12.28 + 0.78 0.64 0.02 
Low calcium 
(n=13) 
9.45 + 0.61   11.52 + 0.69 0.61 0.03 
Period 2. 
Low calcium 
(n=12) 
10.23 + 0.76  10.80 + 0.53  0.34 0.27 
High calcium 
(n=13)  
9.53 + 0.38 11.64 + 0.74 0.47 0.11 
Values are mean + SEM  
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  4.2.3.1.5 Calcium metabolism 
  4.2.3.1.5.1 Intact parathyroid hormone (iPTH) 
Intact parathyroid hormone was measured at baseline and at the end of the study 
(week 12).  The change from baseline was used to determine if iPTH had been 
suppressed in the high dairy group with less suppression in the low dairy group.  This 
was not the case in this study and there was no difference in iPTH when combined 
across both arms. Refer to Table 4.7.      
 
Table 4:7  With-in diet and treatment effect of parathyroid hormone (μmol/L), 
following a high versus a low calcium diet.   
HC LC 
W
ith
in
 
di
et
 
T
re
at
m
e
nt
 e
ffe
ct
  
B’line End Diff. B’line End Diff.   
3.46 
+ 0.14 
3.34 
+ 0.18 
-0.12 + 
0.18 
   0.52  
   3.45 + 
0.20 
3.21 + 
0.23 
-0.23 + 
0.18 
0.20 0.83 
Values are mean + SEM, n=25 
   4.2.3.1.5.2 Urinary calcium excretion 
Twenty-four urinary calcium excretion has been widely used as a measure of dietary 
calcium intake, with the explanation that a greater intake of calcium will cause a 
greater increase in urinary calcium excretion due to the down regulation of intestinal 
calcium absorption (Bronner, 2003). However, there are suggestions that 24-hour 
urinary calcium may not be the most accurate indicator of calcium intake (Toren & 
Norman, 2005; Weaver, 2006).  Data from this study showed no consistent patterns 
or statistically significant correlations between urinary calcium levels and calcium 
intake.  
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Table 4:8 Comparison of correlations between 24-hour urinary calcium 
excretion (mg) and dietary calcium intake (mg)    
 mg Ca / 24 
hour 
collection  
mg Ca in 
diet  
Correlation  
(R)  
P Value 
High calcium 
(n=25)  
153.70 + 
14.14 
1332.28 + 
14.27 
0.12 0.58 
Low calcium 
(n=25) 
146.74 + 
13.12 
626.28 + 
11.06 
-0.18 0.40  
Period 1– 
High calcium 
(n=12)  
154.0 + 17.22 1352 + 27.37 0.48 0.112 
Low calcium 
(n=13) 
111.9 + 11.33 647 + 15.97 0.023 0.942 
Period 2 – 
Low calcium 
(n=12) 
184.5 + 19.54 604 + 12.97 0.10 0.755 
High calcium 
(n=13) 
153.4 + 22.75 1314 + 10.06 -0.47 0.111 
Values are mean + SEM 
Table 4:9  Changes in urinary calcium (mg) from baseline to end of study  
HC LC Paired 
t-test 
Baseline End Diff. Baseline End Diff.  P 
value 
154.81 
+ 13.10 
153.70 
+ 
14.14 
1.11 + 
14.56 
   0.94 
   151.03 
+ 11.8 
146.74 
+ 
13.12 
4.29 + 
11.05 
0.70 
Values are mean + SEM, n=25 
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   4.2.3.1.5.3 Vitamin D status 
The vitamin D status of subjects is important as it plays a major role in the 
absorption of calcium. This study was designed to minimise changes in vitamin D 
status by conducting the study during the spring and summer seasons. Serum 25-
hydroxyvitamin D3, (Nowson & Margerison, 2002) was used as a measure of vitamin 
D status and measured at baseline and at week 12 on each dietary treatment.  We 
found no differences between the change from baseline between the 2 treatments 
(P=0.30).   
 
Table 4:10 With-in diet and treatment effect on vitamin D (nmol/L), following a 
high (HC) versus a low calcium (LC) diet.   
HC LC 
W
ith
in
 
di
et
 e
ffe
ct
 
T
re
at
m
’t 
ef
fe
ct
  
B’line End Diff. B’line End Diff.   
70.91 + 
5.28 
70.34 + 
4.10 
-0.57 + 
2.44 
   0.82  
   66.58 + 
4.15 
69.55 + 
4.41 
2.96 + 
2.65 
0.28 0.30 
Values are mean + SEM  
   4.2.3.1.5.4 Free 3,5,3’-triiodothyronine T3 
Thyroid function was assessed, as measured by free triiodothyronine (fT3), at 
baseline and week 12 of each period of the study.  As would be expected with any 
weight loss, fT3 declines (Douyon & Schteingart, 2002). Our study shows a very 
similar (non-significant) decrease in fT3, comparing the treatment groups (Table 
4:11).  
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Table 4:11 Changes in Free 3,5,3’-triiodothyronine T3, following an RCT of 
hypocaloric high calcium (HC) and low calcium (LC) diets.   
HC 
 
LC 
W
ith
in
 d
ie
t 
ef
fe
ct
  
(P
 v
al
ue
) 
T
re
at
m
en
t 
ef
fe
ct
  
(P
l
)
Baseline End Diff. Baseline End Diff.   
4.54 + 0.09 4.46 + 0.08 0.088+ 
0.06 
   0.12  
   4.70 + 0.08 4.60 + 0.08 -0.10 + 
0.09 
0.27 0.93 
Values are mean + SEM  
 
4.2.3.2  Subjective measures of compliance 
    4.2.3.2.1 Completion of daily food diaries  
All subjects had to complete a proforma outlining the food intake module they had 
chosen for breakfast, lunch and dinner and any deviations from the prescribed 
module had to be noted. The subjects also entered an M (milk) and Y (yoghurt) to 
indicate when they had consumed these products (Appendix H). The chief researcher 
also checked the appropriate number of returned, empty yoghurt containers and milk 
containers at each fortnightly visit.  Results from this method of assessment indicated 
excellent compliance (98.6 + 0.4 %) to the intake of the intervention products.    
   4.2.3.2.2 Qualitative assessment of non-adherers  
Detailed notes were made of conversations with all subjects at face-to-face 
interviews (fortnightly) and over the phone (alternate week with appointment). 
Subjects were asked further questions, if comments were made regarding their 
compliance over the proceeding week. Subjects were also asked to complete a 
questionnaire (on completion of the study) asking if they had done anything 
differently throughout the study during period 1 versus period 2.    
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4.2.4 Changes in pre-and post- measurements 
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Table 4:12 Changes in anthropometry and body composition measurements between periods on each diet.   
Treatment Treatment  M
easure
m
ent  
Period 
HC LC 
Period  
HC LC 
Sig. P value  
Period effect 
(paired t test) 
Weight (kg) 1 -7.03 + 0.43  -8.18 + 0.42 2 -5.74 + 0.48 -4.4 + 0.38 0.00005 
Waist (cm) 1 -5.83 + 0.64 -6.18 + 0.83 2 -7.35 + 0.67 -4.67 + 0.42 0.98 
Hip (cm) 1 -4.96 + 0.53 -6.22 + 0.40  2 -4.62 + 0.47 -4.00 + 0.30 0.02 
Total body fat 
(%) 
1 -1.91 + 0.18 -2.62 + 0.27 2 -1.69 + 0.32  -0.9 + 0.14 0.00005 
Total FM (kg) 1 -3.88 + 0.20 -4.69 + 0.26 2 -2.98 + 0.35 -2.30 + 0.17 0.00005 
Total FFM (kg) 1 -2.27 + 0.27 -2.13 + 0.21 2 -2.32 + 0.28  -1.96 + 0.24 0.51 
Trunk fat (kg) 1 -2.11+ 0.23 -3.43 + 0.38 2 -2.35 + 0.47 -1.24 + 0.22 0.02 
ROI fat (kg)  1 -2.15 + 0.29 -3.81 + 0.57 2 -3.48 + 0.56 -1.79 + 0.28 0.39 
Values are mean + SEM, n=25, Abbreviations: FM fat mass, FFM fat free mass, ROI region of interest  
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Table 4:13 Whole Body Composition measurements to demonstrate within diet effects (change from baseline) and treatment effect  
 
HC LC Within diet 
effect (P 
value) 
T
reatm
ent 
effect  
(P value) 
A
N
O
V
A
 Baseline End Diff. Baseline End Diff. P value P value 
Weight (kg) 82.53 + 1.98  76.17 + 1.88 -6.36 + 0.47    0.0005  
    83.58+2.01 77.22 + 1.70 -6.36 + 0.55 0.0005 0.78 
%Wt change   -7.70 + 0.50      
      -7.47 + 0.57 0.0005 0.78 
TBF  % 37.90 + 1.36 36.12 + 1.46 -1.80 + 0.26    0.0005  
    38.29 + 1.26 36.50 + 1.33 -1.79 + 0.27 0.0005 0.85 
Total FM(kg) 30.83 + 1.40 27.42 + 1.45 -3.41 + 0.30    0.0005  
    31.50 + 1.33 27.95 + 1.26 -3.54 + 0.33 0.0005 0.79  
Total FFM 
(kg) 
50.36 + 1.52 48.07 + 1.34 -2.29 + 0.27    0.0005  
    50.70 + 1.51 48.55 + 1.38 -2.15 + 0.23 0.0005 0.51 
Values are mean + SEM,  n=25,  Abbreviations: FFM fat free mass, FM  fat mass, ROI region of interest, Diff. Difference (between baseline and end of study), TBF % Total 
Body Fat %.    
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Table 4:14  Regional Body Composition measurements to demonstrate within diet effects (change from baseline) and treatment effect 
Measurement HC LC Within diet 
effect  
Treatment 
effect  
ANOVA 2x2  
 Baseline End Diff.  Baseline End Diff. P value  P value  
Waist (cm) 96.66 + 2.09 90.04 + 1.97 -6.62 + 0.69    0.0005  
    97.83 + 2.22 92.43 + 1.99 -5.39 + 0.68 0.0005 0.052 
Hip (cm) 111.62 + 1.63 106.84 + 1.53 -4.78 + 0.51    0.0005  
    112.36 +1.45 106.3 + 1.38 -6.06 + 0.83 0.0005 0.53 
Trunk fat % 36.72 + 1.31 34.48 + 1.48  -2.23 + 0.37    0.0005  
    37.45 + 1.29 35.07 + 1.36 -2.38 + 0.38 0.0005 0.78 
Trunk FFM (kg) 24.60 + 0.71 23.42 + 0.62 -1.18 + 0.15    0.0005  
    24.71 + 0.71  23.65 + 0.64 -1.06 + 0.12 0.0005 0.78 
Trunk FM (kg)  14.36 + 0.68  12.53 + 0.73  -1.83 + 0.17    0.0005  
    14.84 + 0.65 12.84 + 0.61 -2.00 + 0.20 0.0005 0.42 
ROI fat % 34.91 + 1.15  32.07 + 1.38 -2.84 + 0.46    0.0005  
    35.73 + 1.14 32.89 + 1.20 -2.84 + 0.49 0.0005 0.97 
ROI FFM (kg) 6.20 + 0.16 5.84 + 0.18 -0.36 + 0.13    0.01  
    6.26 + 0.19 5.93 + 0.16 -0.33 + 0.12 0.01 0.80  
ROI FM (kg) 3.40 + 0.20  2.87 + 0.21 -0.53 + 0.08    0.0005  
    3.55 + 0.21 3.06 + 0.22 -0.49 + 0.12 0.0005 0.67 
Values are mean + SEM, n=25, except waist and hip n=23. Abbreviations: FFM fat free mass, FM fat mass, ROI region of interest, Diff. Difference (between baseline and end 
of study). 
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Table 4:15  Body Composition measurements to demonstrate the treatment 
effect (includes all completers, n=29)   
Measurement 
(change from 
baseline) 
Treatment  Sig. P value  
(ANOVA for 2x2 
crossover design)  
 HC LC Treatment 
effect 
Period 
effect 
Weight (kg) -5.9 + 0.50  -6.36 + 0.53 0.86 0.0005 
% weight  -7.10 + 0.55 -7.09 + 0.56 0.95 0.0005 
Waist (cm) -6.42 + 0.59 -5.56 + 0.60 0.14 0.49 
% total body fat  -1.57 + 0.23 -1.63 + 0.25 0.72 0.0001 
Values are mean + SEM  
Table 4:16 Intention-to-Treat analysis: Body Composition measurements to 
demonstrate the treatment and period effect   
Measurement 
(change from 
baseline) 
Treatment  Sig. P value  
(ANOVA for 2x2 crossover 
design) 
 HC LC Treatment 
effect 
Period effect 
Weight (kg) n=40 -5.08 + 0.46 -5.57 + 0.48 0.71 0.0005 
Waist (cm) 
n=35 
-6.07 + 0.64 -5.12 + 0.56  0.14 0.48 
Hip (cm) 
n=35 
-4.43 + 0.50 -4.44 + 0.43 0.76 0.001 
Total body fat (%) 
n=35 
-1.56 + 0.21 -1.57 + 0.23 0.51 0.0005 
Total FFM (kg) 
n=35 
-2.11 + 0.22 -2.12 + 0.21 0.86 0.13 
Total FM (kg) 
n=35 
-3.09 + 0.27 -3.25 + 0.30 0.66 0.0005 
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Table 4:17 Changes in weight (kg) between dietary treatments, on including 
only those with baseline calcium intake <600mg/day (n=19) 
   Sig. P value  
(ANOVA for 2x2 crossover 
design) 
HC LC Difference Treatment 
effect 
Period effect 
-6.48 + 0.45  -5.58 + 0.44  -0.9 + 0.009 0.27 0.0012 
 
Figure 4:5 Correlation of resting metabolic rate (RMR) and change in total fat 
mass (kg), in subjects on the high calcium (o) and low calcium diets ().   
HC r=-0.08, P=0.71, LC r=-0.59, P=0.002  
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Table 4:18 Partial correlation coefficients between RMR and change in 
endpoint variables controlling for fat free mass and fat mass at the start of the 
study  
 ΔWeight ΔWaist ΔHip  ΔTotal 
fat 
mass 
ΔTotal 
fat free 
mass 
ΔTotal 
fat 
mass 
Diet:HC 
R  
P value 
 
0.0355 
0.87 
 
-0.3142 
0.14 
 
0.2709 
0.21 
 
-0.1995 
0.36 
 
0.0866 
0.69 
 
-0.1311 
0.55 
Diet:LC 
R 
P value  
 
-0.5746 
0.006 
 
-0.2147 
0.35 
 
-0.3757 
0.093 
 
-0.4448 
0.043 
 
-0.0928 
0.69 
 
-0.5441 
0.011 
Δ = change in variable (12 week – 0 week); HC = high calcium, LC = low calcium 
 
Figure 4:6  Reduction in waist circumference (cm) between dietary treatments.    
There was a significant with-in diet effect between baseline measurements and week 12 on the high 
and the low calcium diets (T-test, P=0.0005) and a significant treatment effect with the high calcium 
treatment eliciting a greater reduction in waist circumference (RM-ANOVA for 2x2 crossover design, 
P=0.052)  
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Figure 4:7 Reduction in hip circumference (cm) between dietary treatments.    
There was a significant with-in diet effect between baseline measurements and week 12 on the high 
and the low calcium diets (T-test, P=0.0005). There was no significant difference between dietary 
treatments and reduction in hip circumference.  
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4.2.4.1  Body composition changes 
As can be seen in Table 4:13 and 4:14 the high dairy calcium diet did not result  in 
greater weight or body fat loss as measured by weight, total body fat %, total fat 
mass, trunk fat nor by an abdominal region of interest (fat % or absolute FFM).  
Similarly, there was no significant difference between treatment groups on total fat 
free mass.  A greater reduction in waist circumference of 1.23 cm was observed 
when subjects had consumed the HC diet; this however was just short of significance 
(P=0.052). This observation was consistent in both of the crossover trial (Table 4:14 
& Figure 4:6).    
 
To investigate why we may not have achieved differences in body composition 
measurements between treatment groups various correlations were run with possible 
confounders of interest (refer to Appendix J).  The most reoccurring relationship was 
between resting metabolic rate (RMR) at the start of the study and various body 
composition measurements. Correlations of RMR and change in total fat mass 
(Figure 4:5) demonstrated a significant negative relationship within subjects on the 
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LD diet (P=0.002), but not when the subjects consumed the HC diet. Furthermore, 
this relationship persisted when controlled for fat free mass and fat mass at the start 
of the study. On the low calcium diet RMR correlated negatively with weight loss 
(P=0.006), total fat percentage lost (P=0.043) and total fat mass lost (P=0.011). 
However, these variables were not correlated with RMR on the high calcium diets  
(Table 4:18). Table 4:13 & 4:14 also shows the with-in diet effect of the various 
body composition measurements. All body composition measurements (weight, 
waist circumference, total body fat %, total fat mass & fat free mass, trunk fat mass 
and an abdominal region of interest, showed significantly changes from baseline to 
the end of the study across both dietary treatments.  
    
Table 4:12 shows body composition measurements for the 2 study periods (1 & 2). 
There is a significant period effect for weight loss, hip circumference, total body fat 
%, total fat mass and truck fat, with period 2, showing a lesser change. This may 
indicate less compliance or study fatigue of the subjects during this period.    
 
The analysis was also completed on all subjects who had completed both arms of the 
study (n=29), this reanalysis did not change the previously reported results (Table 
4:15). Similarly an intention-to-treat analysis did not alter the results with no change 
between treatment groups for weight, waist and hip circumference, total body fat 
percentage, total fat free mass and total fat mass (Table 4:16).  
 
4.2.4.2 Fasting glucose, insulin levels and HOMA score 
Fasting blood glucose levels were not altered by consumption of a high calcium diet 
versus a low calcium diet (treatment effect).  However, both diets resulted in 
significant reductions in fasting glucose levels (Table 4:19 & 4:20). Fasting insulin 
levels and HOMA score were not significantly different between the dietary 
treatments. As with the fasting glucose levels, there were significant with-in diet 
effects for both high and low calcium diets.  There were no significant differences for 
Hba1c changes from baseline, either a treatment effect or with-in diet effect.   
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4.2.4.3 Fasting Lipid levels   
   4.2.4.3.1  Fasting total cholesterol  
There was no significant treatment effect on fasting cholesterol levels; however, both 
diets individually resulted in a small decrease in fasting cholesterol levels (HC -0.17 
+ 0.60, LC -0.41 + 0.81 mM, P=0.07) (Table 4:19).  
   4.2.4.3.2  Fasting LDL-cholesterol levels  
There was a significant treatment effect on fasting LDL-cholesterol levels, with both 
dietary treatments eliciting a small increase in LDL-C (HC 0.38 + 0.65, LC 0.03 + 
0.76 mM, P= 0.04), there was a greater increase within the HC group.  Fasting LDL-
cholesterol levels were slightly higher on the low calcium diet at the start of the 
study; however, this did not reach significance (HC 3.24 + 1.03, LC 3.52 + 0.89. 
P=0.07) (Table 4:19).  
   4.2.4.3.3  Fasting HDL-cholesterol levels 
There was no significant treatment effect on fasting HDL-cholesterol levels; 
however, both dietary treatments resulted in a small decrease from baseline (Table 
4:19).  
   4.2.4.3.4  Fasting triglycerides levels 
No treatment effect was demonstrated on either diet; however, there was a with-in 
diet effect with the HC and LC diets both showing significant reductions in fasting 
triglyceride levels (Table 4:19).   
 
4.2.4.4 Blood Pressure  
Systolic and diastolic blood pressure were significantly reduced following both 
dietary interventions (with-in diet effect). However, no treatment effect was 
demonstrated (Table 4:19).    
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Table 4:19  Changes in fasting levels of glucose, insulin, HOMA score and Hba1c, total cholesterol, HDL and LDL-cholesterol, 
triglycerides and blood pressure (treatment and period effect)   
 HC LC ANOVA 2x2 
crossover design  
(P value) 
 Change  from 
baseline  
Period 1  Period 2  Change from 
baseline 
Period 1  Period 2 Treat’ 
effect  
Period 
effect 
Insulin 
(uIU/ml) 
-1.33 + 0.63   -1.65 + 0.92   0.84  
  -3.04 + 0.64 0.25 + 0.41   -2.48 + 1.23 -0.75 + 0.36  0.03 
Gluc.(mmol/L) -0.54 + 0.12   -0.68 + 0.12   0.39  
  -0.45 + 0.12 -0.63 + 0.13  -0.63 + 0.12 -0.74 + 0.13  0.37 
HOMA score -1.33 + 0.63   -2.32 + 0.63   0.19  
  -3.04 + 0.64 0.26 + 0.41  -3.88 + 0.64 -0.75 + 0.36  0.0002 
Hba1c -0.0083 + 0.05   0.029 + 0.06   0.60  
  -0.05 + 0.05 0.033 + 0.05  -0.03 + 0.07 0.092 + 
0.034 
 0.16 
TC (mM) -0.17 + 0.12   -0.41 + 0.16   0.07  
  0.11 + 0.13 -0.42 + 0.09  -0.083 + 0.14 -0.76 + 0.16  0.0003 
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 HC LC ANOV 2 x 2 
crossover design 
(P value)  
 Change 
from 
baseline 
Period 1  Period 2 Change 
from 
baseline 
Period 1  Period 2 Treat’ 
effect 
Period 
effect 
HDL-C (mM)  -0.15 + 0.07   -0.17 + 0.07   0.78  
  -0.09 + 0.02 -0.20 + 0.10  -0.071 + 0.05 -0.27 + 0.08  0.10 
LDL-C (mM)  0.38 + 0.13    0.03 + 0.76   0.04  
  0.62 + 0.09  0.16 + 0.15  0.41 + 0.14 -0.38 + 0.12  0.001 
Trigs. (mM) -0.74 + 0.13   -0.69 + 0.12   0.63  
         
Systolic BP 
(mmHg) 
-5.86 + 1.65   -7.1 + 1.51   0.57  
  -7.08 + 1.66 -4.73 + 1.67  -9.15 + 1.62 -4.88 + 1.31  0.10 
Diastolic  BP 
(mmHg) 
-1.86 + 1.10   -2.86 + 0.99   0.45  
  -1.63 + 0.92 -2.08 + 1.28  -4.88 + 1.02 -0.67 + 0.77   0.14 
Values are mean + SEM,  P-values for with-in diet effects and treatment effects. 
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Table 4:20 Changes in fasting levels of glucose, insulin, HOMA score and Hba1c, total cholesterol, HDL and LDL-cholesterol, 
triglycerides and blood pressure (with-in diet effect)    
 HC LC  
 Baseline End Change Baseline End Change  With-in diet 
effect (P 
value) 
Insulin 
(uIU/ml) 
8.51 + 1.38 7.18 + 1.13 -1.33 + 0.63    0.04 
    8.42 + 1.14  6.10 + 0.77 -2.32 + 0.62  0.0013 
Gluc(mmol/L) 5.62 + 0.12 5.07 + 0.10 -0.54 + 0.12    0.0002 
    5.79 + 0.13 5.11 + 0.08 -0.68 + 0.12 0.0005 
HOMA score 2.12 + 0.33  1.61 + 0.25   -0.51 + 0.17    0.005 
    2.12 + 0.27 1.31 + 0.17 0.81 + 0.17 0.0005 
Hba1c 5.33 + 0.06 5.33 + 0.04 -0.0083 + 0.05    0.87 
    5.37 + 0.06 5.39 + 0.06 0.029 + 0.06 0.66 
TC (mM) 5.78 + 0.22 5.62 + 0.21 -0.17 + 0.12     0.18 
    5.97 + 0.19 5.57 + 0.18 -0.41 + 0.16 0.02 
HDL-C (mM)  1.60 + 0.07 1.45 + 0.07 -0.15 + 0.07    0.05 
    1.61 + 0.08 1.45 + 0.08 -0.17 + 0.07 0.02 
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 HC LC  
 Baseline End Change Baseline End Change With-in diet 
effect (P 
value) 
LDL-C (mM)  3.24 + 0.21 3.61 + 0.17 0.38 + 0.13     0.008 
    3.52 + 0.18 3.55 + 0.17 0.03 + 0.15 0.84 
Trigs. (mM) 1.94 + 0.18 1.20 + 0.12 -0.74 + 0.13    0.00005 
    1.92 + 0.18 1.23 + 0.13 -0.69 + 0.12 0.00005 
Systolic BP 
(mmHg) 
120.18 + 2.42 114.32 + 1.96 -5.86 + 1.65    0.002 
    121.94 + 2.80 114.84 + 2.12 -7.1 + 1.51 0.0001 
Diastolic  BP 
(mmHg) 
72.9 + 1.42  71.04 + 1.34 -1.86 + 1.10    0.10 
    73.2 + 1.17 70.3 + 1.14 -2.86 + 0.99 0.008 
Values are mean + SEM, P-values for with-in diet effects (n=25, except 1 missing value for HOMA and Insulin)
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  4.3 Discussion   
4.3.1  Body Composition  
Most prospective studies in this area have employed an RCT with a double or multi-
stranded parallel design.  In this design, it is imperative that all volunteers are similar 
in body composition and in metabolic function at the start. This is not always 
reported and hence the end result is open to interpretation.  Confounding variables 
may therefore mask or amplify the expected endpoint.  Our study chose to 
circumvent these issues by having each subject acting as their own control. We 
believe this is the first attempt to conduct a randomised cross-over weight loss trial 
examining the effect of dietary calcium.  In addition, we measured subject 
compliance through a variety of ways; dietetic interviews, bias of reported energy 
intake, correlation between urinary nitrogen excretion and protein intake as well as 
intervention food counts.  Overall, we were confident that 25 of the 29, who 
completed the program, could be classified as adherers.  
 
In chapter 3 we demonstrated, for the first time, that the acute consumption of a high-
calcium meal, both dairy and pharmaceutical, elicited a greater postprandial fat 
oxidation.  Based on these findings and the results from some randomised-controlled 
studies (Zemel et al. 2004b; 2005a; 2005b), we anticipated that the chronic 
consumption of a high calcium meal, when combined with a hypocaloric diet, would 
result in subjects losing a greater amount of weight and/or body fat.  The results of 
this study demonstrate that while subjects lost weight on both diets in both periods, 
neither weight nor fat loss was greater when subjects consumed the higher calcium 
diet. The lack of differences in weight and fat loss is similar to outcomes obtained by 
Thompson et al. (2005) and Harvey-Berino et al. (2005) who examined the effect of 
dairy rather than calcium per se. Additionally in a RCT of overweight/obese subjects 
following an energy-restricted diet with a supplement of 1200 mg of calcium plus 
vitamin D, no differences in weight or fat loss were observed (Major et al. 2007).  
This study does however, demonstrate a trend towards a greater reduction in waist 
circumference on the high calcium diet, this was just short of significance (P=0.052).  
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Based on a reanalysis of data from a nationally representative sample, it was 
predicted that Australians with higher calcium intakes could have lower BMI and 
waist circumferences (Soares et al. 2004).  Therefore some confirmation is obtained 
from this study.  In all three of Zemel’s studies a greater waist circumference along 
with trunkal fat was reported (Zemel et al. 2004b; 2005a; 2005b).  
   
Our finding of a trend for a greater reduction in waist circumference in subjects 
consuming a high calcium diet is of particular important to health, as abdominal 
obesity has been linked with the metabolic syndrome along with an increased risk 
from cardiovascular disease. In a recent meta-regression analysis study  it was 
demonstrated that a 1 cm increase in waist circumference increased the relative risk 
of a cardiovascular disease event by 2% (95% CI: 1-3%)(de Koning et al. 2007).   
Visceral fat has been classified as being highly metabolic, with a high lipolytic rate 
(Wajchenberg, 2000). It has been suggested that the improvements in health 
outcomes with a small amount of weight loss, is due to the reduction in visceral fat 
mass and has been linked with the activation of the sympathetic nervous system 
(Rupp & Maisch, 2003). It has been suggested by Zemel (2004) that there may be a 
role for autocrine production of cortisol by adipose tissue. Human adipose tissue 
expresses significant 11-β-hydro-xysteroid dehydrogenase-1 (11-β-HSD-1), which 
can generate active cortisol from cortisone.  It has been demonstrated that visceral 
adipose tissue (greatest in the waist region) has greater 11-β-HSD-1 expression than 
does subcutaneous adipose tissue (Rask et al. 2001). In the mice model over-
expression of 11-β-HSD-1 has lead to central obesity (Masuzaki et al. 2001), whilst 
11-β-HSD-1 knockout mice exhibit protection from features of the metabolic 
syndrome (Kotelevstev et al. 1997). In prelimary in vitro studies calcium agonists 
(such as calcitriol), exert substantial stimulation of cortisol production in human 
adipocytes (Morris & Zemel, 2005).  This could have implications for our study, 
indicating that the possible reduction in waist circumference seen in our subjects 
consuming the high calcium diet could be attributable to a reduction in cortisol 
production by visceral adipocytes.   
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RMR was negatively correlated to weight loss, total fat loss and total fat free mass 
loss but only when the subjects had consumed the low calcium diet. It has long been 
established that a low RMR can predict long-term body weight gain (Ravussin et al. 
1988; Astrup et al. 1999; Buscemi et al. 2005). In this study we demonstrated that 
subjects with a greater RMR at the start of the study tended towards a greater fat loss.  
In fact RMR contributed to ~32% of the variability of weight loss. Similar 
observations were made in a meta-analysis study demonstrating a 4% greater number 
of subjects with a higher RMR in a control versus a formerly obese group, this 
however, did not reach significance (Astrup et al. 1999).  Similarly, a high baseline 
RMR has been suggested as predictor for successful weight maintenance following a 
period of weight loss (Vogels et al. 2005).  However, the fact that the relationship of 
a higher RMR with a greater fat loss was only observed on the low calcium diet 
(consistent in both periods) would indicate that the ingestion of calcium abolishes 
this relationship.  This is a novel finding indicating that higher calcium seems to 
‘equate’ the amount of fat lost by taking away the effect of initial body 
size/composition.   
 
4.3.1.1  Comparison of studies: weight & fat loss  
Of interest between all these studies is the magnitude of weight change between the 
two/three treatment groups. In our study, when grouping the total weight loss over 
period 1 and 2 (24 weeks) and comparing the dietary treatments, the HC group 
achieved a 12.8 kg versus 12.6 kg loss (LC group). A similar magnitude of weight 
loss was seen in Harvey-Berino’s study (2005), with their high dairy-calcium group 
losing 10 kg versus 9.3 kg for the low dairy-calcium group at 6 months.  It is 
important to add that a greater weight loss would be expected on our study, as a 
greater calorie deficit was given -676 kcal/d versus -500 kcal/d.  In the case of Zemel 
and colleagues’ two studies that ran for a period of 6 months; the weight loss 
achieved was -6.6 kg, -8.6 kg and -11.1 kg, following the low dairy, high calcium 
and high dairy-calcium, respectively (Zemel et al. 2004b).  Interestingly, in a recent 
multi-site trial, that replicated the protocols from the Zemel studies, except the study 
ran for 12 weeks and included subjects with a BMI >25.  Although the dairy group 
achieved a two-fold greater weight loss, than the low calcium group, there was no 
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difference with the high calcium group (Teegarden, 2006).  Similarly, in the low 
versus high dairy study, the weight loss was -6 (LD) versus -11 kg (HD) (Zemel et 
al. 2005a).  So the weight loss achieved following the high dairy-calcium diets is 
very similar in all the studies that followed an identical protocol of -500 kcal/d 
energy deficit, or proportional to the calorie-deficit introduced (this thesis) (Zemel et 
al. 2004a; Zemel et al. 2004b; Harvey-Berino et al. 2005; Zemel et al. 2005a; 
Teegarden, 2006). It therefore appears that the ability to demonstrate differences 
between treatment protocols, seems to rest with the amount of weight lost on the 
‘low’ or control arm of the design.   
 
With regard to changes in body fat, participants in our study both lost a significant 
amount of body fat; however, there was no treatment effect (P=0.51).  Our subjects 
following the high calcium diet (periods 1 & 2) lost 6.9 kg on the high-calcium and 
7.0 kg on the low-calcium diet, these figures are comparable with the fat loss (7.2 kg) 
by the high-dairy group on Zemel’s study (2004b).  As with the weight loss our low-
calcium group did not achieve the lower fat loss that Zemel’s group reports (-4.8 kg).  
In Zemel et al. study in African-American subjects a greater fat loss of 9.1 kg was 
achieved, which may also reflect the fact they were heavier at baseline, with average 
body weights of 101.5 kg and mean body fat content of 52.8 kg (Zemel et al. 2005b), 
compared to our study body weights 89.3 kg and 33.7 kg of body fat.  We do not 
believe we lacked the power to detect differences with the final sample size 
achieved.  As is clear from our analyses, we can detect a difference of ~1.3 kg with 
ease (Table 4:12, period effect=0.00005).   
 
4.3.1.2  Potential reasons for diverse effects  
Recently it has been suggested that African-Americans have a resistance to the bone 
resorptive action of parathyroid hormone, which results in better urinary 
conservation of calcium along with a more efficient intestinal calcium absorption. 
However, long term this adaptation appears to put African–Americans at greater risk 
from several chronic diseases, including cardiovascular disease, obesity and insulin 
resistance syndrome. This may also explain the greater response of this group to a 
high calcium diet and greater weight loss in Zemel’s study (Heaney, 2006).  Whether 
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this ‘ethnic’ effect in weight loss with calcium is a feature of other population groups 
remains to be determined.        
 
It has been suggested by some authors that there could be a threshold effect for the 
effects of calcium, and that calcium enhances weight and fat loss when individuals 
are consuming a low calcium intake (<500 mg Ca/d) (Heaney et al. 2002; Parikh & 
Yanovski, 2003; Sakhaee & Maalouf, 2005).  In our study it was in fact difficult to 
recruit enough subjects, who habitually consumed a very low calcium intake; our 
group consumed a mean of 587 mg Ca/d (range 139-980 mg Ca/d).  It is the authors 
view that some of the subjects may have over-estimated their calcium intake, in the 
believe that they had more chance of being selected for the study, as radio 
advertising had sold the story of a link between dairy intake and weight loss.  In our 
study the low calcium arm of the study was provided at 634.8 (+ 60.5) mg per day 
versus 1341 (+ 72.9) mg for the high calcium diet.  The low calcium arm of the study 
is somewhat higher than that provided in Zemel’s studies and due to the explanation 
of a threshold effect could explain the lack of a weight loss result achieved in our 
study.  However, Harvey-Berino et al. (2005) also did not report a weight loss 
difference between the high and low calcium intake at a similar calcium intake as 
Zemel’s studies.  A sub-analysis of the data was conducted with the high calcium 
consumers (> 600 mg/day) removed from the data set, there was still no difference in 
weight loss between the dietary treatments (P=0.27) (Table 4:17).       
 
4.3.2 Could other dietary components mask calcium’s effect?  
One important difference between the dietary recommendations in our study is that 
the diets provide adequate fibre intake to meet nutrient guidelines for fibre 
recommendations ~28g/day, compared with Zemel et al. studies which gave only 8-
12g/day of fibre.  We chose this level of fibre intake for two reasons, 1. to ensure 
diets were close to recommended intakes and 2. to reduce the risk of constipation, 
often associated with higher calcium intakes (Arnaud & Sanchez, 1990; Soffer, 1999; 
Prince et al. 2006).  Although our diets did meet fibre recommendations, a number of 
female subjects reported symptoms of constipation during the high calcium arm of 
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the study, this was remedied by ensuring adequate fluid intake and exchanging 
prunes within the fruit allowance. There is no mention of such adverse events in 
Zemel’s studies, which are low in fibre intake, whilst following a high calcium 
intake.  Fibre was once considered to reduce the bioavailability of calcium in whole-
wheat bread; however, recent research suggests that purified fibres have little effect 
on calcium bioavailability and the fibres in low oxalate vegetables do not reduce 
calcium bioavailability relative to milk (Weaver & Heaney, 2006). It has been 
suggested that it is more likely the phytate content of fibre, rather than the fibre per 
se that can elicit a negative calcium balance.  The diets provided for our study were 
not particularly high in phytates, regular breakfast cereals were recommended and 
the Health Department message of 2 fruits and 5 vegetables each day. In addition the 
calcium (milk and milk powder combined into yoghurt) was consumed in 3 doses 
distributed over the day.    
 
Another difference between the diets provided to the subjects in this study is the 
addition of vitamin D to dairy products in the United States (Holick et al. 1992; 
Heaney, 2000).  For example with the addition of 3 serves of dairy per day in 
Zemel’s studies an intake of ~300 IU of vitamin D would have been consumed, 
compared to our non-fortified diet of ~50 IU per day (Food Standards Australia & 
New Zealand, 2006).  Vitamin D is required for the optimal absorption of calcium 
and a study providing a high vitamin D intake in combination with a high calcium 
diet was shown to suppress PTH greater than the high calcium only diet (Pfeifer et 
al. 2001).  This may explain the reason why Zemel’s studies have achieved a weight 
change difference between the high and low calcium treatments. However, this does 
not explain why Harvey-Berino’s group did not exhibit the same weight losses 
considering the protocols were very similar and presuming the high dairy diets would 
also be vitamin D-fortified.  More recently in Major et al. (2007) a RCT with 
subjects undertaking a 15 week energy-restricted diet supplemented with 1200 mg of 
elemental calcium and 400 IU of vitamin D, no greater weight or fat loss was 
observed with the treatment compared to placebo.  
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4.3.3  Glucose metabolism 
We reported a reduction in fasting glucose levels, fasting insulin and HOMA score 
on both arms of the study, as might be expected when weight loss is achieved. 
However, there was no significant treatment effect, as in a high calcium diet did not 
elicit a greater reduction in these measures compared with a low calcium intake. This 
demonstrates improvements in insulin resistance that have been experienced by both 
dietary interventions, and is the result of weight loss achieved by the subjects. This is 
in agreement with two other studies Thompson et al.  (2005)  study comparing a 
moderate dairy calcium intake (~800 mg/day) versus a high dairy calcium intake 
(~1200 mg/day), they found no significant weight difference between the groups and 
although there were significant decreases in glucose and insulin levels, there was no 
treatment effect (P=0.44, P=0.89, for glucose and insulin, respectively).  Likewise 
Bowen et al. reported a similar weight loss for subjects following a high protein 
(dairy) diet versus a moderate protein (low dairy) diet, fasting insulin levels 
decreased by the end of a 12 week (weight loss), and 4 week (weight maintenance), 
but was independent of treatment group. There was also no difference in an oral 
glucose tolerance test between dietary groups (2005).   
 
Of the several RCT that have been specifically designed to address the issue of dairy 
calcium intake and weight/fat loss, only two of the studies by Zemel’s group 
indicated improvements in glucose function. Zemel et al. study (2004b), giving 3 
groups a -500 kcal deficit diet with either a low dairy (LD), high calcium (HC) or a 
high dairy (HD) intake.  Glucose tolerance was not significantly different at baseline; 
however, the HD group exhibited a significantly improved glucose tolerance at 24 
weeks and a 27% reduced area under the curve for glucose (P<0.01). Fasting plasma 
insulin levels also showed a 44% decrease in the HD group (P<0.01). Neither the LD 
nor the HC group exhibited any difference with regards to glucose or insulin levels. 
In Zemel’s study of African-American obese subjects, either following a weight 
reduction or weight maintenance diet, along with either a LD or HD diet, the weight 
loss arm of the study the subjects from both groups exhibited decreases in circulating 
insulin levels; however, the HD group had significantly greater reductions than the 
control (P<0.05).  Similarly, on the weight maintenance study, the HD group had 
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significantly greater reductions in circulating insulin levels (P<0.05) (Zemel et al. 
2005b).  Not surprisingly, it would appear that these results were obtained due to a 
greater weight or fat loss from the HD groups in Zemel’s studies.   
 
4.3.4  Lipid metabolism   
We demonstrated no treatment effect on fasting total cholesterol or HDL-cholesterol 
from the start of the study to week 12.  We demonstrated a treatment effect on 
change in fasting LDL-cholesterol levels, with the high calcium diet eliciting a 
greater increase than the low calcium diet (P=0.04).  One explanation could be the 
slightly higher (but non-significant) fasting LDL-cholesterol level with in the 
subjects on the low-calcium diet (HC 3.24 + 1.03, LC 3.52 + 0.89 mM, P=0.07). 
However, the final LDL-cholesterol levels were still with in normal ranges (HC 3.61 
+ 0.83, LC 3.55 + 0.84). We also demonstrated a small decrease in fasting 
triglyceride levels with both dietary treatments, but there was no treatment effect.  
These findings are consistent with recent research, based on omega-3 fatty acids,  
suggesting that modest decreases in triglyceride are frequently accompanied by 
increases in the levels of LDL cholesterol (Balk et al. 2006).  The reasoning behind 
this phenomenon has been suggested as a decrease in the hepatic production of 
triglyceride rich particles occurs (VLDL, the lipoprotein responsible for transporting 
triglycerides for subsequent delipidation by lipoprotein and hepatic lipases by 
peripheral tissues and the liver, respectively) along with an increase in fractional 
clearance rates. In addition to this it has been suggested that (omega-3 fatty acids) 
increase the conversion rate of VLDL to LDL, similar to fibrate drugs (Despres et al. 
2004).  It is suggested that this could be occurring in this study.       
 
Two RCT that have found significant weight loss changes between a diet high in 
dairy/calcium versus a control diet failed to show significant changes in blood lipids  
between the dietary groups (Zemel et al. 2004b; 2005a). Two further RCT that 
manipulated the calcium content of the diets, but did not report greater weight losses 
between a high versus a low dairy/calcium intake, were also unable to demonstrate a 
positive change in blood lipid levels (Bowen et al. 2005; Thompson et al. 2005). 
  
 
 
Chapter 4: The Potential Role of Dietary Calcium in Obesity – a randomised crossover trial 
 
198
Similarly, in a RCT in 193 male and female subjects, given a calcium supplement of 
1 or 2 g of calcium per day for 4 months, no significant differences between the high 
calcium versus the placebo groups for total cholesterol or high-density lipoprotein-
cholesterol were observed (Bostick et al. 2000).              
 
4.3.5  Blood Pressure measurements  
Both systolic and diastolic blood pressure exhibited a significant reduction from the 
start of the study; however, we did not demonstrate a treatment effect.  A reduction 
in blood pressure would be expected with weight loss and a meta-analysis of short-
term studies has indicated an expected reduction in blood pressure of 1:1, to weight 
loss (kg) (Neter et al. 2003).   Our study was consistent with this finding with regards 
to systolic blood pressure reduction (HC weight loss 12.8 kg, SBP reduction 11.8 
mmHg; LC 12.6 versus 14.0 mmHg); however, a slightly lower diastolic blood 
pressure reduction was shown (HC 3.7 mmHg; LC 5.6 mmHg).    
 
Evidence that dietary calcium can have an impact on blood pressure first emerged 
with the publication of McCarron’s paper in the early 1980s (McCarron et al. 1984). 
McCarron & Reusser (1999), in their paper “Finding consensus in the Dietary 
Calcium-Blood Pressure Debate” state that there is evidence from meta-analyses of 
23 observational studies and 42 randomised controlled trials that identify statistically 
significant reductions in hypertension risk through an adequate calcium intake.  
Findings from these meta-analyses seem to demonstrate considerable diversity in the 
blood pressure responses.  The variations in the results of blood pressure lowering 
seem also to be due to the intake of additional nutrients.  In fact, in studies that used 
dietary sources of calcium as compared to calcium supplements, a two-fold greater 
effect was demonstrated on blood pressure (McCarron & Reusser, 1999).  As our 
study used a milk-calcium powder as the high-calcium source, rather than dairy 
foods, this may explain why we were unable to demonstrate a significantly greater 
blood pressure reduction between the two diets.  Zemel et al. initial weight loss study 
with subjects either on a low calcium, high calcium or high dairy diet demonstrated a 
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significant reduction in systolic blood pressure on only the high dairy group; 
however, no difference was observed with diastolic blood pressure (2004b).   
 
It has also been suggested that calcium’s effect on blood pressure could be 
attributable to a “threshold effect”. From McCarron’s paper it suggests that the 
threshold could be 600-700 mg calcium per day.   As our low calcium diets were 
close to this cut off threshold, the additional calcium received by the high-calcium 
consumers may explain why we did not elicit a greater blood pressure response with 
in this group of subjects.   It has also been suggested that subjects within a normal 
range of blood pressure may not experience greater blood pressure reductions with 
the addition of more dietary calcium (Barr et al. 2000). Our subjects were within 
normal blood pressure ranges (<130/85) at the start of the study.    
 
4.3.6  Positive aspects of this study  
Positives of this study is that this was the first Australian study to test the hypothesis 
proposed by Zemel et al. (2000) that a diet high in calcium would elicit a greater 
weight loss in adults. For our study we used a typical Australian diet, this meant the 
reliance on calcium-rich products that are not fortified with vitamin D, as is the case 
in the United States (as discussed above).   
 
Our study was the only one (out of the studies designed to address weight loss on a 
high versus low calcium intake) to utilise Indirect Calorimetry methods to determine 
the energy requirements of the subjects.  This is a more accurate method, compared 
to using energy equations and allows for individualised weight loss programs.  In 
contrast other studies have used fixed energy deficits for all subjects, which would 
introduce a variable weight loss depending on subject’s energy intake at the start. In 
a parallel design, if subjects are not matched at the start then a difference in weight 
loss would easily be assigned to a treatment effect.   
 
Our study was also unique in that we used a cross-over design and controlled for a 
period, sequence and treatment effect.  This type of study allowed for blinding of 
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subjects to which diet they were on.  We were also able to demonstrate that the 
subjects had been well blinded, as our questions at the end of each arm of the study 
indicated that they rated the milk and yoghurt provided, to the same level of 
satisfaction. Similar studies where a parallel design was used, the subjects were 
either consuming dairy products or not or the report did not mention any attempt to 
blinding the diets (Zemel et al. 2004b; Thompson et al. 2005; Zemel et al. 2005a; 
Zemel et al. 2005b).  Only the study by Harvey-Berino et al.  which also found no 
difference between treatment groups, mentioned that the participants were blinded to 
the purpose of the study and the nature of the diets being studies (2005).   Subjects 
who realise they are allocated to the “control” diet, can reduce their compliance and 
adherence to the study protocol.  
 
Another strength of this study was that one investigator was responsible for all 
aspects of the study, which involved the recruitment of the subjects and the ongoing 
dietary appointments, which gave the researcher a strong rapport with all the 
subjects. Hence adherence to the diet and study protocol was left in the hands of an 
experienced dietitian. It is for this reason that we could be confident to include a 
group of participants as non-adherers and exclude them from the data analysis.  
Interestingly, only one other study (Thompson et al. 2005) mentions non-adherers, 
and this group were treated with additional appointments with the researchers, which 
in itself may have caused bias amongst the participants.   
 
Finally, we have used a number of objective, as well as subjective measures to 
determine compliance. We charted weight loss at each time point (every 2 weeks) 
over the duration of the study and demonstrated a significant weight loss at each time 
point and across both dietary treatments.  Most studies fail to mention this aspect of 
their study. Harvey–Berino et al.  (2005) in their year long weight loss study briefly 
mentions that at 6 months the subjects on the low dairy-calcium diet have lost 9.3 kg, 
whereas the high-dairy consumers lost 10 kg; however, at the end of the study 
(another 6 months), the subjects had only lost a further 0.6 kg and 0.8 kg, 
respectively. Likewise, in Thompson et al.  (2005) study, also one year in duration, 
states that their subjects achieved greater weight loss in the first 24 weeks of the 
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study; however, a graph clearly displays a plateau effect after the half-way mark. It 
must be suggested that this is likely due to study fatigue or a reduction in compliance 
to the study protocol, in addition as weight loss is achieved and metabolic rate 
reduces, over time a reduction in energy intake is also going to be required. Either 
way it is an important point to consider in study design as lack of weight loss is an 
often cited reason for subject drop out (Dalle Grave et al. 2005).  It appears that not 
only is it difficult to get subjects to remain on weight loss studies, there have been 
reports of attrition rates ranging from 10-80% depending on the clinical setting and 
experimental design (Grossi et al. 2006).  Considering each participant in this study 
underwent two weight loss periods, a loss of 27.5% (includes non-adheres) – 37.5% 
(excluding non-adheres) of the original sample is not unreasonable.   
 
4.3.7  Limitations of this study  
It was the intention of this study to eliminate previous biases of other parallel 
designed studies, such as initial baseline differences between the groups, non-
blinding of the control versus the test diet. A crossover design does however have its 
own limitations, the main one is that of study fatigue possibly leading to poor 
compliance. Whilst we aimed to limit this by a long washout period (during the 
Christmas holiday period), our participants lost more weight during the first arm of 
the study.  
 
During this study 24 hour urinary collections were used to determine nitrogen and 
hence protein intake.  In the first period of the study there was a strong correlation  
between the recorded dietary protein intake and 24-hour urinary protein excretion; 
however, no correlation was reported between these two measures during the second 
period of the study.  This could indicate poor compliance to the dietary intervention 
during this period; however, it could also be suggested that there was a poor 
compliance to complete 24-hour urine collections. The lack of completeness of urine 
collection seems more likely. Anecdotal feedback by all subjects indicated that ‘urine 
collections’ was the “worst” / “most difficult” task of being a subject on this study.  
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Future studies would certainly require the verification of completeness of urinary 
collections, as recommended by (Bingham, 2003).     
 
DEXA had not been commissioned at Curtin University at the start of this study, and 
so we had no choice but to utilize the services of a clinical/commercial facility close 
to our campus. While the centre is accredited, we are unable to guarantee the control 
over each measurement protocol/scan analysis. It would have been more appropriate 
for all outcome measures to be undertaken by one investigator.  
  
Finally, the question of a threshold effect of calcium on body composition needs to 
be considered.  Two changes that would shed more light on a similar designed study 
would include, 1. Recruitment of subjects with habitually low calcium consumption 
and 2. Provision a really low calcium diet that has less than 500 mg calcium per day.   
 
4.4  Summary  
Based on a crossover design, we could not demonstrate an added benefit of calcium 
intake on weight loss or fat mass loss. However, a high calcium intake modified fat 
distribution by demonstrating a trend towards a greater reduction in waist 
circumference. It is very common for dieters, in particular women to eliminate dairy 
foods from their diets, believing them to be high fat foods.  However, our study 
shows that by substituting milk power (providing ~1300 mg Ca/d) into a regular 
eating pattern can elicit weight loss over a 12 week period. Although this eating 
pattern did not cause a greater weight loss than a low calcium diet, it still 
demonstrates that dairy containing foods do not have to be eliminated from the diet 
to assist with weight loss, providing the energy intake is hypocaloric.  Because 
calcium intake is associated with many other significant health benefits, notably the 
prevention of osteoporosis and hypertension (Nordin, 1997; McCarron & Reusser, 
1999; Heaney, 2000; Sakhaee & Maalouf, 2005), it is suggested that public health 
messages should still include the promotion of dairy products for optimal health, 
with out the causing the fear of weight gain.  However, our study suggests that a 
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high-calcium diet does not improve weight or fat loss beyond that achieved by a 
regular hypocaloric diet.    
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Chapter 5:  Chronic effects of  Dietary Calcium on 
postprandial energy metabolism     
5.1  Introduction  
Zemel’s hypothesis states that an increase in calcium intake should lower the 
calcitrophic hormones, parathyroid (PTH) and vitamin D3, reduce intracellular 
calcium and protect against fat gain (Zemel et al.  2000).  Furthermore, high-calcium 
diets protect against fat gain by creating a balance of lipolysis over lipogenesis in 
adipocytes.  This increase in lipolysis may in turn promote an increase in fat 
oxidation.  Zemel’s hypothesis is based on animal studies demonstrating a greater 
liver carnitine palmitoyltransferase (CPT) activity, demonstrating a greater liver fat 
oxidation rate, in animals fed a high dairy and/or high calcium intake (Sun & Zemel, 
2004).  In addition Zemel’s group have also demonstrated increase in lipolysis (in the 
animal model), as measured by incubation of perirenal adipose tissue and the ensuing 
glycerol release into the culture medium (Sun & Zemel, 2004).  In our acute study 
we demonstrated a greater fat oxidation rate following the consumption of a high 
dairy and a high calcium breakfast meal (chapter 3).  We also demonstrated a 70% 
higher (relative to a low calcium intake) higher serum glycerol level (although his 
did not reach significance).  Evidence of a significantly higher glycerol level 
following high calcium intakes, has also been obtained under hypocaloric weight loss 
conditions in humans (Zemel, 2005a; Zemel, 2005b).  A greater 24 hour fat oxidation 
following higher calcium intake has also been demonstrated under energy restricted 
conditions (Melanson et al.  2005).           
 
Our weight loss study (chapter 4), was hence based on the expectation that higher 
calcium intakes would result in greater weight/fat loss.  It was important to 
investigate whether feeding a high calcium diet would have similar postprandial 
effects as was seen acutely with high calcium. To enable us to determine chronic 
effects of calcium, we utilized a low calcium standard meal on both arms of the 
study. As has been demonstrated in other (non-calcium) studies, if the test meal 
provided mimics the background diet given to the subject, an acute on chronic effect 
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is determined (Weintraub et al.  1988).  The postprandial testing was conducted 
during week 10 (rather than at the end of the study at week 12), to ensure that 
metabolic measurements were taken during a dynamic period of weight loss rather 
than during a possible plateau.    
 
The largest component of energy expenditure is, for most people, the basal metabolic 
rate (BMR), the BMR is closely related to the amount of non-fat tissue (or fat free 
mass) (Frayn, 2003).  As weight loss pursues, a persons fat free mass also decreases 
which is one reason why a decrease in energy expenditure would be expected on a 
weight restricted diet.  In addition to a reduction in energy expenditure, a reduction 
in fat oxidation has been demonstrated (Weyer et al.  2000).  The further decline in 
EE can be explained by a decrease in the thermic effect of food (due to a lower 
energy intake), along with a reduced cost of physical activity, due to the lower body 
weight (Ravussin et al.  1985).  As this study design was based on giving the subjects 
hypocaloric diets, both a reduction in energy expenditure and fat oxidation were 
expected; however, we wished to demonstrate an attenuation this lowering of energy 
expenditure and fat oxidation rates when subjects were fed the high calcium diet.   
 
Many of the metabolic changes in obesity have been shown to be linked with insulin 
resistance.  Along with an increased susceptibility to the development of type-2 
diabetes; insulin resistance also has effects on lipid metabolism, in particular the 
metabolic picture of obesity is for a tendency to have elevated LDL-cholesterol 
concentration, a depression of HDL-cholesterol and an elevation of plasma 
triaclyglycerol concentration.   
 
5.1.1  Study design 
The study employed a single-blind, randomised crossover design comparing the 
effects of a high calcium diet (milk mineral powder) ~1200-1300 mg/d against a low 
calcium (~550-700 mg/d) hypocaloric mixed meal diet. The study involved 2 x 12 
weeks of weight loss with a 12-week wash-out period (timed to coincide with the 
Christmas season (refer to Chapter 4). Postprandial measurements were made in the 
10th week of each diet period using a low calcium, high fat test meal.  
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5.1.2  Subjects 
Refer to chapter 4 for subject details.  
5.1.3  Postprandial measurements (week 10) 
Postprandial measurements were taken over a 5 hour period, following the 
consumption of a low calcium, high fat test meal, to determine differences in 
substrate oxidation rates following the high calcium versus the low calcium diets.     
 
Figure 5:1 Postprandial measurements  
 
       
      
5.1.3.1  Postprandial Study Design 
Refer to section 2.2.4.1 for details of postprandial study design.  The postprandial 
testing period was 5 hours in duration and hence all subjects made two separate urine 
collections, baseline and 0-5 hours after the meal.  
5.1.3.2  Standard meal used for Postprandial Study 
The low calcium, high fat breakfast meal provided consisted of 45 g cornflakes 
(Kellogg™, Pagewood, NSW, Australia), 20 g sultanas (Sunbeam sultanas, Sunbeam 
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Foods, Irymple, VIC, Australia), 35 g cream (Pura Pure cream, National Foods Ltd, 
VIC, Australia), 70 g full-cream milk (Brown’s Dairy, Balcatta, WA, Australia) and 
made up to 145g with de-ionised water. This meal provided 1680 kJ of energy; 7% 
as protein, 35% as fat and 58% as carbohydrate.  The fibre content of the meal was 
2.0 g. The macronutrient content of the breakfast meals was determined using the 
nutrient analysis package FoodWorks (Version 3.0, 2003, Xyris software, Brisbane, 
Australia), incorporating nutrient tables for use in Australia (AUSNUT, Canberra, 
2000) (Table 5:2).   
 
5.1.3.3  Dietary assessment questionnaire  
After the consumption of each breakfast meal, subjects were given a questionnaire to 
determine their assessment of the meal provided. For each question they were asked 
to make a mark (l or X) on a 150 mm line which extended between two extreme 
ranges. The length of the mark was then measured with a ruler. The questions were: 
1. How would you rate the overall amount of the meal provided? 2. How would you 
rate the taste of the meal provided? 3. How would you rate the overall acceptability 
of the meal provided?    
 
5.1.3.4  Blood samples  
Fasting venous blood samples were drawn at baseline and at the end of each 30 
minute RMR measurement. Blood samples for the determination of insulin, glucose 
and triaclyglycerol (TG) were left to stand for 30 minutes at room temperature or on 
ice for EDTA plasma tubes, and then centrifuged at 3000xg for 10 minutes. 
Methodology for assay measurements (refer to Chapter 2).  A sample of plasma for 
the determination of intact PTH, and an anaerobically collected serum sample, for 
the determination of ionised calcium were couriered to an accredited pathology 
laboratory in Perth at the end of the test day (refer to Chapter 2 for methodology).   
As recommended by Heaney iPTH was expressed as percentage change from 
baseline (Heaney, 2003b).  For consistency all blood assay results were reported in 
this manner.  
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5.1.4  Statistical analysis  
All data are presented as mean values + standard errors of the mean (unless 
otherwise stated). Change between fasting and fed states, was calculated by 
subtracting the fasting value x duration of measurement, from the total postprandial 
value over 5 hours. Since the intervals of measurement in the postprandial period 
were equal, this summary statistic was analogous to determining the incremental area 
under the curve (Mathews et al.  1990).  The difference between the changes in the 
variables of interest, or the differences in variables at the end of each diet period, 
were analysed using ANOVA for the 2 x 2 crossover study design. This is similar to 
repeated measures, except that the treatment factor (effects of the two diets in 
question) was assigned across the time periods.  Each subject received both 
treatments in a particular sequence (sequence in which the diets were administered: 
HC diet then LC diet = 1, LC diet then HC diet = 2). Within each subject, a period 
effect was also assessed.  A significant sequence effect, was ignored, as 
recommended by (Senn, 1994), when assessing TREATMENT effects using an 
ANOVA for a 2 x 2 cross-over study.  A paired t-test was used to compare paired 
data within individuals.  Data were analysed using the STATA Statistical Software 
(Release 8.0, College Station, TX, USA) package.  
 
Regression analysis with robust variance estimates was used to test for any treatment, 
sequence and period effects, after adjusting for confounding factors (STATA 
Reference Manual: Version 8.0, 2003; STATA Corporation).   
5.1.5  Ethics  
The Human Research Ethics Committee of Curtin University of Technology (HR 
245-2001) approved the protocol and conformed to the Helsinki Declaration. All 
measurements were made in the clinical rooms of the Bentley Campus of Curtin 
University, Perth. 
5.2  Results  
5.2.1 Subject characteristics  
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Table 5:1 Physical characteristics of subjects 
 Value  
age (years) 54.04 + 5.09 (38 - 65) 
weight (kg) 85.86 + 9.65 (65.9 - 104) 
BMI (kg/m2) 32.19 + 3.44 (27.19 - 38.05) 
waist (cm) 99.26 + 10.22 (83.5 - 116) 
% body fat  39.38 + 6.18 (25.9 - 47.8) 
fat free mass (kg) 50.96 + 6.64 (34.98 - 68.05) 
All values are mean + SD, n=25. BMI – body mass index.  
  
The average age of the subjects was 54.04 + 5.09 years. The average BMI was 32.19 
+ 3.44 kg/m2.  
 
5.2.2  Dietary intake  
Table 5:2  Energy, macronutrient and calcium composition of breakfast meals 
provided to the subjects    
 HC LC ANOVA 2x2 
crossover design  
(P value) 
Energy (kJ) 1678.27 + 3.46 1675.94 + 7.62 0.23 
Protein (g) 6.68 + 0.01 6.68 + 0.01 0.24 
Carbohydrate (g) 57.35 + 0.20 57.32 + 0.16 0.62 
Fat (g) 15.99 + 0.04 15.94 + 0.18 0.21 
Calcium (mg) 116.17 + 0.19 116.14 + 0.27 0.78 
All values are mean + SD. n=25. HC = high calcium diet, LC = low calcium diet.    
 
The breakfast meals provided to the subjects were of the same energy, macronutrient 
and calcium composition between the time they were on the high calcium versus the 
low calcium dietary period.   
5.2.2.1  Acceptability of the breakfast meals provided  
The breakfast meals provided to the subjects were well accepted and there was no 
significant difference recorded for 1. Overall amount; HC (8.15 + 1.91) versus LC 
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(9.00 + 2.67) (ANOVA, P=0.17). 2.  Overall taste; HC (11.99 + 2.21) versus LC 
(11.82 + 2.36) (P=0.77) and 3. Overall acceptability; HC (12.07 + 2.52) versus LC 
12.19 + 2.26) (P=0.85).  
5.2.3  Metabolic measurements 
5.2.3.1 Energy expenditure and substrate oxidation (week 0 (fasting) 
to week 10 (fasting)  
Table 5:3 With-in diet effects of changes in fasting substrate oxidation, 
Respiratory Quotient and Energy Expenditure between baseline and week 10  
 HC 
initial  
HC 
week 10  
Diff. LC 
initial  
LC 
week 10  
Diff. Paired 
t test 
(P 
value) 
ANOVA 
for 
treatment 
effect  
RQ 0.83 + 
0.008 
0.82 + 
0.008 
-0.02 + 
0.01 
   0.08 0.68 
    0.83 + 
0.01 
0.82 + 
0.012 
-0.01 + 
0.014 
0.51  
FOR (g/hr) 2.32 + 
0.23 
2.84 + 
0.22 
0.51 + 
0.28 
   0.08 0.28 
    2.66 + 
0.24 
2.69 + 
0.24 
0.024 + 
0.29 
0.94  
COR (g/hr) 5.34 + 
0.39 
4.51 + 
0.41 
-0.83 + 
0.56 
   0.15 0.91 
    5.34 + 
0.45 
4.61 + 
0.55 
-0.72 + 
0.73 
0.33  
POR (g/hr) 3.44 + 
0.26  
2.64 + 
0.19 
-0.80 + 
0.28 
   0.008 0.24 
    3.02 + 
0.17 
2.57 + 
0.16 
-0.44 + 
0.18 
0.02  
EE (kJ/hr) 235.47 + 
6.32 
224.32 + 
5.61 
-11.15 + 
2.21 
   0.0005 0.06 
    241.53 + 
7.90 
223.53 + 
5.79 
-18.00 + 
3.24 
0.0005  
All values are mean + SEM. FOR fat oxidation rate, COR carbohydrate oxidation rate, POR protein 
oxidation rate, EE energy expenditure, HC = high calcium, LC = low calcium.  
 
There was a trend towards a greater decrease in respiratory quotient from baseline to 
week 10, when the subjects consumed the high calcium diet (P=0.08). A trend for a 
greater fasting fat oxidation rate between baseline to week 10 when subjects were 
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consuming the high calcium diet (P=0.08), but not when the subjects consumed the 
low calcium diet (with-in diet effect). There were significant decreases in fasting 
protein oxidation rates when both diets were consumed (HC, P=0.008, LC, P=0.02). 
No treatment effects were observed between any of these variables. Significant 
reductions in fasting energy expenditure were observed by subjects consuming both 
diets (HC, P=0.0005, LC, P=0.0005).  A trend (P=0.06) was observed for a lesser 
reduction in fasting energy expenditure (from baseline to week 10) following the 
high calcium diet.     
5.2.3.2  Fasting levels  
Table 5:4 Fasting levels of fat, protein, carbohydrate oxidation rates, 
Respiratory Quotient and Energy Expenditure at week 10 
Measurement  HC LC ANOVA 2x2 
crossover design  
(P value) 
FOR (g/h) 2.84 + 0.22 2.69 + 0.24 0.56 
COR (g/h) 4.51 + 0.41 4.61 + 0.55 0.88 
POR (g/h) 2.64 + 0.19 2.57 + 0.16 0.59 
RQ  0.81 + 0.008 0.82 + 0.012 0.78 
EE (kJ/h) 224.32 + 5.61 223.53 + 5.79 0.61 
All values are mean + SEM. FOR fat oxidation rate, COR carbohydrate oxidation rate, POR protein 
oxidation rate, RQ respiratory quotient, EE Energy Expenditure. HC = high calcium, LC = low 
calcium.  
 
There were no differences between fasting levels during each dietary period for each 
of the metabolic measurements undertaken.  
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Table 5:5 The influence of diet composition (high versus low calcium) on 
postprandial thermogenesis and substrate oxidation following a standard meal  
Measurement Treatment Period effect  
(ANOVA 2x2 
crossover 
design) 
P value  
Treatment 
effect 
(ANOVA 2x2 
crossover 
design) 
P value 
 HC LC   
Change in RQ* 0.17 + 0.034 0.15 + 0.052 0.09 0.71 
DIT (%) 4.72 + 0.46 5.52 + 0.61 0.46 0.21 
Change in energy 
expenditure*  
79.25 + 7.63 92.43 + 10.30 0.46 0.22 
Change in fat 
oxidation (g/5h)* 
-2.30 + 0.77 -2.52 + 1.25 0.21 0.91 
Change in 
carbohydrate 
oxidation (g/5h)* 
10.70 + 1.66 9.87 + 2.63 0.03 0.74 
Values are mean + SEM. n=25. HC, high calcium; LC, low calcium. DIT, diet induced thermogenesis. 
*Calculated as sum of postprandial values over 5 h – (fasting value per h x 5).  
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Table 5:6 The influence of diet (high versus low calcium) on postprandial 
thermogenesis and substrate oxidation with all subjects included (n=27) 
 HC LC Treatment effect 
(ANOVA 2x2 
crossover design) 
P value 
Change in fat 
oxidation rate (g/5h) 
-2.19 + 0.73 -2.77 + 1.16 0.90 
Change in 
carbohydrate (g/5h) 
10.76 + 1.55 10.33 + 2.55  0.55 
Change in energy 
expenditure (kJ/5h) 
84.27 + 7.91 93.58 + 9.29 0.41 
 
We observed no treatment effects for any of the postprandial measurements (Table 
5:5). There was a significant period effect on change in carbohydrate oxidation, with 
period 1 having a greater oxidation rate compared to period 2 (14.04 + 9.24, 6.54 + 
11.32 g/5h) (Table 5:5).  We also observed a trend (P=0.06) for a lesser reduction in 
fasting energy expenditure when subjects consumed the high versus the low calcium 
diet (HC -11.15 + 11.03, LC -18.00 + 16.20 kJ/h) (Table 5:3). However, no 
difference was observed with RQ, between subjects consuming the high versus the 
low calcium diet (-0.019 + 0.05, -0.009 + 0.074, P=0.65).   Fat and carbohydrate 
oxidation rates and energy expenditure were examined with 2 additional subjects 
who were discarded as non-adherers to the study protocol; this did not change our 
study outcomes (Table 5:6).  
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5.2.3.3  Changes in postprandial blood levels  
Table 5:7 Fasting levels for triglycerides, glucose, insulin, parathyroid hormone 
and ionised calcium  
Fasting levels  Treatment Treatment effect  
(ANOVA 2x2 crossover 
design) 
P value   
 HC LC  
Triglycerides 
(mM) 
1.66 + 0.13 1.65 + 0.13 0.88 
Glucose (mmol/L) 5.70 + 0.1 5.51 + 0.12 0.44 
Insulin (μIU/ml) 8.74 + 1.13 9.55 + 0.99 0.32 
iPTH (pmol/L) 2.90 + 0.1 3.28 + 0.16 0.03 
pH corrected 
ionised calcium 
(mmol/L)  
1.19 + 0.006 1.20 + 0.008 0.96 
Values are mean + SEM, n=25 
 
 
There were no differences observed between fasting levels for triglycerides, glucose, 
insulin or pH corrected ionised calcium. However, iPTH demonstrated a significantly 
lower baseline level when the subjects commenced the high calcium diet.  When the 
baseline iPTH was corrected for, no treatment effect on postprandial iPTH (% 
change from baseline) (P=0.82) was observed.    
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Table 5:8 The influence of dietary treatment on blood parameters over 5 hours 
of testing (% change from baseline)  
Measurement (% 
change from 
baseline) 
Treatment Period 
effect  
(ANOVA 
2x2 
crossover 
design 
P value 
Treatment 
effect  
(ANOVA 2x2 
crossover 
design) 
P value   
 HC LC   
Triglycerides 
(mM) 
54.98 + 29.78 57.23 + 16.26 0.053 0.94 
Glucose (mmol/L) 28.70 + 8.06 41.53 + 9.97 0.38 0.29 
Insulin (μIU/ml) 756.36 + 97.12 754.45 + 94.48 0.004 0.99 
iPTH (pmol/L)  31.19 + 12.95 12.64 + 23.99 0.66 0.57 
pH corrected 
ionised calcium  
(mmol/L) 
-0.13 + 1.59 0.38 + 1.36 0.26 0.77 
All values are mean + SEM, n=23 (due to incomplete sampling from 2 subjects). Values are 
percentage change from baseline.  
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There was no treatment effect demonstrated for any of the blood parameters 
measured; glucose, insulin, triglycerides, intact parathyroid hormone nor ionised 
calcium, 5 hours postprandially following the consumption of a low calcium, high fat 
breakfast meal. We observed a period effect for percentage change in insulin, with 
period 1 eliciting a greater percentage change from baseline over the postprandial 
period, compared to period 2 (924.75 + 427.14, 586.06 + 446.21%).  A similar 
observation was demonstrated in percentage change in triglycerides with period 1 
(86.45 + 106.76 %) eliciting a greater change compared to period 2 (25.76 + 114.90 
%).   Both these variables were regressed using robust clusters to determine whether 
the greater changes in insulin and triglyceride were due to the subject’s fat mass (kg) 
at the start of each period, this was shown to be the case for both change from 
baseline for insulin and triglycerides.        
 
5.3  Discussion  
An increased 24 hour RQ has been associated with high rates of weight gain (Zurlo 
et al.  1990).  This inability to oxidise lipids has been implicated in the aetiology of 
obesity and type-2 diabetes (Kelley et al.  2001; Achten & Jeukendrup, 2004).  It has 
been suggested that only relatively small differences in energy expenditure (70 cal/d 
or 293 kJ/d) and / or substrate oxidation could impact markedly on body weight over 
time (Ravussin et al.  1988).  However, Weyer et al. (2000) demonstrated that 
responses of both 24 hour energy expenditure and fat oxidation can vary widely 
amongst individuals.  
 
The study of postprandial metabolism within the design of the dietary intervention, 
was to understand the potential mechanisms underlying weight loss on low and high 
calcium intakes.  Accordingly, subjects were measured during the dynamic phase of 
weight loss. As expected in subjects undergoing weight loss there was a significant 
reduction in RMR. This was true for both diets (Table 5:3).  A reduction in RMR is 
an adaptive mechanism, aimed at lowering energy requirements so that further losses 
in FM and FFM are minimised. However, the RMR was less on the high calcium 
diet. As we did not observe any significant differences in FFM between diets 
(chapter 4), these data suggest that increasing calcium intake resulted in a trend 
(P=0.06) for the stimulation of resting energy metabolism.  It was interesting that the 
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change in RQ (P=0.08) and FOR (P=0.08) on this diet favoured a greater fasting fat 
oxidation, relative to the low calcium arm of the study (Table 5:3); however, it is 
acknowledged that no treatment effect was observed. Overall, higher calcium intakes 
stimulated resting (fasting) energy expenditure even under hypocaloric conditions, 
and favoured the utilisation of fat as a fuel source.   These data extend our previous 
observations of the acute effects of calcium during weight stability.     
 
The postprandial responses to the same standard low calcium meal, were not 
different on the two dietary arms.  There were no differences on DIT or substrate 
oxidation, suggesting that under conditions of calorie deficiency, calcium does not 
modulate postprandial metabolism.  Alternatively, changes in fat oxidation and EE 
may have occurred earlier in the study such that by week 10, differences between 
diets were indistinguishable.  Also DIT accounts for at most 10-15% of total energy 
expenditure, so that small differences in metabolism may be difficult to detect.  In 
contrast resting metabolism accounts for 60% of total energy expenditure, making 
the effects of calcium more readily seen.           
 
There were no detectable postprandial differences in other hormones and substrates 
between dietary arms (Table 5:8).  We observed improvements in insulin sensitivity 
and triglyceride concentrations between period 1 and 2, but no significant treatment 
effects. A possible reason for the former is the greater fat mass lost during period 1 
versus period 2 (chapter 4).       
 
To the best of our knowledge, the present study is the first to investigate mechanisms 
for weight/fat loss following high calcium intakes. We found no effect of calcium on 
postprandial events when measured, towards the end of a weight loss program.  In 
contrast, resting energy expenditure was less reduced on the high calcium arm and 
was accompanied by a relatively greater fat oxidation rate. These effects occurred 
during weight loss, a period that normally favours a reduction in RMR and an 
increase in fat oxidation. Calcium may hence modulate thermogenesis and substrate 
oxidation in man.         
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Chapter 6:  Summary & Future Directions  
6.1  Overview of Thesis     
Australia like the rest of the developed world is in the grip of an epidemic of obesity. 
To date, the role of macronutrients and weight management have been widely 
studied; however, the role of micronutrients have not until recently been investigated. 
A large number of cross-sectional and longitudinal studies from around the world are 
in agreement that there is an association between calcium and/or dairy in body 
composition; however, these studies cannot be used to elicit a causal link.  It is 
important to note that dairy intake is often a surrogate measure for calcium intake; 
because dairy calcium comprises the primary source of dairy intake in the United 
States and Australian diets. In addition, a low calcium intake may be associated with 
a less healthier lifestyle, diet or social status (Barger-Lux et al.  1992; Teegarden, 
2005).   
 
As the concept of calcium, and in particular dairy calcium is a fairly new area of 
research there have only been a limited number of well-designed randomised control 
trials. In chapter 1 these studies were graded according to the National Health and 
Medical Research Councils, levels of evidence I to V (2000). We demonstrated a 
lack of level I and II evidence based studies.  We would also conclude from these 
studies that there is a lack of consistency of study endpoints. Only, one group of 
researchers have been able to draw consistent and significant conclusions of a role 
for calcium and dairy calcium in weight/fat loss (Zemel et al.  2004b; 2005a; 2005b), 
or dairy alone (Zemel et al.  2005a; 2005b). Other studies, which have looked at only 
the role of dairy calcium on weight loss, have failed to show any significant 
difference between the treatment groups (Harvey-Berino et al.  2005; Thompson et 
al.  2005).  We propose that there are some flaws in the methodology of these studies 
which may explain an inconsistency in results. There is a lack of a true placebo-
controlled experimental arm, the addition of vitamin D as well as calcium as the 
treatment, methodology used for determining energy deficiency (empirical versus 
measured) and the lack of control of confounders in the parallel-designed studies.      
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We therefore propose that the findings from this thesis have addressed some of the 
limitations currently present in the literature, and hence adds invaluable knowledge 
towards the presently inconclusive link between dietary calcium and its role in 
weight and fat loss in the overweight / obese adult population.   
 
6.1.1 Summary of Findings 
Overall, the background for this PhD research stemmed from inconsistent findings, 
lack of prospective RCT designed with weight loss in mind and a need to clarify 
potential mechanistic outcomes.  As this was the first study to be conducted in 
Australia, we believed that the outcomes of this PhD research are particularly 
pertinent for the health and well-being of Australians.     
 
This thesis focused on overweight/obese subjects with the primary aims being:- 
 
(1) To study the acute (meal related) effects of dairy calcium and pharmaceutical 
calcium on postprandial thermogenesis, substrate oxidation and lipemia, along with 
hunger/satiety ratings and subsequent food intake.   
 
(2) To determine the chronic (dietary) effects of dairy calcium on body composition 
and fat distribution following weight loss.   
 
Our findings suggest that in an acute setting when subjects are fed a breakfast meal 
that is high in dairy calcium and high in calcium (pharmaceutical preparation) a 
greater fat oxidation is achieved over a 6 hour postprandial period (Chapter 3).  This 
finding was accompanied by lesser suppression of NEFA, which may indicate a 
greater lipolysis in the postprandial period. We found no differences in the subject’s 
feelings of hunger or satiety, nor immediate food intake (buffet), nor 24-hour food 
intake following the 3 test meals (Chapter 3).  However, we demonstrated a trend for 
a greater inter-meal interval in the order of HD>HC>LD. There was also a reduction 
in the intake of fat between the HC and the LD meal, with food intake recorded 
immediately post-testing until mid-night.   
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In addition, when subjects were fed an energy-restricted diet, high in calcium, there 
was no greater weight loss or total body fat loss compared to a low calcium diet.  
However, a trend (P=0.052) for a greater reduction in waist circumference was 
observed when subjects consumed a high calcium diet (Chapter 4).  Mechanistically, 
the greater postprandial fat oxidation seen after an acute meal, was not evident when 
a standard (low calcium) meal was tested on the high calcium diet.  However fasting 
fat oxidation increased from start of the study to week 10 only on the high calcium 
arm of the crossover trial (Chapter 5).  In the weight loss trial we have consistent 
effects of a good inverse correlation between weight loss and adjusted RMR 
indicating that a higher energy expenditure is associated with greater weight loss.  
However, this was true for the low calcium but not the high calcium arm of the trial 
(Chapter 4).  This finding is of interest as it indicates that higher calcium seems to 
‘equate’ the amount of fat lost by taking away the effect of initial body 
size/composition.          
 
6.1.2  Implications of these findings  
We believe we have developed a RCT that eliminates many of the pitfalls of present 
RCT research.  In brief:-   
 
1. Previous studies had utilised open parallel designs, which necessitates greater 
control of potential confounders between groups, no other study has made a good 
attempt to examine their data controlling for confounders. We chose to eliminate 
many of these issues by employing a with-in subject, cross-over designed study. Our 
analysis allowed us to account for a period, sequence and treatment effect.  
 
2. Our study was the first RCT to utilise Indirect Calorimetry methods to determine 
BMR and hence fix the energy requirements of the subjects at the same level of 
intake. This is not only a more accurate method, but also allows for more control 
based on fat/fat free mass.  This is particularly pertinent relevant to our findings 
discussed above (section 6.1.1).   
 
 Chapter 6:  Summary & Future Directions  
221
3. Our study design being a true placebo-controlled design, allowed the elimination 
of bias from subjects not on the “dairy-rich” diet. Lack of blinding can result in 
subjects being less compliant to the study protocol.  
 
4. This study was the first Australian study to address the issue of dietary calcium 
and body composition and hence the use of Australian foods meant only calcium-rich 
foods that were not vitamin D enriched, as in the US. We also opted for higher fibre 
intakes (compared to Zemel’s studies - (Zemel, 2004; 2005a; 2005b) to a. be closer 
to Australian dietary recommendations and b. avoid constipation that can occur with 
high calcium intakes (Arnaud & Sanchez, 1990; Prince et al.  1995; Soffer, 1999; 
Prince et al.  2006).       
 
We believe that the controlling of these above factors have lead to a tightly 
controlled weight loss study designed specifically to address the effect of a high 
versus a low calcium intake on overweight and obese subjects.  
 
Our findings of a trend for a greater reduction in waist circumference tie in neatly 
with both our acute study findings of a greater fat oxidation in subjects given a high 
dairy and high calcium meal, along with a trend for an increase in fasting fat 
oxidation from the start of a weight loss study to measurements taken at week 10.  
The regulation of fat balance is critical to energy balance and the equilibrium of fat 
stores in the body (Flatt, 1995b). Fat balance is determined by the body’s ability to 
match fat oxidation to fat intake; hence any dietary factor that can stimulate fat 
oxidation over a prolonged period would hence reduce fat stores, providing there was 
no compensatory increase in fat intake. These findings have been confirmed by our 
group using a sequential meal design (Soares et al.  2004b), along with population 
data (Soares et al.  2004a). Our results also compare favourably with cross-sectional 
evidence, (Melanson et al.  2003) and prospective data (Melanson et al.  2005). One 
long-term study has also demonstrated a greater fat oxidation rate in subjects who 
followed a high calcium diet for a year (Gunther et al.  2005b).  In our acute study 
circulating levels of NEFA were less suppressed following both high calcium meals, 
which parallel the changes in fat oxidation.  The findings of an increase in fat 
oxidation in our acute studies, supports Zemel’s hypothesis of an increased lipolytic 
effect of calcium from cellular (Zemel et al.  2000; Shi et al.  2002) and animal 
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studies (Shi et al.  2001b; Sun & Zemel, 2004), and more recently human studies 
using the measurement of glycerol (Zemel et al.  2005a).    
 
Visceral adipocytes are more lipolytic (Masuzaki et al.  2001; Rask et al.  2001) and 
the higher fasting FOX on the high calcium diet may explain the lower waist 
circumference we observed on the high calcium arm of the weight loss study. An 
attempt to verify this greater loss of visceral adiposity through a model of body 
composition from DEXA; however, did not prove fruitful.  Additionally, we have 
observed that chronic increases in calcium intake may also modulate weight loss 
through changes to RMR.  While there is sufficient evidence linking a low relative 
RMR to weight gain, a strong case for the opposite effect is seen only in some 
studies (Hansen et al.  2001).  With a greater increase in fat oxidation demonstrated 
with the high calcium diets, it may be expected that this will elicit a greater increase 
in energy expenditure. Although there was a greater increase in energy expenditure 
and diet induced thermogenesis with both high calcium containing diets fed acutely, 
these did not reach significance (Chapter 3). This is likely due to the reciprocal 
decrease in carbohydrate oxidation as the fat oxidation increased (was less 
suppressed). As far as we are aware, our chronic study is the only one that has 
investigated mechanisms for weight/fat loss following high calcium intakes. We 
found no effect of calcium on postprandial events when measured, towards the end 
of a weight loss program.  In contrast, resting energy expenditure was less reduced 
on the high calcium arm and was accompanied by a relatively greater fat oxidation 
rate. These effects occurred during weight loss, a period that normally favours a 
reduction in RMR and an increase in fat oxidation.      
 
The intake of dietary calcium has long been associated with the prevention of 
osteoporosis and there are a vast array of studies and reviews linking a role for 
calcium and bone health (Nordin, 1997; Heaney, 2000; Cosman, 2005; Nieves, 
2005).  However, more recently studies have indicated that weight loss is associated 
with elevated calcium requirements; it has even been suggested that normal intake of 
calcium during energy restriction can result in inadequate calcium absorption; and 
compromising calcium balance and bone mass (Cifuentes et al.  2004). This is 
pertinent as it is common for dieters to restrict the intake of dairy products, believing 
these foods to be fattening (Radak, 2004; Dwyer et al.  2005). Results from our 
 Chapter 6:  Summary & Future Directions  
223
weight loss study show that if subjects are educated to follow an energy restricted 
diet (as would be required to elicit weight loss), that high calcium containing foods, 
such as dairy products, are an acceptable alternative, as long as the intake is energy 
restricted and dairy snacks are replacing other snack foods.  Several studies have 
indicated that the provision of at least 1 g / day of calcium is likely to reduce loss of 
bone mineral and alter makers of bone resorption (Bowen et al.  2004; Radak, 2004), 
whereas some studies have suggested a higher calcium intake may be required (Riedt 
et al.  2005). It would therefore seem prudent and ethical to ensure that at least 1 g of 
calcium per day is consumed, whilst undergoing energy restriction.       
 
6.1.3  Future directions 
Our acute data demonstrated a role for dairy calcium and pharmaceutical calcium 
given in a one off dose over the day. It could be said that 500 mg is a large dose to 
consume in one sitting and further studies need to be developed to elicit whether 
there is in fact a dose response for the intake of calcium.  Some authors have 
suggested that there could be a threshold effect for the weight loss benefits of 
calcium, and that calcium only enhances body composition changes when individuals 
are consuming a low calcium intake (<500 mg Ca/d) (Heaney et al.  2002; Parikh & 
Yanovski, 2003; Sakhaee & Maalouf, 2005).  In our weight loss study, due to the 
nature of our design (cross-over and single-blind) our low calcium group were given 
intakes of 550-700 mg of calcium per day. In Zemel’s studies the LC diet was 
achieved by intakes of 500 mg (Zemel et al.  2004b). In our blinded-design this could 
only be achieved by specifically designed very low calcium dairy products. It must 
also be noted that in our weight loss study we found it difficult to recruit enough 
subjects, who habitually consumed a very low calcium intake (mean 587 mg, range 
139-980 mg Ca/d).  We tried to eliminate this possible confounder by running a sub-
analysis, removing the high calcium consumers (>600 mg Ca/d) from the data set, 
this did not change our conclusion of no treatment effect on weight loss.  Although a 
couple of studies have not found a difference in weight loss between a low-calcium 
(500-600 mg) and a high-calcium diet (Ricci et al.  1998; Bowen et al.  2005), this 
“threshold-effect” theory warrants further investigation.   
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One of the differences between Zemel’s studies and our study is that dairy foods 
fortified with vitamin D were used, as is the practice in the US.  Bell et al. (1985) 
have proposed that obesity is often associated with vitamin D deficiency, as this 
becomes stored in the large fat stores of overweight people and is not bioavailable 
(Wortsman et al.  2000).  We endeavoured to eliminate any possible confounders of 
vitamin D sufficiency, but firstly ensuring our subjects were vitamin D replete, as 
measured by 25, dihydroxy vitamin D3 at the start of the study. We also designed the 
crossover design to fall within the sunniest seasons within Australia (August to 
December and January to May).  It is also worth mentioning that even though the 
issue of vitamin D is worth further investigation, it does not explain the lack of 
consistent results found in other US based studies (Harvey-Berino et al.  2005; 
Thompson et al.  2005).        
 
As with the findings of our study and supported by several other studies (Zemel et al.  
2004b; 2005a; 2005b) a greater reduction in waist circumference was observed. With 
recent evidence linking visceral adipocytes to a lesser cortisol production. Future 
studies need to investigate this further by the measurement of visceral fat through 
radiographic methods, such as computerised tomography or magnetic resonance 
imaging.    
 
It is not only difficult to get subjects to remain on weight loss studies, attrition rates 
have been reported from 10–80% depending on the clinical setting and experimental 
design (Grossi et al.  2006); however, the other issue is compliance. Within our study 
we built in many measures, both subjective and objective to determine compliance 
and controlled for this by the elimination of non-adherers in the data set.  Interesting, 
the RCT designed to address weight loss and dietary calcium, either make no 
correction for non-adherers (Zemel et al.  2004b; Harvey-Berino et al.  2005; Zemel 
et al.  2005a; Zemel et al.  2005b) or implement measures to enhance adherence, 
which may lead to bias (such as additional appointments with the dietitian) 
(Thompson et al.  2005).  It is suggested that future studies should invest in doubly-
labelled water techniques to ensure an independent measure of compliance.    
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There has been some suggestion that dietary calcium may have a greater role on 
adiposity, gender and ethnicity (Heaney, 2003a), it is therefore suggested that future 
studies are tightly controlled to ensure homogenous subject groups.  
 
Future research into this area is worth considering the aspect of weight loss versus 
maintenance.  When the body undergoes a period of energy deficit, it is under a 
considerable amount of stress.  The role of calcium and its effect on weight loss have 
been described by some as small, in one review paper the magnitude of ~3% is 
suggested (Parikh & Yanovski, 2003). Therefore it is proposed that calcium’s effects 
may be difficult to uncover in the weight loss situation. Mechanistically we were 
able to demonstrate a role for calcium in weight stable situation (acutely) but not 
chronically. Research has demonstrated a role for calcium in weight stable subjects 
(Zemel et al.  2005b), and this warrants further investigation.  
 
Finally, calcium has been linked with eliciting a greater satiety, it has been suggested 
that this may be due to certain components in milk (Schneeman et al.  2003; Moran, 
2004).  In our laboratory we have demonstrated a significant reduction in food 
consumption of human subjects following a HD breakfast meal versus a LD meal 
(Ping-Delfos et al.  2004). In this thesis we utilised VAS questionnaires to determine 
the subjects’ feelings of hunger and satiety before, during and after the test period; 
however, we observed no significant differences between the dietary treatments. We 
did; however, observe a trend (P=0.07) for a longer time lag before the next meal 
was consumed with the high dairy meal versus the low dairy meal.  This aspect of 
satiety warrants further investigation within the area of dietary calcium and weight 
loss studies.      
 
6.1.4  Conclusion  
In conclusion this thesis was the first prospective study that demonstrates a greater 
postprandial fat oxidation rate following high calcium meals, both dairy and non-
dairy.  It is suggested that the lesser postprandial suppression of NEFA would drive 
the increase in the fat oxidation, and the trend for a greater lipolysis would serve to 
maintain the relatively higher NEFA levels following such meals.  These acute 
studies did not demonstrate that calcium rich meals altered subjective feelings of 
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hunger or satiety, nor immediate food intake (ad libitum buffet).  However, the inter-
meal interval was prolonged relative to a low calcium diet, with some indication of a 
decrease in fat intake. Such data provide a mechanistic framework for understanding 
how the intake of calcium rich foods may influence human energy balance. 
 
Furthermore, subjects fed high calcium, energy-restricted diets achieved the same 
weight and fat loss compared to subjects on a low calcium diet over a 12 week 
period. However, a trend for a greater reduction in waist circumference was achieved 
by the subjects when consuming the energy-restricted, high calcium diet and may 
have long-term health benefits for overweight/obese adults with the Metabolic 
Syndrome.          
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Appendix  A. Food Frequency Questionnaire  
Food Type Serving 
Amount 
I Eat This Food:       
Every Week   
I Eat This Food:        
Every Day   
mg Ca / 
Serving 
mg Ca/week 
(Investigator 
Use Only) 
mg Ca/wk 
(Investigator 
Use Only) 
mg Ca/day 
(Investigator 
Use Only) 
Full cream milk, UHT, reconstituted full 
cream powder, soy milk (full cream or 'lite') 
and flavoured  milk 
1 Cup   290 0 0 0 
Low fat modified milk (incl. Fitness, 
reconstituted skim powder, & Slim) 
 1 Cup   420 0 0 0 
Reduced fat modified milk - Hi Lo, Hi Lo 
(UHT), 
1 Cup   360 0 0 0 
Yogurt, low fat, plain 200g 
carton 
  420 0 0 0 
Yoghurt, flavoured  low fat or regular, and 
plain regular 
200g 
carton 
  340    
Hard cheese 30 g   220 0 0 0 
Cheese slices 1 slice   190 0 0 0 
Ricotta cheese 1 Tbs   50 0 0 0 
255 
Appendix  
Cottage cheese 1 Tbs   15 0 0 0 
Cream cheese 1 Tbs   25 0 0 0 
Ice cream and 'lite' ice cream 2 Scoops   120 0 0 0 
Custard 1 Cup   260 0 0 0 
Salmon canned  1/2 Cup   280 0 0 0 
White fish  1 Fillet   20 0 0 0 
Sardine, canned, drained 5 Whole   290 0 0 0 
Cappuccino 1 Cup    190 0 0 0 
Coffee, black 1 Cup   5 0 0 0 
Soup, canned or packet 1 Cup   45 0 0 0 
Cauliflower cheese 1 Cup   190 0 0 0 
Cauliflower or broccoli, boiled 1 Piece   15 0 0 0 
Carrot/pumpkin/peas/cabbage, boiled or 
steamed 
1/2 Cup   20 0 0 0 
Lettuce 2 Leaves   15 0 0 0 
Tomato 1 Whole   10 0 0 0 
Orange or grapefruit 1 Whole   40 0 0 0 
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Orange juice (100%, unsweetened) 1 Cup   20 0 0 0 
Mandarin 1 Whole   15 0 0 0 
Strawberry 1/2 Cup   10 0 0 0 
Banana 1 Whole   10 0 0 0 
Figs, dried 3 Pieces   70 0 0 0 
Prunes, dried 3 Medium   10 0 0 0 
Egg 1 Egg   20 0 0 0 
Baked beans 1/2 Cup   60 0 0 0 
Almonds 10 Nuts   40 0 0 0 
Bread - wholemeal, mixed grain, white, 
fibre-increased white or wholemeal, rye, 
fruit loaf 
1 Slice   15 0 0 0 
Muesli, untoasted 1/2 Cup   65 0 0 0 
Breakfast cereals (toasted muesli, rolled 
oats, all-bran) 
1/2 Cup   20 0 0 0 
Chocolate cake or a scone 1 Serving   40 0 0 0 
Chocolate 4 Squares   50 0 0 0 
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Wine, red or white 1 Glass   30 0 0 0 
Beer 375mls   5 0 0 0 
  Total Calcium 
Intake/Day 
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Appendix  B. Study Design & Consent Form  
1.  
 
 
 
 
 
 
 
 
 
Investigation into the effects of dairy calcium on fat & glucose utilization and blood 
fat patterns 
 
Project Title: Dairy calcium and its effects on rates of whole-body nutrient utilization 
(HR 245/2001) 
 
INFORMATION TO VOLUNTEERS 
 
Thank you for agreeing to participate in the above-mentioned study.  This document is to 
assist you to understand what is involved in this project.  There is a consent form attached, 
which you will be asked to sign at the time of your visit.  Please be sure you fully 
understand the nature of the study and any potential risks before signing. 
 
BACKGROUND INFORMATION 
Previous surveys have shown that many Australians are either overweight or obese, which 
can put them at greater risk of developing diabetes and heart disease. Both these 
conditions arise from the body’s inability to properly handle glucose and fat that comes 
from the diet. There is evidence to suggest that calcium, particularly dairy calcium, has 
beneficial effects on the metabolism of fat and glucose. This study is the first step in 
determining whether dietary calcium can assist the body in handling both fat and glucose. 
 
STUDY AIM 
 
The aim of this study is to determine the amount of energy spent in digestion, absorption 
and utilization of fat and glucose when the diet is supplemented with calcium. This will 
enable us to calculate the amount of fat and carbohydrate (glucose) that is burnt by the 
body, and evaluate the beneficial effects of calcium.  
 
STUDY PLAN/REQUIRMENTS 
 
Visit 1 (1-2 hours only) will give you an opportunity to meet the investigators and have 
the study procedures and protocol fully explained to you. At this stage you will be asked 
to read and sign the ‘Informed Consent’ form. You will also complete a Food Frequency 
Questionnaire, which looks at your typical eating patterns.  
  
Visit 2, 3 & 4 will be 7-hour visits to the clinical rooms of the School of Public Health, 
Curtin University.  On each of these visits, you will be given the same type of breakfast 
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each meal you will also be asked to consume two (2) 500mg tablets of Paracetamol [Panadol].
This is a safe over the counter drug commonly used for relief of headache, muscular and joint
pain. We use this drug to trace the absorption pattern of the meal. 
 
At each of these visits you will be required to fast for 12-14 hours (the night before). On arrival, 
you will be asked to rest for half an hour before testing begins.  We will place a large semi-
transparent plastic hood over your head, through which you will be breathing room air whilst 
lying comfortably on a bed. This allows us to measure levels of oxygen and carbon dioxide.
After 15 minutes, you will be given one of the special meals, the hood will be replaced and we
will continue the testing for up to 6 hours following the meal.  Measurements are made at
hourly intervals and take approximately 30 minutes. In between measurements you can listen to
music, read, chat, or just relax. 
 
During the 7 hours of testing, we will be taking regular blood samples of 15 ml each. We will 
only be taking around 100 mL in total (approximately 6 tablespoons) of blood at each visit.  To
make the sampling more comfortable for you, a certified person (phlebotomist) will insert an
indwelling catheter in your arm, similar to that of a hospital drip. We will also be collecting any 
urine passed during the study, for which you will be able to go to the toilet as per usual. The
blood and urine samples will be used to measure such things as hormones, glucose,
triglycerides etc. In the rare event of a medical emergency, fully qualified physicians & nursing
staff are available. 
 
Following the testing period it is likely that you will be quite hungry and we will provide you
with a buffet meal. As this is still part of the study protocol it is important that you are able to 
stay for this part of the study period.  
 
For the next 24-hours (following the test day) we require you to complete a food diary.  You
will be provided with a diary and instructions on how to complete the information accurately. 
We will provide you with a stamped addressed envelope so you can post the completed diary
back to the researchers.   
  
FURTHER INFORMATION 
 
We assure you confidentiality of information collected as part of this study.  Participation is
purely voluntary and you may withdraw at any point in time. 
 
If you have any further queries, please do not hesitate to contact: 
 
Dr Mario Soares MBBS, Ph.D. R.Nutr  OR Ms Nikki Cummings BSc, Grad Dip 
Diet 
Telephone: (08)- 9266 3220    Telephone: (08) – 9266 2817 
 
Department of Nutrition, Dietetics & Food Science, Curtin University. 
 
This study HR 245/2001,  has been approved by the Curtin University Human
Research Ethics Committee.  IF needed, verification of this approval can be obtained
either in writing to the Curtin University Human Research Ethics Committee c/-
Office of Research Development, Curtin University of Technology, GPO Box U1987,
Perth 6845, or by telephoning 9266 2784.  
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Investigation into the effects of dairy calcium on fat & glucose utilization and blood 
fat patterns.  
 
Project Title: Dairy calcium and its effects on rates of whole-body nutrient utilization 
(HR 245/2001)  
CONSENT FORM 
 
I,__________________________________________________________ 
Hereby consent to be a volunteer for the above-mentioned study.  I understand that as part 
of the study, I will allow myself to be screened for suitability as a volunteer.  
 
I have read the patient information sheet and have satisfied myself that this is a safe 
technique. I consent to ingesting a breakfast meal on three separate occasions. These meals 
may or may not be supplemented with calcium. With each breakfast meal I agree to 
swallow two 500 mg tablet of Panadol (Paracetamol) or equivalent. I consent to have my 
oxygen and carbon dioxide measured for the duration of 7 hours on each of these 
occasions.  I also consent to having an indwelling catheter inserted into a vein in my 
arm/hand for the purposes of blood collection. I understand that a total of 100 ml of blood 
will be collected on each visit. 
 
I fully understand all of the potential risks of these procedures as explained to me.  I also 
understand that my participation is purely voluntary and that signing this form DOES NOT 
prevent me from withdrawing from the study at any time. I have been assured that 
confidentiality will be maintained at all stages throughout the study. 
 
Signature:___________________________________  Date:__________ 
 
 
Witness:____________________________________   Date:__________ 
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Appendix  C.  Information for Volunteers  
 
Investigation into the effects of dairy calcium on fat & glucose utilization 
and blood fat patterns 
 
INFORMATION TO VOLUNTEERS 
 
Thank you for agreeing to participate in the above-mentioned study.  To ensure 
the same study conditions occur before each of the three test days, please can 
you follow the protocol outlined below.  
 
1. Do not undertake any strenuous exercise 24-hours before the test day.  
2. Do not undertake any exercise (not even a light walk) the evening before 
the test-day.  
3. The evening before the test-day you will be provided with a meal, please 
eat this no later than 7:30pm and only drink the water (deionised) 
provided to you.   
4. After you have completed the meal, do not eat any other food (do not 
consume coffee or tea after this time).  You must only consume the 
deionised water provded.  
5. Please ensure you have a good nights rest (~ 8hours) 
6. The morning of the test  
a. Do not consume any food and only drink the deionised water 
provide (do not drink any coffee or tea) 
b. Do not shower, but you can have a light-wash 
c. If possible have a friend or family member drive you to the centre 
at Curtin.  
d. If you drive yourself, you will be provided with a parking permit 
for the day.  
e. If are running late, please do not panic (I need you to be calm on 
the morning of testing).  
f. Wear light comfortable clothing 
g. It is suggested you bring a book, magazine or walk-man (if you 
bring a tape, I can provide you with a walk-man)  
    
If you have any questions about this study protocol, please do not hesitate 
to contact Nikki Cummings 9266 2817 or 0412 705 355.  Or leave a 
message on 9266 3220.   
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Sensory Evaluation of meal(s) 
 
Subject ID: ______________________  Date: _______________________ 
 
Time:___________________________  Study code: __________________ 
 
 
Please mark a point on the line which best corresponds to your response to the question.  
 
 
 
1. How did you feel about the amount of the meal? 
 
Too small          Too much 
 
 
 
 
2. How did you feel about the taste of the meal? 
 
 
Very bad         Very good 
  
 
 
 
 
3. How did you feel about the overall acceptability of the meal?  
 
 
Un-  Very 
acceptable acceptable 
  
 
   
 
Appendix  D. Sensory Evaluation of meal  
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VAS Questionnaire 
 
Subject ID: ______________________  Date: _______________________ 
 
Time:___________________________   
 
Please mark a point on the line which best corresponds to your response to the question.  
 
1. How hungry do you feel? 
 
Not hungry                                                                                                     As  hungry 
at all                                                                                                                as I’ve ever 
                                                                                                                                   felt 
  
 
2. How full do you feel? 
 
Not at               As full  
all full                                                                                                             as I’ve ever 
                                                                                                                                   felt 
  
 
 
3. How strong is your desire to eat? 
 
 Very strong         Very weak 
 
  
 
4. How much do you think you could eat now? 
 
Nothing  A large     
at all  amount             
 
  
 
5. Preoccupation with thoughts of food? 
 
No thoughts    Very 
of food difficult to     
concentrate  
on other things  
 
Appendix  E. Visual Analogue Scale  
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Appendix  F.  Food Recording Booklet  
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Appendix  G. Information to volunteers – Chronic Study  
INFORMATION TO VOLUNTEERS 
 
Thank you for agreeing to participate in the above-mentioned study.  This document is to 
assist you to understand what is involved in this project. For my study to be successful I need
volunteers who are able to adhere to all parts of the study – please read this protocol 
carefully before you agree to take part in the study.  There is a consent form attached, which
you will be asked to sign at the time of your first visit.  Please be sure you fully understand
the nature of the study and any potential risks before signing. 
 
BACKGROUND INFORMATION 
Previous surveys have shown that many Australians are either overweight or obese, which
can put them at greater risk of developing diabetes and heart disease. Both these conditions
arise from the body’s inability to properly handle glucose and fat that comes from the diet.
There is evidence to suggest that calcium, particularly dairy calcium, has beneficial effects on
the metabolism of fat and glucose and further to this may assist in weight loss.   
 
STUDY AIM 
The aim of this study is to determine if a hypocaloric diet supplemented with dairy calcium
will induce a greater weight loss compared to a low calcium diet.   
 
STUDY DESIGN 
You will follow a prescribed diet for 12-weeks, followed by a second 12-week period 
(November 2004 – January 2005) whereby you will resume normal eating habits, with
minimal intervention from the research team.  The dietary intervention will then resume at the
end of January / early February for a further 12-weeks.  Please be aware that you need to 
undertake both 12-week weight loss periods to participate in this study.     
 
STUDY PLAN/REQUIRMENTS 
 
Visit 1 (1-2 hours only)  
This visit will give you an opportunity to meet the investigators and have the study
procedures and protocol fully explained to you. At this stage you will be asked to read and
sign the ‘Informed Consent’ form. I will also take a blood sample at this stage and will test
this for vitamin D status and thyroid function. You will also complete a food frequency 
questionnaire to determine your usual eating habits. At this visit I will also explain how to
complete a detailed food diary and physical activity diary (which you will complete over the
next week).  I will provide you with a large coloured bottle, which will be used to collect a 
24-hour urine sample (this will be repeated in week 6).  I will also book you a medical
appointment at the Health Centre (Curtin University) to ensure that there is no medical reason
you may be ineligible to participate in the study.        
  
Visit 2 (Sir Charles Gardiner Hospital) 
You will be allocated a time to attend SCGH for a Dual Energy X-ray (DEXA) scan. DEXA 
is used to measure your body composition (amount of fat, bone and lean tissue). As the name
denotes this technique utilizes a very small dose of X-rays, the dose of radiation is very small, 
in fact less than the amount of natural background radiation that we all receive each day. This 
test will be repeated in week 12 (following the dietary intervention).
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Visit 3 (Curtin University, Building 400 room 101) 
On this day I will be determining your resting metabolic rate (how much energy your body
uses) using a method called Indirect Calorimetry. This machine is a very sensitive measure of
energy usage and it is important that you attend each test day in the “same state”. Therefore
you will be provided with a meal that must be consumed the night before, you will then fast
(not eat anything) until you arrive at Curtin early in the morning (time to be determined).  
 
On arrival you will empty your bladder and then rest for 30 minutes. A large semi-transparent 
plastic hood will be placed over your head, through which you will be breathing room air
whilst lying comfortably on a bed. This allows us to measure levels of oxygen and carbon 
dioxide.  Following this testing period we will take a blood sample of 15 ml. The blood
sample will be used to measure hormones, glucose, and blood fats. In the rare event of a
medical emergency, fully qualified physicians & nursing staff are available close by. Please 
note that you will be required for ~2 hours for this test.    
 
A week following this testing day you will commence the dietary intervention period. You
will be provided with a detailed diet (listing types and amounts of foods). This diet is a 
hypocaloric diet (less energy than you require), and you will be provided with some dairy
foods each week that you need to consume (as specified). It is important that you only eat 
the types and amounts of foods as prescribed by the researcher.   During the dietary 
intervention period you will be requested to complete 2 food diaries and 2 activity charts.
During the study it is important that you maintain your usual exercise habits (please do not 
increase your physical activity).    
  
Visit 4,5,6,7 (week 2,4,6,8) 
Each fortnight you will attend Curtin University in a fasted state (early in the morning) to
have your weight measured. At this appointment you will also be asked about your progress
on the diet (approximate appointment time ~ 1 hour).  During your visit in week 6 I will also 
record your weight, hip/waist and blood pressure, and a fasting blood sample of 15ml will be
taken. You will be provided with a cup of tea or coffee and a snack before you leave.  
 
Visit 8 (week 10) 
This visit will require you to attend Curtin University for a 7 hour period. The aim of this day 
is to determine your energy expenditure and substrate utilisation following the consumption 
of a test meal. You will be provided with a meal that you consume the night before and then 
yo will fast over-night. On arrival you will empty your bladder and then rest for 30 minutes. 
We will then measure your levels of oxygen and carbon dioxide consumption. A 15 ml blood 
sample will be taken at this time. You will then be given a test meal and the above procedure 
will be repeated every hour. A total of 90ml (~4 ½ tablespoons) of blood will be taken over 
the day. We will also be collecting any urine passed during the study, for which you will be 
able to go to the toilet as per usual.     
 
Visit 9 (week 12)  
Repeat of DEXA at SCGH, followed by final weight, waist, and hip and fasting blood sample
taken at Curtin University.  
 
Following this initial 12-week period you have a 12-week period (approx Nov 
2004 – Jan 2005) whereby the dietary rules will be relaxed and there will be less 
contact with the researchers.  The second dietary intervention (commencing end-
January-February 2005) will follow the same protocol (as outlined above). 
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FURTHER INFORMATION 
To be included in the study it is essential that you remain in the study for the two diet periods
(12-week diet period followed by a 12-week period, and then a final 12-week dietary 
intervention period). This study is due to commence July/August 2004, with a 12-week break 
over the Christmas period. The second dietary period (12-weeks) commences at the end of 
January/February and will finish April /May 2005.  
 
In summary 
To participate in this study you need to be able to: 
9 Attend Curtin University for a medical examination, initial appointment with
the researchers, initial resting metabolic rate test (2 hours), body fat test
(Victoria Park) 
9 Be available to attend fortnightly meetings (~ 1 hour) with the researchers (at
Curtin University) 
9 Attend Curtin University in week 10 for a 7-hour test day (blood collection 
will be required) 
9 Maintain your present activity levels (do not increase or decrease) during the
study period 
9 Strictly follow the diet plan and consume dairy products provided by the 
researchers   
 
As a participant on this study you will be provided with the following benefits: 
☺ A nutritionally-balanced personal weight loss program that has been designed 
by an Accredited Practicing Dietitian (APD)   
☺ Motivation ! If you have previously tried to lose weight without success, this 
program will provide you with ongoing support (fortnightly visits with two
Accredited Practicing Dietitians, alternated with a fortnightly phone call) 
☺ On completion of the study you will be provided with a complete medical & 
health profile  
 blood test results will include; total cholesterol, HDL and LDL,
triglycerides, glucose, insulin, free fatty acids, apo B48.  
 additional your blood will be analysed for specific hormones
associated with fat and calcium metabolism (vitamin D status, 
ionised calcium, parathyroid hormone, leptin, glucagon-like-peptide)
 you will also receive your body composition results (weight, waist,
hip) and body fat levels (including fat mass, and fat free-mass as 
provided by Dual Energy X-ray Absorptiometry).  
☺ You will also receive a complete nutrition & metabolic-testing profile
outlining energy expenditure, fat and carbohydrate oxidation (usage), and
further advice on appropriate food choices – this information can be used to 
help you achieve further weight loss or weight maintenance once the study is
complete.     
☺ The opportunity to lose weight safely & effectively under the guidance of a
medically qualified doctor and Accredited Practicing Dietitians.  
 
* Unfortunately medical, health and nutritional profiles will not be available to subjects not completing
the whole study.   
  
We assure you confidentiality of information collected as part of this study.  Participation is
purely voluntary and you may withdraw at any point in time. 
 
If you have any further queries, please do not hesitate to contact: 
 
Ms Nikki Cummings BSc, Grad Dip Diet  Dr Mario Soares  MBBS, PhD, 
RNutr 
 9266 2817 or 0412 705 355              9266 3220
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Project Title: The Potential Role for Dairy Calcium & Weight Loss   
CONSENT FORM 
 
I,__________________________________________________________ 
Hereby consent to be a volunteer for the above-mentioned study.  I understand that as part of 
the study, I will allow myself to be screened for suitability as a volunteer.  
 
I have read the patient information sheet and have satisfied myself that this is a safe
technique.  
 
I consent to the following measures: 
1. To attend for a medical examination, including an Electrocardiogram 
2. I agree to have a blood sample taken a part of the screening process to check for vitamin
D and thyroid function.   
3. To have my oxygen and carbon dioxide measured using the Indirect Calorimetry method 
4. To undergo blood collection on 4 separate visits. On visit 1,6 and 9 only 15ml of blood 
with be collected. During visit 7, 90 ml (4 ½ tablespoons) of blood will be taken.   
5. To have a total body scan by DEXA; I understand that this procedure involves a very
small amount of radiation. This test will be undertaken 12 weeks apart (on 4 occasions). 
6. To collect a 24-hour urine sample on 4 separate days. 
  
I consent to the following procedures:  
1. I agree to complete a 3-day food diary and 3-day activity chart on 6 occasions. 
2. I agree to follow the dietary protocol as administered by the chief researcher 
3. I agree to consume the dairy products provided by the researchers. 
4. I am able to attend all appointments as outlined in the protocol attached.   
 I fully understand all of the potential risks of these procedures as explained to me.  I also 
understand that my participation is purely voluntary and that signing this form DOES NOT
prevent me from withdrawing from the study at any time. I have been assured that
confidentiality will be maintained at all stages throughout the study. 
 
Signature:___________________________________  Date:__________ 
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Appendix  H. Food intake recording sheets (sample and blank)   
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Appendix  I. Example of completed activity recording sheet 
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Appendix  J:  Correlations between weight loss and confounders (SPSS for 
Windows (Version 11, SPSS Inc.  USA) statistical software package   
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